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ABSTRACT 
Marine environments were investigated and actinomycetes were isolated on selective media. Thirty-four (34) actinomycete 
strains were isolated and identified: 21 Micromonospora strains, 10 Streptomyces strains, and 3 Pseudonocardia strains. A 
polyphasic approach was employed to determine the novelty of the isolates. Potentially, all 21 Micromonospora strains are 
novel, as revealed by an original identification scheme developed to assess quickly and easily the novelty of newly isolated 
environmental Micromonospora strains. Standardized media for testing physiological characters of Micromonospora strains 
were developed, and additional physiological characteristics of 15 of the validly published members of the genus 
Micromonospora are described. Furthermore, 14 of the 15 validly published Micromonospora species, and 20 of the 21 
environmental Micromonospora isolates grew under anaerobic conditions. Eight (8) new Micromonospora species are 
proposed: 'Micromonospora aquatica' strain MMS5T, 'Micromonospora arenincolae' strain MMSrr, 'Micromonospora cinerea' 
strain MMS3T, 'Micromonospora grateloupicolae' strain R2IlT, 'Micromonospora hermanusense' strain MMS6T, 
'Micromonospora lacunae' strain MMS4T, 'Micromonospora stanfordense' strain MMS1T, and 'Micromonospora terrae' strain 
MMS-OAT At least 7 Streptomyces strains are novel, on the basis of their morphological and physiological characters. A new 
Streptomyces species is proposed: 'Streptomyces noordhoekensis' strain BAM4T. The antibiotic biosynthetic capability of the 
strains was assessed by PCR targeted amplification of antibiotic biosynthetic and resistance genes. Five sets of PCR 
primers (oxy8, ARO-PKS, ANSA, grm, fmr) were used to detect genes involved in the biosynthesis of, or resistance to, 
various antibiotic types. An aminoglycoside antibiotic susceptibility plate assay and the grm and fmr peR primers revealed 
the presence of aminoglycoside resistance genes in the genome of Micromonospora strains and suggested that these 
strains are capable of synthesizing aminoglycoside-type antibiotics. The antibiotics produced by 5 Micromonospora strains 
were investigated: 2 antibiotic samples were partially purified and their physicochemical properties determined. The 
antimycobacterial activity of strains MMS2 and MMS7 shows great promise. 
III 
Un
ive
r i
ty
of 
Ca
pe
 To
wn
Outline 
Acknowledgements 
Abbreviations ii 
Abstract iii 
Chapter 1: General Introduction 
1.1 Background: Actinomycetes, Antibiotics, and Unexplored Niches 
1.2 Tuberculosis, a Heavy Burden 
1.3 The Aims of This Study 
1.4 References 
Chapter 2: Micromonospora Identification and Systematics 
2.1 Introduction: The Micromonospora Identification Key 
2.2 Materials and Methods 
2.2.1 Strains Used in This Study 
5 
6 
8 
9 
10 
12 
13 
14 
14 
2.2.2 Physiological Testing and Media Used Specifically for the Micromonospora Identification Key 14 
2.2.3 Other Physiological Tests, Morphological Observations, and Anaerobic Growth Studies 15 
2.3 Results and Discussion 16 
2.3.1 The Identification Key 16 
2.3.2 Additional Characteristics of the Validly Published Micromonospora Species 20 
(i) Micromonospora chalcea 
(ii) Micromonospora endolithica 
(iii) Micromonospora inositola 
(iv) Micromonospora nigra 
(1/) Micromonospora pal/ida 
(vi) Micromonospora purpureochromogenes 
2.3.3 Anaerobic Studies on the Validly Published Micromonospora Species 
2.4 Conclusion 
2.5 References 
21 
21 
21 
21 
21 
22 
25 
27 
27 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Chapter 3: Isolation, Enumeration, and Systematics of Actinomycete Strains 29 
3.1 Introduction: This Study 31 
3.1.1 The Hermanus Lagoon: A Dynamic Estuarine Environment 31 
3.1.2 Isolation Media and Selective Inhibitors 33 
3.1.1 The Aim of This Study 33 
3.2 Materials and Methods 33 
3.2.1 Sampling 33 
3.2.2 Sample Treatment, Isolation Media, and Selective Inhibitors 34 
3.2.3 Morphological Observations, Physiological Tests, Cryo Electron Microscopy, and Anaerobic Growth Studies 34 
3.2.4 Chemotaxonomic Observations 36 
3.2.5 peR Amplification and DNA Sequencing 36 
3.2.6 Rapid Molecular Identification: Amplified Ribosomal DNA Restriction Analysis (ARDRA) 36 
3.2.7 Phylogenetic Analysis 36 
3.2.8 Strains Used in This Study 36 
3.3 Results and Discussion 36 
3.3.1 Isolation and Enumeration 37 
3.3.2 Application: Using the Identification Key 37 
3.3.3 Anaerobic Studies on Environmental Micromonospora Strains 40 
3.3.4 The Group A Micromonospora Strains: MMS-1 to -7, MMS-DA, MLR, and R2Il 42 
(1) 'Micromonospora stanfordense' strain MMS1 T 44 
(2) 'Micromonospora cinerea' strain MMS3T 46 
(3) 'Micromonospora lacunae' strain MMS4T 46 
(4) 'Micromonospora hermanusense' strain MMS6T 47 
(5) 'Micromonospora aquatica' strain MMS5T 47 
(6) 'Micromonospora areninco/ae' strain MMS7T 47 
(7) 'Micromonospora grate/oupicolae' strain R2/l T 47 
(8) 'Micromonospora terrae' strain MMS-DAT 49 
(9) Micromonospora sp. strain MMS2 50 
(10) Micromonospora sp. strain MLR 51 
3.3.5 Group B: Micromonospora Strains MMS-8 to -12 and MMS-14 to -19 52 
(il Micromonospora sp. strain MMS10 54 
(ii) Micromonospora sp. strain MMS12 54 
(iii) Micromonospora sp. strain MMS14 55 
(iv) Micromonospora sp. strain MMS17 55 
3.3.6 The 7 Streptomycetes 55 
(1) 'Streptomyces noordhoekensis' strain BAM4T 58 
(2) Streptomyces sp. strain HMS88 58 
(3) Streptomyces sp. strain BAM7 59 
(4) Streptomyces sp. strain PB 61 
(5) Streptomyces sp. strain BAM1 61 
2 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
(6) Streptomyces sp. strain BAM3 
(7) Streptomyces sp, strain SVM65 
3,3.7 Six Other Strains of Interest: 3 Streptomyces and 3 Pseudonoc8rdi8 Strains 
3.4 Conclusion 
3.5 References 
Chapter 4: Micromonospora Antibiotic Biosynthetic Capability 
4.1 Introduction 
4.1.1 Micromonospora Antibiotic Classes in Brief 
4.1.2 Aminoglycoside Antibiotic Biosynthesis and Resistance Genes 
4.1,3 This Study 
4.2 Materials and Methods 
4.2.1 Phylogenetic Analysis 
4.2.2 DNA Extraction 
4.2.3 PCR Amplification and Agarose Gel Electrophoresis 
4.2.4 Aminoglycoside Antibiotic Susceptibility Assay on Solid Agar Media 
4.2.5 Strains Used in This Study 
4.3 Results and Discussion 
4.3.1 Phylogenetic AnalysiS 
4.3.2 Selective Amplification of Antibiotic Biosynthetic and Resistance Genes by PCR 
4.3.3 Aminoglycoside Antibiotic Susceptibility Plate Assay 
4.4 Conclusion 
4.5 References 
Chapter 5: Antibiotic Isolation and Partial Purification 
5.1 Introduction 
5.1.1 Antibiotic Classes from Micromonospora 
(i) Aminoglycosides 
Oi) Macrolides 
(iii) Ansamysins 
(iv) Eveminomicins 
(v) Other Micromonospora Antibiotics 
5.1.2 This Study 
5.2 Materials and Methods 
5.2.1 Solid Media Overlays: The Sloppy-agar Method 
5.2.2 Solvents Used in This Study 
70 
71 
71 
76 
77 
77 
77 
77 
77 
80 
80 
80 
80 
83 
85 
88 
89 
5.2.3 Fermentation and Methods for Obtaining Antibiotic Samples Produced by the Micromonospora Strains 
5.2,4 The Micromonospora Macrolide Protocol 
5.2.5 Thin Layer Chromatography 
3 
61 
62 
65 
67 
67 
91 
92 
92 
92 
93 
93 
94 
94 
94 
95 
95 
95 
95 
96 
97 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
5.2.6 Bioautography for the Visualization of Antibiotically Active Spots 
5.2.7 Physicochemical Properties and Antibacterial Spectrum 
5.2,8 The Modified Eli lilly Procedure to Test for Antimicrobial Activity 
5.3 Results and Discussion 
5.3,1 Solid Media Overlays 
5.3.2 Initial Fermentation Experiments 
5.3.3 The Micromonospora Macrolide Protocol 
5.3.4 Physicochemical Properties and Antibacterial Spectra of Antibiotic Samples No.2 and NO.3 
5.3,5 Antibiotics from Strains MMS3, MMS4, and MMS-DA 
5.4 Conclusion 
5,5 References 
Chapter 6: Conclusion and Future Work 111 
4 
97 
97 
98 
98 
98 
100 
100 
103 
106 
108 
109 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
apt r 
G I u 
1.1 Background: Actinomycetes, Antibiotics, and Unexplored 
Niches 6 
1.2 Tuberculosis, a Heavy Burden 8 
1.3 The Aims of This Study 9 
1.4 References 10 
5 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Chapter 1 
General Introduction 
1.1 Background: Actlnomycetes, Antibiotics, and Unexplored Niches 
Actinomycetes are Gram-positive aerobes that are widely distributed and abundant in soil and are responsible in part for the 
earthy odour of soil. Streptomyces species make up approximately 95% of all actinomycetes found in soil (11). 
Consequently, they are the easiest actinomycetes to isolate and have thus been extensively studied, resulting in 
streptomycetes being the best characterised of all actinomycetes (4). Many strains produce one or more antibiotics (14). 
Colonies are initially relatively smooth surfaced but later develop a weft of aerial mycelium that may appear floccose, 
granular, powdery, or velvety (14). A wide variety of pigments are produced that are responsible for the colour of the 
vegetative and aerial mycelia. On occasion, coloured diffusible pigments are produced. 
Streptomycetes do not have specific growth requirements (they are nutritionally versatile) and show tolerance of 
potentially inhibitory media additives (14). Many competing bacteria and fungi grow or spread more rapidly than 
actinomycetes on isolation plates. Thus, most selective isolation procedures have been designed as much to inhibit growth 
of competing microbes as to stimUlate development of actinomycetes (14). Whatever the composition of the isolation 
medium, it is usually necessary to increase its efficiency by adding selective inhibitors. 
Morphology has played a major role in distinguishing members of the genus Streptomyces from other spore-forming 
actinomycetes and in their characterization and identification to the species level. The life cycle of a streptomycete offers 
three features for characterization, namely, substrate mycelium, aerial mycelium bearing chains of arthrospores, and the 
arthrospores themselves (14). The latter two features provide the most important systematic information. 
There are three recognized categories of spore chain morphology (14): RectifJexibiles (straight to flexuous), Retinaculiaperti 
(hooks, loops or spirals with one to two turns), and Spirales (spirals possessing many tight turns). 
Spore surface ornamentation can be described as smooth, spiny, hairy, warty, or rugose (wrinkled) (14). The ornaments are 
borne on the spore sheath. Scanning electron microscopy is used to confirm the spore chain morphology (observed by light 
microscopy) and to determine the spore surface ornamentation. 
Streptomycetes are also macroscopically characterized according to the colour of the spore mass, pigmentation of the 
substrate mycelium, and diffusible pigments. The spore mass can be assigned to one of 7 colour series: blue, grey, green, 
red, violet, white, or yellow (14). The colour of the substrate mycelium and of the diffusible pigments are allocated to one of 5 
categories: yellOW-brown (including strains lacking distinctive pigmentation), red-orange, green, blue, or violet (14). The 
distribution of strains according to these characteristics is unequal and thus striking colours are considered to be of great 
value as a large proportion of strains are placed in the grey series. Colour determinations are based on standardized media 
and methodology. 
In order to propose that an isolate represents a new species, its morphological and physiological characteristics should not 
match with the features of any known streptomycete species included in Volume 4 of Bergey's Manual of Systematic 
Bacteriology (14) and those subsequently described in the literature. 
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The genus Micromonospora has few distinctive morphological characteristics. The mycelium of almost all Micromonospora 
species is coloured orange, turning black upon sporulation. The spore mass becomes mucoid with age. Scanning electron 
microscopy has revealed that the spores of almost all Micromonospora species are blunt spiny surfaced (10) and unlike the 
genus Streptomyces, the spore surface ornamentation is not a useful diagnostic aid for differentiation of Micromonospora 
species. 
Actinomycetes produce antibiotics that are antagonistic to other soil microbes (9). This assumes that antibiotics are 
produced in normal untreated soils in the same way as they are produced in special laboratory media. Competition certainly 
occurs between organisms in soil, but it is difficult to demonstrate that actinomycetes produce in untreated soils antibiotics at 
levels high enough to inhibit other soil organisms (9). 
It is because of their ability to produce antibiotics and because of their great potential for producing new and useful 
antibiotics that actinomycetes are perhaps best known. Except for the few antibiotics produced by fungi (most notably, 
penicillin and cephalosporin) and non-actinomycete bacteria, all other antibiotics that have widespread, useful medical 
applications are synthesized by actinomycetes (9). By 1970, approximately 85% of all antibiotics discovered in the U.S.A. 
and Japan were produced by actinomycetes. The most commonly reported new antibiotics were those with antibacterial 
activity, followed by antifungal agents, antitumour, antiviral, and antiprotozoal antibiotics (9). 
The genus Streptomyces has been the focus of a long-standing debate with regard to their role in marine environments: it is 
not clear whether streptomycete isolates are an indigenous component of the marine bacterial community or whether they 
germinate from spores which washed in from terrestrial habitats (8, 15, 20). The greater abundance of culturable 
streptomycetes in marine environments located adjacent to terrestrial habitats has been taken as evidence for the 
germination of spores of terrestrial origin during isolation (8). Moran et al. (15) suggested that the higher concentration of 
culturable streptomycetes in coastal environments than in deepwater marine environments might be explained by the high 
concentrations of organic detritus, much of which is derived from vascular plants, which characterize many shallow marine 
environments. T akizawa et al. (20) showed that the requirement of seawater for growth of actinoplanete isolates indicates 
that autochthonous actinomycete populations exist. This is also suggested by the isolation of actinomycetes from deep 
oceanic sediments distant to land (8). 
Moran at al. (15) used a 16S rRNA genus-specific probe to determine whether Streptomyces populations are an indigenous 
component of marine sediment bacterial communities. Their method allowed for differentiation between spore- and 
mycelium-derived DNA. The genus-specific probe indicated that Streptomyces spores were not the source of the 
hybridisation signal, thus indicating that streptomycete isolates found in marine sediment are indigenous to that marine 
environment. Their studies portrayed a relatively stable bacterial community in which one genus consistently accounts for a 
predictable fraction of the community rRNA over an entire annual cycle, contrasting with the view of distinct seasonality in 
species composition. Sediment communities might be expected to be more stable through time because of the constancy of 
the sediment organic matrix and the regular availability of natural polymers as substrates ( 15). To be cautious in 
interpretation of results, the possibility of wash-in from surrounding terrestrial habitats must always be considered. 
Rare genera of actinomycetes have gained increasing relevance as potential producers of new antibiotics (12). The 
development of new methodologies with which to isolate rare actinomycetes is of great importance to extend our 
understanding of their ecology, taxonomy and bioactivity (17). It has been shown that when selective isolation methods are 
developed and extensively applied, some genera, such as Actinomadura, Actinoplanes, Micromonospora, and 
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Microtetraspora are not rare at all and can be recovered from many soil samples (8, 12). The current focus is on the isolation 
of members of such genera, given their potentially promising chemical diversity. 
Actinomycetes are routinely screened for new bioactive substances as they have provided many bioactive compounds of 
great value, including many of medical importance. Presently, there is a severe lack of discovery of novel bioactive 
compounds, coupled with the growing problem of bacterial resistance to antibiotics used to treat medically important 
diseases. In a world that expects effective antibiotics available for every disease, the rapid spread of antibiotic resistant 
bacteria and the threat of bioterrorism are of grave concern (1, 21). Furthermore, inattentiveness to the importance of the 
need for new antibiotics to treat bacterial infections and the departure of many large pharmaceutical companies from the field 
of antibiotic development has added to the problem (18, 21). Actinomycetes are abundant in terrestrial soils, a source of the 
majority of isolates shown to provide bioactive compounds (20). Expanding the source of actinomycetes by carrying out 
ecological assessments of environments other than terrestrial soils, and investigating the rare, nonStreptomYcete genera of 
actinomycetes as sources of novel compounds, may aid in the discovery of novel bioactive compounds, and help in 
addressing the problem of bacterial resistance (20). The marine environment is a bountiful resource for the isolation of less 
exploited microorganisms; marine-derived microorganisms exist in untapped habitats with unique characteristics. The 
potential contribution of marine sources to the discovery of novel bioactive compounds has been recognized and has 
prompted the search for new antibiotic-producing microorganisms from marine habitats including marine sediments and 
organisms (see 8, 15, 19,20). 
The isolation of actinomycin from Streptomyces antibioticus in 1940 stimulated extensive screening for bioactive 
compounds, with proof of novelty of antibiotics frequently resting on the description of the producer as a new species (14, 
22). Furthermore, different species and different individuals within a species are distinguished by variations among their 
organic molecules (3). Hence, screening for the production of new metabolites with new isolates andlor new test methods is 
the only way to obtain completely new classes of substances (5). 
1.2 Tuberculosis, a Heavy Burden 
The emergence of multidrug-resistant (MDR) bacteria is a phenomenon of concern to the clinician and the pharmaceutical 
industry, as it is the major cause of failure in the treatment of infectious diseases (6). In the 1980s, pharmaceutical 
manufacturers believed that infectious diseases were essentially conquered (13). Consequently, the search for additional 
antibiotics was no longer a priority, and if one drug failed, another in the arsenal would usually work. Now we are faCing the 
threat of increasing bacterial resistance to many antibiotics that once readily cured bacterial diseases. Researchers are 
searching for novel antibiotics again, however, the few that may reach the market are usually structurally similar to existing 
antibiotics and could easily encounter bacteria that already have resistance to them (13). 
According to a recent report compiled by the World Health Organization (WHO; 24), the total number of new cases of 
tuberculosis (TB) worldwide in 2002 had risen to approximately 9 million (7). A key driving force of this increase is synergy 
with the HIV epidemic, and the emergence of strains of Mycobacterium tuberculosis (MDR-TB) resistant to all of the first-line 
drugs in use (7). New drugs are urgently needed with activity against MDR-TB and latent TB, and which would help shorten 
the duration of treatment from the current 6 to 8 months, to two months or less (7). 
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Fig. 1.1. TB infection statistics for the greater Cape Town area, Westem Cape, South Africa (2). 
Drug resistance poses a serious threat to tuberculosis control programmes in the Western Cape province of South Africa, 
contributing to the increasing tuberculosis epidemic in the region (23). Tuberculosis (TB) accounts for more than 80% of all 
communicable diseases notified in South Africa (23). The Western Cape has the ninth highest incidence of TB in the world 
(2, 24), and in some areas, at least 1 person in every 3 households has had an infectious case of TB in the last 10 years 
(Fig. 1.1) (2). Cape Town's most recent TB control report indicates that TB is one of the major contributors to the city's 
burden of disease, with a 66% increase in the number of reported TB cases over the past 6 years (2). An increase in the 
number of drug-resistant TB cases (especially MDR-TB cases) has been observed both locally and intemationally due to 
ineffective treatment, patient non-compliance, and to the spread of HIV. 
The advent of the HIV epidemic in sub-Saharan Africa has seen not only a dramatic increase in the incidence of TB cases 
in the region, but also a dramatic increase in the number of people dying from what is a curable disease. The HIV epidemic 
has fuelled the TB epidemic in the region. In the Western Cape, TB is responsible for a third of all deaths in HIV-infected 
people (2). In the poorer, developing nations, 95% of TB cases occur, 98% of TB deaths occur, and additionally, sub-
Saharan Africa is home to over 67% of the HIV-infected people in the world (16). In 1999 it was estimated that 68% of the 
people worldwide co-infected with HIV and M. tuberculosis are living in this region (16). Furthermore, these co-infected 
people have at least a 30% lifetime risk of developing active TB (16). HIV-compromised immunity increases the susceptibility 
of individuals to develop TB either from a reactivation of latent infection or a rapid progression of recent infection by the 
opportunistic M. tuberculosis (16). Insidiously, the host's immune response to M. tuberculosis enhances HIV replication and 
might accelerate the natural progression of HIV infection (16). Although education and prevention do help to combat TB, 
novel antitubercular antibiotics are required to combat the threat posed by MDR M. tuberculosis strains. 
1.3 The Aims of This Study 
Selective isolation and enumeration techniques were used to isolate strains of the actinomycete genus Micromonospora 
from unexplored marine habitats, and these strains were characterized. In order to make identification to the species level a 
quicker process, a simple identification system for Micromonospora species needed to be created. The secondary metabolite 
capabilities of the strains were investigated, not only by investigating the physicochemical properties of the antibiotics 
produced during fermentation, but also by investigating the biosynthetic capability of the strains at the genetic level. 
9 
Un
ive
rsi
y o
f C
ap
e T
ow
n
Importantly. antibiotics from newly discovered strains were tested for antimycobacterial activity, in the search for novel anti-
TB drugs. 
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Chapter 2 
Micromonospora Identification and Systematics 
2.1 Introduction: The Micromonospora Identification Key 
Modem bacterial systematics makes use of a polyphasic approach towards taxonomic determinations. This means that an 
isolate's phYSiological characters, further descriptive information (such as chemotaxonomy and morphological features by 
scanning electron microscopy, in the case of actinomycetes), and 16S rONA sequence analysis all contribute to determining 
the novelty of an isolate. 
Scanning electron microscopy has revealed that the spores of almost all Micromonospora species, including those having 
been described as having a smooth spore surface, are blunt spiny surfaced (7). It is the size of the blunt spiny projections 
that shows variation. Unlike the genus Streptomyces, the spore surface ornamentation is not a useful diagnostic aid for 
differentiation of Micromonospora species. 
Chemotaxonomy, at most, allows one to identify bacteria to the genus level and thus is of little use for differentiating 
Micromonospora species from each other. The cell wall type, whole cell sugar pattern, phospholipid type, fatty acid methyl 
esters, and the absence of mycolic acids, are similar for all Micromonospora species. Perhaps the only useful 
chemotaxonomic diagnostic aid, are the major menaquinones. Menaquinones with 9, 10, or 12 isoprene units are found in 
Micromonospora strains. The subspecies, Micromonospora echinospora subsp. pallida is the only Micromonospora strain 
possessing major menaquinones with 12 isoprene units, and thus it was suggested that this subspecies be transferred from 
M. echinospora to new species status (7). However, it was as a result of DNA-DNA hybridisation experiments (6) that M. 
echinospora subsp. pal/ida was elevated to species level, viz. M. pallida. 
Thus, if one were to disregard scanning electron microscopy and chemotaxonomy in determining the novelty of an isolate, 
what remains is 16S rONA sequence analysis. However, if an isolate's 16S rONA sequence shows greater than 97.5% 
similarity to another strain, it is recommended that DNA-DNA reassociation (hybridisation) experiments be performed to 
determine whether the strains belong to the same species (12). Strains that have a DNA relatedness of 70% or more by 
DNA-DNA hybridisation are considered to belong to the same species (14). Few laboratories are set up for DNA-DNA 
hybridisation experiments, and having the experiments performed by an outside facility is very costly. Furthermore, when 
DNA-DNA hybridisation experiments are carried out, two strains sharing 99% 16S rDNA sequence homology often do not 
show more than 60% DNA similarity, and thus they are not related at the species level (12). 
When screening environmental samples for new actinomycete species, the novelty of an isolate can be suggested by the 
sequencing of the isolate's 16S rONA (a sequence of more than 1450 nucleotides is sufficient, as it represents more that 
90% of the length of 16S rRNA genes). However, even a short, partial16S rONA sequence is enough to inform a researcher 
of the genus to which an isolate belongs. For actinomycete researchers in developing countries, such as South Africa, there 
are difficulties, such as limited financial and technological resources. Due to the number of potentially novel actinomycete 
isolates obtained from environmental samples, it would be extremely costly to obtain such sequences for all the isolates. The 
return on effort could be dismal, if it is found that strains of existing species have been re-isolated. 
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A less expensive option is to examine an isolate's physiological characters. The genus Streptomyces has 139 
recommended characters that could be examined (8). The genus Micromonospora could also be examined to such an 
extent. However, it is unnecessary to use so many characters to determine the novelty of environmental Micromonospore 
isolates. A few discerning characters can be used. 
Using phYSiological testing to discern quickly between species may be the answer to the problem. Having a defined set of 
physiological characters to examine would be inexpensive, easy to perform, and could allow one to differentiate between 
Micromonospora isolates. It would be important that for these phYSiological characters to be tested, the media used be 
standardized and that every strain be tested on the speCific standardized medium for a specific physiological character. 
Furthermore, the selected tests should allow one to determine whether a newly isolated strain is likely to be a strain of a 
known species, or a probable new species. 
A dichotomous key for the identification of Micromonospora strains was developed to allow one to determine easily and 
inexpensively the novelty of a Micromonospora isolate in a period of 21 days from the time of inoculation of the test media. 
Due to the lack of attention attributed to the genus Micromonospora, standardized media were carefully chosen, or 
developed, for each physiological test to be performed for the proposed identification key. 
2.2 Materials and Methods 
2.2.1 Strains Used in This Study 
Micromonospora aurantiaca NRRL B-16091 T, Micromonospora carbonacea subsp. carbonacea NRRL 29721, 
Micromonospora cha/cea subsp. chalcea NRRL B-2344T, Micromonospora echinospora subsp. echinospora NRRL 2985T, 
Micromonospora halophytica subsp. halophytica NRRL 2998T, Micromonospora inositola NRRL B-160951, Micromonospora 
nigra NRRL 3097T, Micromonospora o/ivasterospora NRRL 8178T, Micromonospora echinospora subsp. pallida NRRL 
2996T, Micromonospora purpureochromogenes NRRL 8-16094T, and Micromonospora rosaria NRRl 3718T were kindly 
provided by Dr David P. labeda, curator of the Actinobacterial Culture Collection at the U.S. Department of Agriculture 
Agricultural Research Service, Peoria, Illinois, United States of America. Micromonospora chersina DSM 44151T, 
Micromonospora coem/aa DSM 431431, and Micromonospora matsumotoanse DSM 44100T were purchased from the 
DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH. Braunschweig. Germany. Micromonospora 
endolithica strain AA-459T was kindly provided by Prof. emer. Dr. Peter Hirsch, Institut fUr Allgemeine Mikrobiologie, 
Christian-Albrechts-Universitat Kiel, Germany. Micromonospora auratinigra could not be obtained and thus information from 
the publication describing this species was used (13). 
2.2.2 Physiological Testing and Media Used Specifically for the Micromonospora Identification Key (Table 2.1) 
All cultures were incubated at 28°C 30°C (unless otherwise stated) for 3 weeks, and were examined at 7, 14, and 21 
days. Maximum sodium chloride tolerance (% w/v) was performed as recommended by locci (8) on Bennett's agar (BM) (1), 
containing (gIl): glucose (10.0), casitone (Difco; 2.0), yeast extract (1.0). beef extract (1.0), agar (20.0), pH 7.0, and the 
required amount of sodium chloride. Growth at 37°C was determined on Bennett's agar as recommended by Locci (8). The 
production of diffusible pigments were tested on ISP Medium No. 2 (11), Bennett's-glycerol agar (10 gIL glucose was 
replaced with 10 gIL glycerol), and on modified 172F agar, containing (giL): glucose (10.0), yeast extract (5.0), starch (10.0), 
casitone (Difco; 5.0), MgS04·7H20 (2.5), CaS04·2H20 (2.0), agar (15.0), pH 7.2. The utilization of compounds as sole 
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carbon sources (1.0% wlv) was performed as recommended by Locci (8) and Shirling and Gottlieb (11). Growth on ISP 
Medium NO. 4 was determined according to the methods of Shirting and Gottlieb (11). 
Table 2.1. A list of selected physiological tests to be performed and the corresponding standardized media to be used for identification of 
Micromonospora strains. 
Standardized Media to be Used 
Physiological Characters to be Tested: (Abbreviations in parentheses): 
Maximum Sodium Chloride Tolerance (% w/v): 
1.5%,2.0%, 3.0%,4.0%,5.0%,6.0%, and 7.0%. Bennett's Agar (BM-Glucose) 
Growth at 37°C. 
Bennett's Agar, with glucose 
Production of Diffusible Pigments and, 
replaced by glycerol (BM-
Glycerol); 
Diagnostic Mycelial Pigment Colour. 
ISP Medium No. 2 Agar (YEME); 
Modified 172F Agar (m172F). 
Growth and Colour of Mycelia. ISP Medium No.4 Agar (lSP4) 
Utilization of Glycerol (1.0% w/v) and myo-Inositol (1.0% w/v) as Sale Carbon Sources 
[a negative control containing no carbon source, and a positive control, glucose (1.0% ISP Medium NO.9 Agar (lSPS) 
wlv) must be included]. 
2.2.3 Other Physiological Tests, Morphological Observations, and Anaerobic Growth Studies 
International Streptomyces Project (IS?) media were prepared according to the methods of Shirling and Gottlieb (11). 
Controls were used for each test: positive controls, negative controls and/or un inoculated controls. Micromonospora 
morphological characteristics were determined on YEME, Bennett's agar (1), and modified 172F agar. Production of 
diffusible pigments by Micromonospora strains was tested on YEME, Bennett's agar, modified 172F agar, and glycerol-
asparagine agar (/SP Medium No.5). The pH sensitivity of both the substrate mycelium and diffusible pigments was 
assessed by noting any colour changes induced by the addition of 50 mM HCI or 50 mM NaOH. 
Physiological characteristics were determined as recommended by Locci (8). For Micromonospora strains, growth was 
determined on inorganic salts-starch agar (lSP Medium No. 4), Middlebrook 7H9 agar [(Difco Laboratories, Detroit, Michigan) 
AD supplement was not added, but glucose was added to a final concentration of 10 mM], Czapek-solution agar (1), and on 
potato slice and potato slice plus CaC03. Potatoes were bought from a local supermarket and sliced. Half of the sliced 
potatoes were autoclaved in a container, and the other half were autoclaved in another container after the addition of CaC03 
10 the slices. 
Growth at 4°C, 37°C, 45°C, at pH 4.3, and in the presence of 0.1% 2-phenylethanol was determined as recommended by 
Locci (8) and was lested on Bennett's agar. Degradation of adenine, allantoin, casein, cellulose, gelatin, guanine, 
hypoxanthine, starch, L-Iyrosine, xanthine, and xylan was determined as recommended by Locci (8). Tween 80 degradation 
was determined according to Sierra (10), and degradation of urea was determined according to Gordon et al. (3). Melanin 
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pigment production was determined on peptone-yeast extract-iron agar (/SP Medium No.6) and on tyrosine agar (/SP 
Medium No.7). Hydrolysis of aesculin, arbutin, hippurate, and pectin, H2S production, and nitrate reduction were determined 
as recommended by locci (8). 
Antibiotic resistance was determined by incorporation of the antibiotics into Bennett's agar plates (1). Sole nitrogen sources 
were tested at a concentration of 0.1% (w/v), as recommended by Locei (8). 
All tests were carried out at 28 - 30°C (except for testing growth at 4, 37 and 45°C). Micromonospora strains were 
incubated for 21 days (except for degradation of starch and gelatin, and nitrate reduction, which were incubated for 7 days 
and 14 days, respectively). 
Anaerobic growth of Micromonospora strains was tested on the following media: BM-Glycerol agar, modified 172F agar, 
YEME agar, and ISP Medium NO.9 with sucrose (1.0%) as the sole carbon source. A second set of plates of 8M-Glycerol 
agar and /SP Medium No. 9 containing sucrose were made with the addition of an indicator, bromocresol purple, as 
recommended by Gordon et a/. (3) to detect acid production. This indicator is purple above pH 5.5 and is yellow below pH 
5.5 (4). Plates were inoculated in duplicate: one set of plates was incubated under aerobic conditions at 37°C, while the 
other set was incubated under anaerobic conditions at 37°C in an anaerobic chamber (Forma Scientific, Model 1024) in an 
atmosphere of 5% H2, 10% C02, and 85% N2. An incubation temperature of 37°C was employed, as this was the incubator 
temperature in the anaerobic chamber. 
2.3 Results and Discussion 
2.3.1 The Identification Key 
The Identification Key is presented in Figure 2.1 and Tables 2.2 - 2.5. The Key is based on the 16 validly published 
members of the genus Micromonospora as at December 20, 2004 (2). 
Before using the Micromonospora Identification Key, strains must be identified as members of the genus. Environmental 
isolates were identified as strains of the genus Micromonospora on the basis of colony morphology and ARDRA (see 3.2.6). 
Maximum sodium chloride tolerance is a very important physiological characteristic of the genus Micromonospora as this is 
the character that most readily differentiates strains into groups. The diagnostic mycelial pigment colour, as well as diffusible 
pigment colour, are also very significant characters. Since the mycelial pigment colour, prior to sporulation, of the majority of 
Mieromonospora strains, is orange, a different mycelial pigment colour is very useful in distinguishing species. The 
diagnostic mycelial pigment colours of M. eoeru/ea, M. eehinospora, M. o/ivasterospora, and M. pallida, and the diffusible 
pigments of M. aurantiaca, M. earbonacea, M. chaleea, M. ha/ophytiea, M. olivasterospora, M. purpureochromogenes, and 
M. rosaria, are well-known by taxonomists as easily identifiable characters of these species. To date, M. inosito/a is the only 
Micromonospora species able to utilize inositol as a sole carbon source, and M. purpureochromogenes is the only species 
able to utilize glycerol as a sole carbon source. Thus, it was important that these Significant characters be included in the 
identification key. M. matsumotoense is the only species of the 16 members that does not sporulate. This is also a significant 
determinant and was included in the identification key. 
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VPM of the '2.0% 
Group': 
M. auratinigra 
VPM of the '1 .5% Group': 
M. chersina 
M. echinospora 
M. coerulea 
M. purpureochromogenes 
M. endolithica 
M. inositola 
M. matsumotoense 
VPM of the '3.0% 
Group': 
M. aurantiaca 
M. camonscea 
M. nigra 
M. olivasterospora 
M.pal/ida 
M. rosaria 
VPM ofthe '4.0% 
Group': 
M. chalcea 
M. halophytica 
Probable New 
Species 
Fig. 2.1. The crucial first step of the identification key is to detennine an isolate's maximum sodium chloride tolerance on BM-Glucose. 
Illustrated in this scheme is to which 'maximum sodium chloride tolerance group', the validly published members (VPM) of 
Micromonospora belong. 
Table 2.2. Dichotomous key for the identification of Micromonospora strains of the '1.5% NaCI Group'. 
2.1 Is the diagnostic mycelial pigment a purple colour on 8M-Glucose? 
(a) Yes 
(b) No 
Probably M. echinospor8. 
Go to 2.2. 
2.2 Produces a dark brown diffusible pigment on 8M-Glucose? 
(a) Yes Go to 2.3. 
(b) No Probable New Species. 
2.3 Is glycerol (1.0% w/v) utilized as a sole carbon source? 
(a) Yes 
(b) No 
Probably M. purpureochromogenes. 
Probable New Species. 
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Table 2.3. Dichotomous key for the identification of Micromonospora strains of the '2.0% NaCI Group'. 
3.1 Growth on ISP4? 
(a) Yes 
(b) No 
3.2 Is there an absence of sporulation? 
(a) Yes 
(b) No 
3.3 Is the diagnostic mycelial pigment a blue-black colour? 
(a) Yes 
(b) No 
Probably M. auratinigra. 
Go to 3.2. 
Probably M. matsumotoense. 
Go to 3.3. 
Probably M. eoeru/ea. 
Go to 3.4. 
3.4 Is mya-inositol (1.0% w/v) utilized as a sole carbon source? 
(a) Yes Probably M. inositola. 
(b) No Go to 3.5. 
3.5 Growth at 37°C? 
(a) Yes 
(b) No 
Probably M. endolithiea. 
Probably M. ehersina. 
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Table 2.4. Dichotomous key for the identification of Micromonospora strains of the '3.0% NaCI Group'. 
4.1 Produces a 
(a) Yes 
(b) No 
diffusible pigment on m172F? 
Probably M. Burantiaca. 
Go to 4.2. 
4.2 Produces a brown (but not reddish-brown) diffusible pigment on m172F? 
(a) Yes Probably M. carbonacea. 
(b) No Go to 4.3. 
4.3.Produces a wine-red diffusible pigment on m172F and YEME agars? 
(a) Yes Probably M. rosaria. 
(b) No Go to 4.4. 
4.4 Is the diagnostic mycelial pigment an olive-green colour on 8M-Glucose? 
(a) Yes Go to 4.5. 
(b) No Go to 4.6. 
4.5 Produces an olive-green diffusible pigment on 8M-Glucose and YEME agars? 
(a) Yes Probably M. olivasterospora. 
(b) No Probable New Species. 
4.6 Is the diagnostic mycelial pigment a pale whitelivory colour on 8M-Glucose? 
(a) Yes Probably M. pallida. 
(b) No Go to 4.7. 
4.7 Grows on ISP4 producing orange mycelia? 
(a) Yes 
(b) No 
Probably M. nigra. 
Probable New Species. 
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Table 2.5. Dichotomous key for the identification of Micromonospora strains of the '4.0% NaCl Group'. 
5.1 Produces a 1I1m~ diffusible pigment on m172F? 
(a) Yes 
(b) No 
Probably M. chalcea. 
Go to 5.2. 
5.2 Produces a reddish-brown diffusible pigment on m172F? 
(a) Yes Probably M. ha/ophytica. 
(b) No Probable New Species. 
2.3.2 Additional Characteristics of the Validly Published Mlcromonospora Species 
Tables 2.6 and 2.7 show the results of the tests performed on the validly published members of the genus Micromonospora. 
Many of the published descriptions do not fully examine the physiological characteristics of the species and thus many of the 
characteristics shown and discussed in this section have not been widely used in Micromonospora taxonomy. These tests, 
listed in Table 2.6, will aid in differentiating between species. The results of tests that have been previously used in taxonomy 
agree with published data. Maximum sodium chloride tolerance tests were performed three times and do not correlate with 
previously published values for all species as the media used to assess the sodium chloride tolerance varied between 
publications. In this study, standard media were used to assess the maximum sodium chloride tolerance and the production 
of diffusible pigments (see Table 2.1). 
It must be noted that potatoes are acidic and have a pH between 5.5 and 6.5 depending on the type of potato used (9). 
Calcium carbonate is added to neutralize the acidity. 
Micromonospora coem/ea is said to have a blue-green diagnostic mycelial pigment, however M. coem/ea DSM 43143T 
appeared blue-black on all media examined. 
The red diffusible pigment produced by M. paflida mentioned in Bergey's Manual of Systematic Bacteriology Volume 4, was 
only seen on /SP Medium NO.7 (the red pigment is not melanin, which is brown or black in colour). 
The brown-red pigment typically seen during tyrosine degradation was produced by M. aurantiaca, M. echinospora, and M. 
palJida. However, no pigment was produced by M. nigra, which strongly degraded tyrosine. 
The diffusible pigments and substrate mycelial pigments were tested for sensitivity to acid and base. The diffusible pigment 
and the substrate mycelium of M. ha/ophytica changed colour from reddish-brown to yellow on addition of 50 mM HCI and 50 
mM NaOH. The purple coloured substrate mycelium of M. echinospora changed to blue upon addition of NaOH and to pink 
upon addition of HCI. The olive-green substrate of M. olivasterospora (grown on Bennett's and modified 172F agars) 
changed to a light green with NaOH and to blue with HCI. The substrate mycelium of M. purpureochromogenes (grown on 
Bennett's agar) changed from brown to maroon upon addition of NaOH. On YEME agar, the wine-red diffusible pigment 
characteristic of M. rosaria changed colour to yellow upon addition of HCI. 
If one examines the published descriptions of the current 16 validly published members of the genus, only M. rosaria is said 
to have tufts or "blooms" of grey aerial mycelia (5). However, many strains were found to produce aerial mycelia, which 
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appeared in very visible tufts close to the periphery of the growing strains. This was more closely examined with a light 
microscope. The agar medium, modified 172F, appears to be a very good medium for examining the morphological features 
of the Micromonospora species and seemed to promote the appearance of aerial mycelia. Thus on m172F agar, M. rosaria 
produces grey-white aerial mycelia, and M. nigra and M. carbonacea produce grey aerial mycelia. 
Some Micromonospora species were tested on other media not listed in the tables. The additional taxonomic features are: 
(i) Micromonospora chl/cea 
No diffusible pigment is produced on ISP Medium No.5, nor is melanin produced on ISP Media No. 6 and NO.7. M. 
cha/cea grows well on Middlebrook 7H9 agar and at pH 4.3 but does not grow in the presence of 0.1 % 2-phenylethanol. 
Pectin is weakly hydrolysed and hippurate is not hydrolysed. Gelatin and Tween 80 are degraded, while adenine, atlantoin, 
cellulose, guanine, hypoxanthine, urea, and xanthine are not. Xylan is weakly degraded and casein is very strongly 
degraded. 
(ii) Micromonospora endolithica 
M. endolithic8 was isolated from the Antarctic, thus testing was carried out at 4, 20, 30 and 37°C to find an optimal 
temperature for growth. Interestingly, the species does not grow on Bennett's agar, modified 172F or YEME agars at 4°C. 
Moderate growth was observed at 20°C, excellent growth was observed at 30 and 37°C, and no growth was observed at 
45°C on BM-Glucose agar. The maximum sodium chloride tolerance is 2.0% (tested at 20 and 30°G). The species does not 
grow on ISP Medium No.4 and does not produce diffusible pigments on BM-Glucose, YEME or m172F agars. 
(iii) Micromonospora inositola 
A diffusible pigment is not produced on ISP Medium No.5, nor is melanin produced on ISP Media No.6 and NO.7. The 
species grows well on Middlebrook 7H9 agar, but not at pH 4.3 or in the presence of 0.1 % 2-phenylethanol. Hippurate and 
pectin are not hydrolysed. Casein, gelatin, and Tween 80 are degraded, but adenine, allantoin, cellulose, guanine, 
hypoxanthine, urea, xanthine, and xylan are not. 
(iv) Micromonospora nigra 
M. nigra does not produce a diffusible pigment on ISP Medium NO.5. The species does not grow at pH 4.3, and grows very 
weakly on Middlebrook 7H9 agar. Melanin is not produced on ISP Media No. 6 and NO.7. Starch is hydrolysed, gelatin is 
degraded but cellulose is not. 
(v) Micromonospora pallida 
M. pal/ida does not produce a diffusible pigment on ISP Medium No.5, nor does the species produce melanin on ISP Media 
No. 6 and NO.7. However, a red pigment is produced on ISP Medium NO.7. The species does not grow at pH 4.3, and 
grows very weakly on Middlebrook 7H9 agar. Starch is hydrolysed, gelatin is degraded but cellulose is not. 
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(vi) Micromonospora purpureochromogenas 
No diffusible pigment is produced on ISP Medium No.5, and melanin is not produced on ISP Media NO.6 and NO.7. The 
species grows weakly on Middlebrook 7H9 agar, and does not grow at pH 4.3 or in the presence of 0.1% 2-phenylethanol. 
Hippurate and pectin are not hydrolysed. Casein, gelatin, and Tween 80 are degraded, but adenine, allantoin, cellulose, 
guanine, hypoxanthine, urea, xanthine, and xylan are not. 
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Table 2.6. Physiological characteristics of 14 of the published Micromonospora species. 
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Characteristics: ::!j ::!j ::!j ::!j ~ ~ ~ ~ ~ ~ ~ ::!j ::!j ::!j 
Maximum NaCI Tolerance (%, ii/v) 3.0 3.0 4.0 2.0 2.0 1.5 4.0 2.0 2.0 3.0 3.0 3.0 1.5 3.0 
Nitrate reduction 5+ - 5+ - - - 5+ + + 5+ 5+ - s+ -
H2S production s+ 5+ + - - 5+ - + + s+ + + - s+ 
l-Tyrosine degradation s+ - + - s+ - + - s+ + -
Growth at: 
4°C + - - - - - - - + - - -
37°C 5+ s+ s+ - - s+ + + - s+ s+ s+ - s+ 
45°C - - - - - - - - - - - -
Growth on: 
-
Potato slice + - + - - - - + - + + + -
Potato slice plus CaC03 + - + - - - - + - + - + + 
Czapek-solution agar + - - - + + - + + + + + 
-. 
Antibiotic Susceptibility; 
Cephaloridine (100 Ilg/ml) - - - - + - - - - -
Lincomycin (100 /.I9/ml) - - - - - - - - - + 
Oleandomycin (100 ug/ml) + - + - - + + - - - - + - + 
-. 
Penicillin G (10 I.U.) - + - - - + - - + + + - -
Rifampicin (50 J,Lg/ml) - - - - + - - -
Tobramycin (50 ug/ml) - - - - - - - - - - + - - -
Vancomycin (50 1J.9/ml) - - - - - - - - - -
Abbreviations: -, negative result/no growth; +, positive result/growth; s, strongly. 
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2.3.3 Anaerobic Studies on the Validly Published Micromonospora Species 
The results of the anaerobic studies on the validly published Micromonospora species are shown in Table 2.8. 
Micromonospora endolithica was tested on two media (8M-Glycerol and sucrose agars) and did not grow under anaerobic 
conditions. It could be assumed that M. endolithica cannot grow under anaerobic conditions, but the strain should be 
incubated on other media to reveal if this is truly the case. There was no pattern regarding the changing of the colour of the 
indicator plates: very few strains produced acid to change the colour of the plates and those same strains did not produce 
acid under both aerobic and anaerobic conditions. Complex (8M-Glycerol, m172F, and YEME agars) and defined (sucrose 
agar) media were chosen and in general the degree of growth was the same or poorer under anaerobic conditions as 
compared to aerobic conditions. Of further interest is that the strains grew well under anaerobic conditions for 14 days, but 
thereafter growth stopped and the orange mycelial pigments disappeared/faded over the next 7 days. This suggests that the 
strains may have been using endogenous metabolism for survival due to nutrient depletion after 14 days. 
Filamentous actinomycetes are generally regarded and treated as aerobes, and thus these findings are very interesting. 
This was a preliminary investigation into the anaerobic growth of members of the genus Micromonospora, and the results do 
not allow determination of whether the facultatively anaerobic Micromonospora species grew by anaerobic respiration or 
fermentation. 
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Table 2.8. Anaerobic and aerobic growth of 15 of the validly published Micromonospora species grown on different media, with or without an indicator, at 37°C. 
BM-Glycerol with Sucrose as Sole Carbon Sucrose as Sole Carbon 
BM-Glycerol m172F YEME 
Indicator Source Source with Indicator 
Micromonospora species: Aerobic: Anaerobic: Aerobic: Anaerobic: Aerobic: Anaerobic: Aerobic: Anaerobic: Aerobic: Anaerobic: Aerobic: Anaerobic: 
M. aurantiaea +++ + p p ++ + p p +++ + ++ + 
M. earbonaeea +++ + p Y +++ + Y P +++ + ++ + 
M. eha/eea + + p p +++ +++ p p +++ + ++ + 
M. ehersina + - p p - - p p +++ + ++ -
M. eoeru/ea - - p p - + p p - - ++ -
M. eehinospora +++ + p p +++ - p p +++ + ++ + 
M. endolithiea +++ - p p + - p P N.T. N.T. N.T. N.T. 
M. ha/ophytiea +++ + p p - - p p ++ + + -
M. inosito/a +++ + p Y - - p p +++ + ++ + 
M. matsumotoense - - p p - + p p - - ++ -
M. nigra +++ + p Y - + p p +++ + ++ + 
M. olivasterospora +++ + p p +++ + p p +++ + ++ + 
M. pallida +++ + p p ++ + p p +++ + ++ + 
M. purpureoehromogenes +++ - Y P - - p p - + ++ -
M. rosaria +++ - Y P ++ - p p +++ + ++ -
Abbreviations: -, no growth; +, weak growth; ++, moderate growth; +++, good growth; P, indicator remained unchanged (purple in colour); Y, indicator changed in colour to yellow; N.T., not tested. 
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2.4 Conclusion 
This study has shown that a Micromonospora Identification Key based on a small number of phenetic characteristics is an 
easy and inexpensive method to determine the potential novelty of Micromonospora isolates obtained from environmental 
samples. As a result of this study, standardized media have been developed for testing maximum sodium chloride tolerance 
and for the production of diffusible pigments by Micromonospora strains. This Identification Key is proposed to be used to 
decide whether an isolate is worth investigating further, and is thus not intended as a stand-alone taxonomic tool. It is 
recommended that when Micromonospora strains are isolated, the isolates' sodium chloride tolerance be determined first. If 
the maximum sodium chloride tolerance is less than 1.5% or greater than 4.0%, the isolate is presumptively identified as a 
novel species and is worth investigating further. If the maximum sodium chloride tolerance is 1.5%, 2.0%, 3.0%, or 4.0%, the 
other physiological tests, indicated in Table 2.1, should be carried out. 
It must also be emphasized that a strain having a diagnostic mycelial pigment colour other than orange is significant. If a 
strain is isolated with an olive-green mycelial pigment colour and its maximum sodium chloride tolerance is not 3.0%, it 
cannot be M. olivasterospora according to the Identification Key, and thus is a potentially novel species. M. olivasterospora is 
currently the only species having an olive-green mycelial pigment. 
The additional physiological tests performed on the validly published Micromonospora members provide more characters to 
be used for species delineation thus allowing a more comprehensive description of new species. Results of growth at 4°C, 
45°C, antibiotic susceptibility testing, hydrolysiS and degradation testing, growth on Middlebrook 7H9 agar and growth in the 
presence of 0.1 % 2-phenylethanol, are physiological tests not reported for species of Micromonospora. 
It is of great interest that 14 of the 15 members of the genus Micromonospora grew under anaerobic conditions, however it 
is unknown whether anaerobic respiration or fermentation is used for growth. 
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Chapter 3 
3.1 Introduction: This Study 
Isolation, Enumeration, and 
Systematics of Actinomycete Strains 
3.1.1 The Hermanus Lagoon: A Dynamic Estuarine Environment 
The Klein Estuary, better known as the Hermanus lagoon, was investigated as a source of actinomycetes to screen for the 
production of novel bioactive compounds. The estuary is located on the southwest coast of South Africa and was selected as 
an ecosystem from which to isolate actinomycetes because it has a wide range of salinities, from freshwater at the head of 
the estuary (. ) to seawater at the mouth (. ) (Fig. 3.1). In addition, a large amount of soil carrying spores of terrestrial 
actinomycetes enters the Hermanus lagoon (. ), via the Kleinrivier at the head of the estuary and by run-off from 
surrounding farmland. There is growing concem over the large quantities of fertilizer entering the estuary from the 
surrounding farmland due to winter rains. This has already caused excessive overgrowth of Zostera capensis (seaweed) 
beds as well as other Chlorophyta (green algae) and Phaeophyta (brown algae) (6). The result is a shift in the bacterial 
community to bacteria employing anaerobic respiration (6). Sampling of different niches in an ecosystem will yield the 
greatest diversity of microbial types, and biological diversity is assumed to imply chemical diversity. 
KLEINRIVIERSBERGE 
sc;~c . -$0000 
Fig. 3.1. Location of sampling areas in the Kleinriviersvlei (the Hermanus estuary) . • , The mouth of the Klein Estuary (the sea); . , the 
main lagoon channel of the estuary; .. , the head of the estuary (the Kleinrivier). The estuary lies at 34°24'S, 19°18'E, between the towns 
of Hermanus and Stanford on the southwest coast of South Africa. The estuary drains into Walker Bay in the Atlantic Ocean. Map taken 
from reference 6. 
Fig. 3.2. A diagram showing maps of the areas from which samples were taken and the areas to which the 34 actinomycete strains were 
isolated. World map obtained from http://go.hrw.com/atlas/normhtmlworld.htm; map of South Africa obtained from 
http://go.hrw.com/atlas/norm htm/safrica.htm; map of Thailand obtained from http://go.hrw.com/atlas/norm htm/thailand.htm; map of 
Bazaruto, Mozambique, obtained from http://www.e-gnu.comiframeset.asp?pagename=maps/maputoinhacamap.html. 
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Strains from Thailand: 
The River Kwai (Kanchanaburi): Pseudonocardia sp. strains RKVB-VW, RKVB-LW, 
RKVB-3CBM2G. 
Phuket Island: Micromonospora sp. strain MMS19; Streptomyces sp. strains LMP-TD, 
LMP-BRP. 
32 
From the southern most point of the 
Bazaruto Island: Streptomyces sp. 
strain PB. 
Strains from South Africa: 
Hermanus: 'Micromonospora aquatica ', 
'Micromonospora arenincolae ', 
'Micromonospora cinerea', 
'Micromonospora hermanusense ', 
'Micromonospora lacunae', 
'Micromonospora stanfordense '; 
Micromonospora sp. strains MMS2, 
MMS8, MMS9, MMS10, MMS11 , 
MMS12, MMS14, MMS16, MMS1?; 
Streptomyces sp. strain HMS88. 
Noordhoek Beach: 'Streptomyces 
noordhoekensis' ; Streptomyces sp. 
strains BAM1 , BAM3, BAM? 
Plettenberg Bay: Micromonospora sp. 
strains MMS15, MMS18; Streptomyces 
sp. strain Kit2004. 
Other Locations: Streptomyces sp. 
strain SVM65; 'Micromonospora 
grateloupicolae' , 'Micromonospora 
terrae' ; Micromonospora sp. strain MLR. 
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Other environments, terrestrial and marine, were also investigated in an attempt to isolate novel actinomycete strains (Fig. 
3,2), Noordhoek and Plettenberg Bay are coastal marine and estuarine environments, also located along the southwest 
coast of South Africa, Bazaruto Island is a small island located off the coast of Mozambique, one of South Africa's 
neighbouring countries. 
Samples were also collected in Thailand, South East Asia: from Patong Beach, Phuket Island {now devastated by the 
tsunami event in December 2004}, and from the historical River Kwai, located in Kanchanaburi, inland Thailand, 
3.1.2 Isolation Media and Selective Inhibitors 
The range of media that have been used to isolate actinomycetes is extensive and many were designed primarily to 
discourage growth of other bacteria, although probably not allowing the growth of all actinomycetes in the sample. 
Competition from fungi is effectively dealt with by incorporation of antifungal antibiotics in the medium. Actinomycetes are 
generally insensitive to these compounds at concentrations of 50 - 100 Jlg/ml (13), Cycloheximide (CHX) has been widely 
used and has the advantage of being heat stable (13). CHX is an antibiotic isolated from streptomycin-producing strains of 
Streptomyces griseus and inhibits eukaryotic protein synthesis (18). Nalidixic acid (NAL) has been used to reduce 
contamination of isolation plates by Gram-negative bacteria common to marine and estuarine environments (called swarmer 
cells) and allow isolation of as broad a range of actinomycetes as possible (8). NAL was added to both terrestrial and marine 
media to prevent Gram-negative bacteria from interfering with the isolation of actinomycetes as pure cultures, NAL is a 
quinolone, containing the 4-quinolone ring and is a synthetic antimicrobial agent (18). NAL inhibits bacterial DNA synthesis 
by inhibiting the bacterial DNA gyrase (18). Although Gram-negative bacteria exist in both the marine and terrestrial 
environment, Gram-negatives are more prevalent in the marine environment and thus NAL is more useful as a selective 
inhibitor of swarmer cells from such environments. 
3.1.3 The Aim of This Study 
In view of the potential importance of marine actinomycetes as a source of novel bioactive compounds, methods were used 
to improve the isolation of actinomycetes from marine and estuarine environments. 
Good classification of actinomycetes is important as it provides an essential base for accurate identification to the genus 
level and ultimately to the species level. 
Thirty-four (34) actinomycete strains, mosHy from rare actinomycete genera, were isolated from the various environments 
investigated. To attempt to describe these isolates as new species, a polyphasic approach to bacterial taxonomy was 
applied, 
3.2 Materials and Methods 
3.2.1 Sampling 
Terrestrial and marine samples were collected from various environments in South Africa and other countries from May 
2002 to July 2004. The South African areas were: The Hermanus Lagoon (HMS); Napier (collected by Marilize Ie Roes); 
Noordhoek Beach; Plettenberg Bay (BS), and Silvermine (SVM). Samples from a seaweed, Grate/oupia filicina, were 
collected from Kommeijie and St. James, Cape Town, South Africa by Donovan Porter over the period of April 2000 to March 
2001, Samples from the southern-most point of Bazaruto Island were collected during January 2003 by Dane Goodwin. 
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Samples from Thailand: the beaches of Phuket Island (LMP), and the banks of the River Kwai, Kanchanaburi (RKVB), were 
collected during June 2004. Every sample of soil (including beach sand) was taken at a depth of 0 - 2 cm and transferred to 
a sterile container. Sediment samples were collected from the Kleinriviersvlei (the Hermanus estuary) on 20 July 2002 by 
using the boat anchor to pull up sediment from the estuary bottom. A sample (2 g) of sediment was removed from the anchor 
and suspended in 10 ml of a sterile 2% (w/v) NaCI solution to mimic the ionic strength of the seawater. Samples were 
processed within 75 min of collection. 
3.2.2 Sample Treatment, Isolation Media, and Selective Inhibitors 
In the case of soil and beach sand samples, 0.25 g of sample was weighed out into a sterile eppendorf, suspended in 1 ml 
of sterile water and vortexed for 2 min. Soils were also air-dried at 30°C for 2 days and stored in a Petri dish sealed with 
Parafilm at room temperature. 
To isolate terrestrial actinomycetes from soil samples, diluted (10-fold, stepwise to 10-5) samples were spread on 
Middlebrook 7H9 agar (containing no AD supplement but glucose was added to a final concentration of 10 mM; Difco 
Laboratories, Detroit, Michigan), a defined medium. To isolate actinomycetes from aquatic samples (beach sand), diluted 
(10-fold, stepwise to 10-5) samples were spread on the following agar media: GM (4); GOT (25); modified 172F agar (see 
2.2.2); and yeast extract-malt extract agar (/SP Medium No. 2)(21) supplemented with 2% (w/v) NaCI and pH adjusted to 7.3 
(YMEM). 
All isolation media contained nalidixic acid (NAL) (Sigma) and cycloheximide (CHX) (Sigma) at final concentrations of 10 
and 50 J.1g1ml, respectively. 
Plates were incubated at 30°C for 5 to 7 days. Single colonies were subcultured onto fresh plates of the medium on which 
the colonies were isolated. Colonies were selected on the basis of the presence of aerial mycelium, or a hard, furrowed 
orange appearance, and allowed to grow for a further week (7 days) at 30°C. 
Estuarine sediment samples were vortexed for 2 min. Marine actinomycetes were isolated by spread-plating 10-fold 
dilutions of sediment samples onto the following agar media: M2 (11); glycerol-asparagine (3); starch-casein (3); and YMEM. 
For the Hermanus plates, after 11 days of growth at ambient temperature (approximately 22°C), colonies characteristic of 
actinomycetes were subcultured onto YMEM agar containing natural extract in place of water. Water from the sampling 
areas (the natural extract) was removed on 20 July 2002, autoclaved and added to the media. The addition of 2% (w/v) NaCI 
and natural extract to the media, as well as the incubaUon temperature, was performed in an effort to mimic the 
ecophysiological parameters of the Klein Estuary. For all other locations, marine actinomycetes were subcultured onto plates 
of the medium on which the colonies were isolated. Colonies were selected on the basis of the presence of aerial mycelium, 
or a hard, furrowed orange appearance, and allowed to grow for a further week (7 days) at 30°C. 
3.2.3 Morphological Observations, Physiological Tests, Cryo Electron Microscopy, and Anaerobic Growth Studies 
International Streptomyces Project (/SP) media were prepared according to the methods of Shirling and Gottlieb (21). 
Controls were used for each test: positive controls, negative controls and/or uninoculated controls. Micromonospora 
morphological characteristics were determined on YEME, Bennett's agar (2), and modified 172F agar. Production of 
diffusible pigments by Micromonospora strains was tested on YEME, Bennett's agar, modified 172F agar, and glycerol-
asparagine agar (/SP Medium No.5). The pH sensitivity of both the substrate mycelium and diffusible pigments were 
assessed by noting any colour changes caused by the addition of 50 mM Hel or 50 mM NaOH. 
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For Streptomyces strains, spore chain morphology, spore sulface ornamentation, spore mass colour, and colour of the 
substrate mycelium were determined after 14 days of growth on inorganic salts-starch agar (/SP Medium No.4) (13). Spore 
mass colour and the colour of the substrate mycelium were determined by visual inspection. Spore chain morphology was 
determined by light and scanning electron microscopy (SEM). Spore sulface ornamentation was determined by SEM of the 
cultures used for the examination of spore chain morphology. Production of diffusible pigments was detected on glycerol-
asparagine agar (/SP Medium No.5). The pH sensitivity of both the substrate mycelium and diffusible pigments was 
assessed by noting any colour changes caused by the addition of 50 mM HCI or 50 mM NaOH. 
Physiological characteristics were determined as recommended by Locci (13). For Micromonospors strains, growth was 
determined on inorganic salts-starch agar (/SP Medium No.4), Middlebrook 7H9 agar (containing no AD supplement but 
glucose was added to a final concentration of 10 mM), Czapek-solution agar (2), and on potato slice and potato slice plus 
CaC03. 
Growth at 4°C. 37°C, 45°C. at pH 4.3, in the presence of 0.1% 2-phenylethanol, and in the presence of 1.5,2.0,3.0,4.0, 
5.0,6.0,7.0 and 11.0 % sodium chloride (%, w/v) was determined as recommended by Locei (13) and was tested on 
Bennett's agar. Degradation of adenine, allantoin, casein, cellulose, gelatin, guanine, hypoxanthine, starch, L-tyrosine, 
xanthine, and xylan was determined as recommended by Locei (13). Tween 80 degradation was determined according to 
Sierra (22), and degradation of urea was determined according to Gordon et al. (9). Melanin pigment production was 
determined on peptone-yeast extract-iron agar (/SP Medium No.6) and on tyrosine agar (/SP Medium No.7). HydrolysiS of 
aesculin, arbutin, hippurate, and pectin, H2S production, nitrate reduction, and lecithinase, lipolysis, and proteolysis (on egg-
yolk medium) were determined as recommended by Locei (13). 
Antibiotic resistance was determined by incorporation of the antibiotics into Bennett's agar plates (2). All sole carbon 
sources for carbon-utilization were tested at a concentration of 1.0% (wlv), and sole nitrogen sources were tested at a 
concentration of 0.1% (wlv) , as recommended by Locci (13). The utilization of organic compounds was tested at a 
concentration of 0.1 % (w/v) as recommended by Gordon et a/. (9). 
All tests were carried out at 28 - 30°C (except for testing growth at 4, 37 and 45°C) and were incubated for the time 
periods recommended by Locci. Micromonospora strains were incubated for 21 days (except for degradation of starch and 
gelatin. and nitrate reduction, which were incubated for 7 days and 14 days, respectively). 
For Cryo scanning electron microscopy, the Micromonospora strains were grown on modified 172F agar for 4 weeks at 
28°C and the Streptomyces strains grown on ISP Medium No.4 for 14 days at 30°C. The procedure was pelformed as 
follows: The cold stage and preparation chamber of the scanning electron microscope (SEM) were cooled to -150°C. The 
plunging chamber was filled with liquid nitrogen and pumped down until the liquid nitrogen turned slushy. A copper stub was 
screwed onto the transfer rod and the sample (an approximately 1 cm by 1 em agar plug, with the bacterial strain) was glued 
on using cryo glue mixed with carbon graphite. The chamber was vented with nitrogen gas and the sample plunged into the 
slushy nitrogen. The transfer chamber was attached to the side of the SEM and the sample on the copper stub was 
transferred onto the cold stage via the preparation chamber, using the transfer rod. The samples were viewed uncoated at 5 
KV. 
Anaerobic testing was performed as described in 2.2.3. 
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3.2.4 Chemotaxonomic Observations 
The method of Minnikin et a/. (16) was used to determine the presence of mycolic acids. The whole cell sugar pattem and 
cell wall chemotype was determined according to the methods of Hasegawa at 131. (10), except that dried cells were used 
instead of colonies from agar plates. The mol% G+C of the genomic DNA was determined in 1.0 x SSC by the method of 
Mandel and Marmur (15). Genomic DNA was extracted according to the method of Wang et a/. (26). 
3.2.5 PCR Amplification and DNA Sequencing 
PCR amplification of 16S rDNA was performed as described by Cook and Meyers (5). The 16S rDNA was sequenced using 
a MegaBACE 500 Automated Capillary DNA Sequencing System (Molecular Dynamics) and a DYEnamic ET Dye Terminator 
Cycle Sequencing Kit for MegaBACE. 
3.2.6 Rapid Molecular Identification: Amplified Ribosomal DNA Restriction Analysis (ARDRA) 
This method was performed according to Cook and Meyers (5). Purified amplicons were digested with enzymes supplied by 
Roche. DNA fragments were separated on 2% agarose gels (20). The APstDNA ladder (the molecular mass marker) was 
included. The bands were visualized on a 254 nm transilluminator (UVP©) and photographs taken. 
3.2.7 Phylogenetic Analysis 
An un rooted phylogenetic tree was constructed from 16S rDNA sequences of the 16 validly published species of the genus 
Micromonospora that were on the Approved Lists of Bacterial Names, last updated on 20 December 2004 (7). Eight 
Micromonospora strains described in this study were also included. All sequences were edited to produce the longest 
sequence region (1311 bp) common to all 24 sequences. Bootstrapping analysis was used to test the significance of the 
proposed phylogenetic affiliations. The tree was generated by neighbour-joining (19), with pairwise distances calculated by 
the Kimura two-parameter estimation, and the percentage bootstrap values obtained by using ClustalX (24), Version 1.81 
and MEGA2, Version 2.1 (12). The GenBank sequence accession numbers are indicated in brackets after the type strain 
names. 
The 16S rDNA sequences of 9 of the environmental strains can be obtained from GenBank: 'Micromonospora 
stanfordense' strain MMSF (nucleotide accession number: AY723730), 'Micromonospora cinerea' strain MMS3T 
(AY723731), 'Micromonospora lacunae' strain MMS4T (AY765353), 'Micromonospora hermanusense' strain MMS6T 
(AY765354), 'Micromonospora aquatics' strain MMS5T (AY863216), 'Micromonospora arenincolae' strain MMS7T 
(AY862317), 'Micromonospora grateloupicolae' strain R21lT (AY862318), 'Micromonospora terrae' strain MMS-DAT 
(AY862315), and 'Streptomyces noordhoekensis' strain BAM4T (AY634625). 
3.2.8 Strains Used in This Study (See 2.2.1) 
3.3 Results and Discussion 
The results of the isolation and enumeration techniques shall be discussed followed by the application of the Identification 
Key to environmental Micromonospora isolates, and the study on the anaerobic growth of the environmental 
Micromonospora strains. Since the morphological features of Micromonospora are not as diverse as those of Streptomyces, 
the physiological characteristics of the genus play an important role in their classification. The strain descriptions of the 34 
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actinomycete isolates will then be presented. All isolates were Gram positive. The antimicrobial activity of the isolates will be 
discussed in Chapter 5. The isolates will be listed as follows: from the 'most characterized' strains to the 'least characterized'. 
If 16S rONA sequences were not obtained for a strain, ARDRA was performed in order to identify accurately the strain to the 
genus level. The selection of restriction enzymes used was based on a rapid identification of filamentous actinomycetes 
scheme proposed by Cook and Meyers (5). 
3.3.1 Isolation and Enumeration 
The addition of the selective inhibitors to the isolation media proved to be extremely useful in limiting the number of Gram 
negative bacteria and contaminating fungi. The media used in this study were chosen because the growth of actinomycete 
strains should be favoured. Middlebrook 7H9 and YEME agars favoured the growth of Streptomyces strains which were 
identified on the basis of the presence of aerial mycelia. Micromonospora strains were isolated from YMEM and modified 
172F agars and were identified on the basis of orange to brown colonies, often including black mucoid spore masses, 
characteristic of the genus. On all other media, the dominant, if not only, bacteria isolated, belonged to the genus Gardonia. 
These isolates exhibited pastel orange colonies, which changed to shades of a darker orange after exposure to light, a 
feature characteristic of the genus. As Gordonia strains are often human or plant pathogens, they were not further pursued. 
The bacterial community of the Hermanus estuary has shifted to bacteria employing anaerobic respiration (6). This was 
evident as the distinctive rotten egg stench of hydrogen sulphide production was overwhelming when sediment samples 
were removed from the lagoon bottom. It is thus perhaps no surprise that the Micromanospora strains isolated from the 
Hermanus lagoon grew very well under anaerobic conditions. 
3.3.2 Application: Using the Identification Key 
Twenty-one (21) environmental Micromonospora strains were isolated by the author. Table 3.1 shows 8 of those strains 
and their physiological characters pertinent to the Identification Key. As described later in this chapter, 16S rONA sequences 
are available for these 8 strains and it is proposed that these strains are novel species. 
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Table 3.1. Testing the Identification Key with unpublished Micromonospora isolates. 
Micromonospora strains: MMS1 MMS3 MMS4 MMS5 MMS6 MMS7 R2J.1. MMS-DA 
Physiological 
Characteristics: 
Maximum Sodium 
Chloride Tolerance (% 5.0 4.0 3.0 5.0 5.0 4.0 4.0 5.0 
wlv): 
Production ot Diffusible 
Pigments On: 
Red Reddish- Light Light Olive-
m172F 
Brown brown Orange brown 
BM-Glucose 
Bright Light Light Olive-
Yellow Brown green 
Light Bright Yellow- Light Light Yellow-
Light 
YEME Orange-
Brown Yellow brown Brown Brown brown 
brown 
Diagnostic Mycelial 
Orange Orange Orange Orange Orange Orange Orange Orange 
Pigment Colour 
Growth on ISP4 + 
Growth at 37°C + + + + + + + + 
Carbon Source 
Utilization (1.0% wlv): 
Glycerol ±a + ± ± ± ± 
myo-Inositol ± + + + + + + 
Probable New Species 
According to: 
The Identification Key ,/ x ,/ ,/ ,/ ,/ ,/ ,/ 
16S rDNA Sequence 
,/ ,/ ,/ ,/ ,/ ,/ ,/ ,/ 
Analysis 
";t, weakly positive utilization. 
The Identification Key revealed that Micromonospora strain MMS3 could be a strain of M. haiophytica, while the 16S rONA 
sequence analysis suggested that strain MMS3 is probably a new Micromonospora species. The physiological characters of 
strain MMS3 should be compared to those of M. halophytica (available in the species description). Strain MMS3 readily 
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produces tufts of grey aerial mycelia on many agar media, while M. halaphytica does not produce aerial mycelia on any of 
the media tested. Furthermore, M. halaphytica does not produce diffusible pigments on 8M-Glucose and YEME. 
Strains MMSS, MMS9, MMS11, and MMS17 have a maximum sodium chloride tolerance of 5.0%, while strain MMS19 has 
a maximum sodium chloride tolerance of 6.0%, and strain MMS18 cannot tolerate sodium chloride (Le. 0.0%), and thus the 
Identification Key suggests that these strains are probable new species. 
Table 3.2 shows the application of the Identification Key to the remaining 7 strains. 
Table 3.2. Identification of 7 Micromonospora strains by using the Identification Key. 
Micromonospora strains: MMS2 MLR MMS10 MMS12 MMS14 MMS15 MMS16 
Physiological Characteristics: 
Maximum Sodium Chloride 
3.0 3.0 3.0 4.0 2.0 3.0 4.0 
Tolerance (% w/v): 
Production of Diffusible Pigments 
On: 
Brown 
m172F 
Ught Yellow-
BM-Glucose 
Yellow brown 
Light Orange- Yellow-
YEME Yellow 
Brown brown brown 
Diagnostic Mycelial Pigment 
Orange Orange Orange Ivory Orange Orange Orange 
Colour 
Growth on ISP4 + + + + + 
Growth at 37°C + ±s + + + + + 
Carbon Source utilization (1.0% 
w/v): 
Glycerol ± ± + + + + + 
mya-Inositol + + + + ± ± 
Probable New Species According 
to: 
The Identification Key x x 
":t, weak growth was observed. 
The Identificauon Key indicates that strain MLR could be M. caroanacea. However, M. caroonacea grows very well on 
ISP4, and very well at 37"C. It can thus be argued that strain MLR is a potentially novel species. 
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The Identification Key suggests that strain MMS14 could be M. auratinigra. M. auratinigra is negative for nitrate reduction, 
grows very well on Czapek-solution agar, and does not utilize L-rhamnose as a sale carbon source (23). Strain MMS14 is 
positive for nitrate reduction, does not grow on Czapek-solution agar, but does utilize L-rhamnose as a sole carbon source 
(Tables 3.6 and 3.7). 
3.3.3 Anaerobic Studies on Environmental Micromonospora Strains 
The results of the anaerobic studies are shown in Table 3.3. Strain MMS18 did not grow on either of the media chosen, 
under aerobic or anaerobic conditions. Strain MMS18 utilizes sucrose as a sole carbon source and grows on 8M-Glycerol 
under the standard incubation temperature, 30°C. The strain does not grow at 37c C. To assess if strain MMS18 can grow 
under anaerobic conditions, the temperature of the anaerobic chamber would have to be kept at 30°C. There is no pattem 
regarding the changing of the colour of the indicator plates: very few strains produced acid to change the colour of the plates 
and those same strains did not produce acid under both aerobic and anaerobic conditions. Complex and defined media were 
chosen and in general the strains showed the same degree of growth or poorer growth under anaerobic conditions as 
compared to aerobic conditions. The sucrose medium was chosen as most members of the genus Micromonospora should 
strongly utilize sucrose as a sole carbon source. Strains grew well under anaerobic conditions for 14 days, but thereafter 
growth stopped and the orange mycelial pigments disappeared/faded over the next 7 days. Some strains did grow better 
under anaerobic conditions, such as strains R21l, MLR, and MMS17, on the sucrose medium. Since almost all of the author's 
strains and the validly published species grew under anaerobic conditions, this characteristic can be said to be widely 
distributed in the genus, not just to strains isolated from oxygen poor environments. It is unknown at this time whether 
anaerobic respiration or fermentation allows growth under these conditions. 
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Table 3.3. Anaerobic and aerobic growth of 21 environmental MicrQmonospora strains grown 00 different media, with or without an 
indicator, at 37°C. 
I I 
BM-Glycerol with I Sucrose as Sole Carbon Sucrose as Sole Carbon 
BM-Glycerol 
Indicator Source Source with Indicator 
Strains: (Aerobic: • Anaerobic: Aerobic: Anaerobic: Aerobic: Anaerobic: Aerobic: Anaerobic: 
MMS1 +++ + p p ++ + p p 
. MMS2 +++ I + p p + -
p P 
MMS3 +++ ! + P P + + p p 
. MMS4 I + + p p - p P 
i 
MMS5 +++ + p y + + p P 
MMSS +++ + p p + + p P 
MMS7 +++ + p p + + p p 
~~ +++ + p p - + p P 
MMS-
+++ + p p + + p P 
DA 
MLR + + y p - + p P 
MMS8 +++ + p y ++ + p P 
MMS9 +++ + p p +++ +++ y P 
MMS10 ++ + p p +++ + y P 
MMS11 +++ + p p ++ + y P 
i 
MMS12 +++ + p p +++ + p P 
MMS14 +++ + i P P +++ +++ y I p i 
MMS15 + + p p +++ +++ y P 
MMS16 ++ 
i 
- P P ++ - p p 
MMS17 +++ + p y - + p P 
MMS18 i - p p - - p P 
MMS19 - Y P + + y p 
Abbreviations: -, no growth; +, weak growth; ++, moderate growth; +++, good growth; P, indicator remained unchanged (purple in colour); 
Y, indicator changed in colour to yellow. 
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3.3.4 The Group A Micromonospora Strains: MM8-1 to ·7, MMS·OA, MLR, and fUll 
The physiological characteristics of these 10 strains are shown in Tables 3.4 and 3.5. 
It must be noted that electron microscopy is performed primarily to show the single spores characteristic of the genus 
Micromonospora. Spore surface ornamentation could not be seen clearly. 
The cell walls of all 10 Micromonospora strains contained meso-diaminopimelic acid (meso-DAP) and glycine. Mycolic 
acids were absent. The genus Micromonospora has 2 sugars in the cell wall that are characteristic of the genus: the 
pentoses xylose and arabinose. 
These 10 strains were placed in the genus Micromonospora based on ARDRA and 16S rDNA sequence analysis. The 
novelty of all 21 of the environmental Micromonospora strains investigated in this study is suggested by the application of the 
Identification Key (3.3.2). 
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Table 3.4. Physiological characteristics of the Group A Micromonospora strains. 
I 
I 
I 
1 
.0:( 
..... N M 'Ot r.n (Q ...... c 
en en en en en en 
::1.. en a:t: fh ::IE ::IE ::IE ::IE ::IE ::IE ::IE ...J ::IE : 
Characteristics: ::IE ::IE ::IE ::IE ::IE ::IE r2 ::IE ::IE ::IE 
Diffusible pigment on ISP Medium NO.5 - - - -
Growth on: 
Czapek-solution agar w+ + + w+ w+ w+ w+ w+ vs+ w+ 
Potato slice - - + + + s+ s+ s+ + I 
Potato slice plus CaC03 + + - + + + s+ s+ s+ + 
Aesculin ~Yt1rolysis + s+ + + vs+ vs+ + + vs+ + 
Arbutin hydrolysis + + + vs+ I vs+ + + + + I 
! Hippurate hydrolysis - - - - + - - -
~ctin hydrolysis + + + - + + + - -
I Nitrate reduction - + - + - - - + 
· H2S production + + w+ + + + + + + + 
Maximum NaCI tolerance (%, w/v) 5.0 3.0 3.0 5.0 4.0 4.0 3.0 5.0 
Adenine degradation NG - - - - - - - NG -
Allantoin degradation - - - - w+ - - - . 
i Casein degradation + + + + + + + + + + 
Cellulose degradation - - - - - - - - - -
• Gelatin degradation + + + + + + + + + + 
Guanine degradation - - - - - + - - - -
Hypoxanthine degradation - - - - - - - - - -
• Starch degradation + + + + + + + + + + 
Tween 80 degradation + + + + + + + + - + 
L-Tyrosine degradation + + - + + + + + - + 
I Urea degradation - - - w+ w+ s+ - - I -
Xanthine degradation - - - - - - - - -
Xylan degradation + - + + + + - + - w+ 
Melanin on ISP Medium NO.6 - - - -
I Melanin on ISP Medium No. 7 - - - - - - - -
Growth at 4°C - - - - - - + - . -
Growth at 37°C + + + + + + + + vw+ s+ 
Growth at pH 4.3 - - - - + - + 
· Growth in the presence of 0.1 % 2-Phenyiethanol - - - - - - - - - -
Growth on a defined medium: 
vw+ + vw+ w+ vw+ vw+ vw+ vw+ + Middlebrook 7H9 Agar -
Antibiotic Susceptibility: 
Cephaloridine (1 OOl::lg/ml) - - - - - - - -
Lincomycin (100 Ilg/ml) - + - + + - - - + 
Oleandomycin (100 Ilg/ml) - + - - - + - + - + 
Penicillin G (10 I,U.) - - - - - - - - -
Rifampicin (50 Ilg/ml) - - 8 - - + Tobramycin (50 Ilg/ml) - - - - - - - - - ! 
Vancomycin (50 IJ,g/ml) - - - - - - - - - -
Lecithinase activity - - - - - - - - -
Lipase activity + + + 
- I + + + - + 
Protease activity + + + - + + + - + 
Abbreviations: +, positive/growth; -, negative/no growth; w, weak growth; vw, very weak growth; s, strong growth; vs, very strong 
growth/reaction; NG, no growth. 
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Table 3.5. Group A Micromonospora sole carbon and nitrogen source utilization. 
• Characteristic: I MMS1 ! MMS2 ! MMS3 . MMS4 MMS5 MMS6 RlJ.l. MMS7 MLR I MM8-0A 
I Carbon Sources: 
I Adonitol I ± ± ± ± ± ± 
I 
L-Arabinose ++ ++ + ++ + - - + ++ + 
I I-:-Glycerol ± ± - ++ ± ± - ± ± ± 
i i I 
myo-Inositol ± ++ 
i 
- ++ + + + + + 
Inulin ± ± ± ++ + ± ± + ± ± 
i 
o-Mannitol - + - ++ + + + + - ++ 
D( + )-Melezitose I ± ± - I ++ I - ± ± - ± ± 
a-Melibiose + + + I ++ i + + + + ++ + 
Raffinose + + + ++ + + + + ± + 
i L(+)-Rhamnose ± ± - ± - + + ± - + 
D(-)-Ribose + - ± - - - - -
I 
± -
i 
Sucrose ++ ++ ± ++ + + + + 
Nitrogen Sources: 
L-Arginine + + + + I 
+ + + + I + 
L-Cysteine - ± - I ± I - - - ± ± ± 
i DL-Ornithine + - + + + + 
L-Serine ++ + + I + - + + + ++ 
i I 
i L-Threonine ++ + + + + ± ± - + + 
Abbreviations: -, no growth/no utilization; ±, weak growth/utilization; +, moderate growth/utilization; ++, good growthiutllization. 
(1) 'Micromonospora stanfordense' strain MMS1T 
Micromonospora stanfordense (stan.foLden'se L. fem. adj. stanfordense, of Stanford, a town) was isolated from a sediment 
sample obtained from the Stanford River, which feeds the Klein Estuary. The diagnostic mycelial pigment colour of this strain 
is orange, tuming black and mucoid upon sporulation. Spores are spherical, appear to be smooth, and are borne singly on 
long or short sporophores [Fig. 3.3 (a)). Growth does not occur on potato slice unless CaC03 is added, indicating sensitivity 
to acidic conditions. Strain MMSF does not grow on the medium used for testing adenine degradation. Maximum sodium 
chloride tolerance for this strain is 5.0% (no growth occurs at 6.0%). The pentoses arabinose and xylose are the only sugar 
constituents of the cell wall, although there is a greater amount of arabinose present than xylose. The 16S rONA nucleotide 
sequence accession number (available from GenBank) is AY723730. 
A BLAST search (1) of the GenBank database revealed that M. stanfordense strain MMS1 T showed 98% homology to the 
16S rDNA sequences of M. chalcea DSM 43026T (sequence accession number: X92594), M. ha/ophytica DSM 43171 T 
(X92601), and M. purpureochromogenes DSM 43821 T (X92611) over 1424 bases. However, when the sequences were 
edited to the same length and pairwise alignments were performed in DNAMAN (Version 4.13, Lynnon Biosoft). the 
percentage identities dropped to 94.54% (over 1434 nucleotides). 94.53% (over 1434 nucleotides), and 94.32% (over 1423 
nucleotides), respectively. 
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(a) (b) 
(c) 
(d)r----::;;~~:=------, 
Fig. 3.3. Scanning electron micrographs of (a) 'Micromonospora sfanfordense' strain MMS1T, and (b, c) 'Micromonospora cinerea' strain MMS3T. 
Photographs of (d) strain MMS3 and (e) 'Micromonospora lacunae' strain MMS4T grown on YMEM agar for 4 weeks at 30oe. 
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The dosest phylogenetic neighbours of strain MMS1 T are M. carbonacea, M. matsumotoense, and 'M. cinerea' strain 
MMS3T• Strain MMS1 T differs from M. carbonacea and 'M. cinerea' strain MMS3T with respect to their maximum sodium 
chloride tolerances, which are 5.0%, 3.0%, and 4.0%, respectively. Strain MMS1T sporulates whereas M. matsumotoense 
does not. 
(2) 'Micromonospora cinerea' strain MMS3T 
Micromonospora cinerea (ci.ne' re.a. L. fern. adj. cinerea, ashy) was isolated from a sediment sample obtained from the 
main lagoon channel of the Klein Estuary, and shows an ash-like morphology on some media, including on ex-melibiose and 
raffinose agars. Spores are abundant, and are borne singly on short sympodial (having lateral 'branches') sporophores [Fig. 
3.3 (b) and (e)]. Spores are spherical and appear smooth. Characteristic gray blooms of short, sterile aerial mycelia are 
produced on some media. Strain MMS3T produces a bright yellow, pH sensitive diffusible pigment on Bennett's agar and 
ISP2, which changes colour from bright yellow to red on addition of 50 mM NaOH. A red-brown diffusible pigment is 
produced on modified 172F agar, which is not pH sensitive. The diagnostic mycelial pigment colour of strain MMS3T is 
orange on all media. The strain shows strong growth on autoclaved potato slice but does not grow on potato slice plus 
CaCOs, indicating an unusual preference for acidic condifions. Most micromonosporas prefer neutral or basic conditions 
(14). Maximum sodium chloride tolerance is 4.0% for strain MMS3T (no growth occurs at 5.0%). Strain MMS3T was 
susceptible to all antibiotics tested. Fig. 3.3 (d) shows a photograph of strain MMS3T on YMEM agar medium. The sugar 
constituents of the cell wall are arabinose, xylose, galactose, and ribose. The mol% G+C content is 72.8%. The 16S rDNA 
nudeotide sequence accession number is AY723731. 
A BLAST search revealed that M. cinerea strain MMS3T showed 98% homology to the 16S rONA sequences of M. 
carbonacea DSM 43168T (X92599), M. chalcea DSM 43026T (X92594), and M. purpureochromogenes DSM 43821 T 
(X92611) over 1421 bases. However, when the sequences were edited to the same length and pairwise alignments were 
performed in DNAMAN, the percentage identities dropped to 93.23% (over 1526 nucleondes), 93.04% (over 1527 
nudeondes), and 93.03% (over 1524 nueleotides), respectively. 
The closest phylogenetic neighbour is M. matsumotoense, and strain MMS3T can readily be distinguished from M. 
matsumotoense on the basis that strain MMS3T sporulates. 
(3) 'Micromonospora lacunae' strain MMS4T 
Micromonospora lacunae (la.cu'nae l. fem. fig. lacunae, lagoon) was isolated from a sediment sample obtained from the 
main lagoon channel of the Klein Estuary. Fig. 3.3 (e) shows a photograph of strain MMS4T on YMEM agar medium. Spores 
are abundant, spherical, and are borne Singly on short sporophores [Fig. 3.4 (a)]. The sugar constituents of the cell wall are 
arabinose, xylose, and galactose. The mol% G+C content is 74.3%. The 16S rDNA nucleotide sequence accession number 
is AY765353. 
A BLAST search revealed that M. lacunae strain MMS4T showed 98% homology to M. endolithica DSM 44398T 
(AJ560635), M. chalcea DSM 43026T (X92594), and M. rosaria DSM 803T (X92631) over 1407 bases. However, in 
DNAMAN, the percentage identities dropped to 94.66% (over 1421 nucleotides), 94.66% (over 1422 nucleotides), and 
94.52% (over 1421 nucleotides), respectively. 
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(4) 'Micromonospora hermanusense' strain MMS6T 
Micromonospora hermanusense (her.ma.nu.sen'se L. fern. adj. hermanusense, of Hermanus, a town) was isolated from a 
sediment sample obtained from the mouth (the sea) of the Klein estuary. Spores are abundant. spherical. and are borne 
singly on short sporophores [Fig. 3.4 (b)]. The sugar constituents of the cell wall are arabinose, xylose, glucose, and 
mannose. The mol% G+C content is 73.8%. The 16S rONA nucleotide sequence accession number is AY765354. 
A BLAST search revealed that M. hermanusense strain MMS6T showed 98% homology to M. endolithica DSM 443981 
(AJ560635), M. chalcea DSM 43026T (X92594), and M. rosaria DSM 803T (X92631) over 1272 bases. However, in 
DNAMAN, the percentage identities dropped to 83.56% (over 1400 nucleotides), 83.84% (over 1404 nucleotides), and 
83.78% (over 1403 nucleotides), respectively. 
(5) 'Micromonospora aquatica' strain MMS5T 
Micromonospora aquatica (a.qua'ti.ca L. fern. adj. aquatica, living in water) was isolated from a sediment sample obtained 
from the main lagoon channel of the Klein Estuary. Spores are abundant, spherical, and are borne singly on short 
sporophores [Fig. 3.4 (c)l. The sugar constituents of the cell wall are arabinose, xylose, and galactose. The 16S rDNA 
nucleotide sequence accession number is AY862316. 
A BLAST search revealed that M. aquatica strain MMS5T showed 97% homology to M. aurantiaca DSM 438131 (X92604), 
M. chalcea DSM 430261 (X92594), M. halophytica DSM 431711 (X92601), and M. purpureochromogenes DSM 438211 
(X92611), over 1436 bases. 
The closest phylogenetic neighbour of strain MMS51 is M. aurantiaca. MMS5T has a maximum sodium chloride tolerance of 
5.0% while M. sursntiscs has a maximum tolerance of 3.0%. Strain MMS5T (Table 3.4) differs from M. sursntisc8 (Table 2.6) 
in that strain MMSST cannot grow on potato slice unless calcium carbonate is added, does not reduce nitrate and cannot 
grow at 4"C. The strains' carbon and nitrogen utilization patterns are also very different (Tables 3.5 and 2.7). 
(6) 'Micromonospora arenincolae' strain MMS7T 
Micromonospora arenincolae (a.re.nin'co.lae L. fern. arenincolae, inhabits sand) was isolated from a sediment sample 
obtained from the main lagoon channel of the Klein Estuary. Spores are abundant, spherical, and are borne singly on short 
sympodial sporophores [Fig. 3.4 (d)]. The sugar constituents of the cell wall are arabinose, xylose, and galactose. The 16S 
rDNA nucleotide sequence accession number is AY862317. 
A BLAST search revealed that M. arenincolae strain MMS7T showed 97% homology to M. endofithica DSM 44398T 
(AJ 560635) , M. chalcea DSM 43026T (X92594), M. rosaria DSM 803T (X92631), and M. chersina DSM 441511 (X92628), 
over 1364 bases. 
(7) 'Micromonospora grate/oupico/ae' strain \QJ.tT 
Micromonospora gratefoupicolae (gra.te.lou.pi'co.lae L. fern. adj. grateloupicolae. living on Grateloupia, a seaweed) was 
isolated from the surface of the seaweed Grate/oupia fi/icina. found along the coast of Cape Town. by Donovan Porter. 
Spores are abundant, spherical, and are borne singly on short and long sporophores [Fig. 3.4 (e) courtesy of D. Porter]. The 
sugar constituents of the cell wall are arabinose. xylose, and galactose. Of note is that strain R2j.lT is the only environmental 
isolate to grow at 4°C. The 16S rDNA nucleotide sequence accession number is AY82318. 
A BLAST search revealed that M. grateioupicolae strain R2j.l T showed 97% homology to M. endolithica DSM 44398T 
(AJ560635), M. rosaria DSM 803T (X92631), and M. chafcea DSM 43026T (X92594) over 1407 bases. 
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(c) (d) 
Fig. 3.4. Scanning electron micrographs of (a) 'Micromonospora lacunae' strain MM , (b) 'Micromonospora herrnanusense' strain MM , (c) 
'Micromonospora aquatica' strain MMS5T, (d) 'Micromonospora arenincolae' strain MMS7T, (e) 'Micromonospora grateloupicolae' strain R21lT, 
and (~ 'Micromonospora terrae' strain MMS-DAT. 
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(8) 'Mlcromonospora terrae' strain MMS·DAT 
Micromonospora terrae (ter'rae L. fem. terrae, from soil) was isolated from garden soil in Cape Town by Deeya Ballim and 
Aimee Whitcroft in August 2003. Spores are abundant, spherical, and are borne singly on short and long sporophores [Fig. 
3.4 (~l . The sugar constituents of the cell wall are arabinose and xylose, present in equal amounts. The 16S rDNA nucleotide 
sequence accession number is AY862315. 
A BLAST search revealed that M. terrae strain MMS-DAT showed 97% homology to M. endolithica DSM 44398T 
(AJ560635), M. cha/cea DSM 43026T (X92594), and M. chersina DSM 44151 T (X92628), over 1331 bases. 
25 
64 
22 
9 
22 
,-----Micromonospora aurstin/gra DSM 44815T (AB159779) 
...-----1 ~--------- Micromonospors olivasterospora DSM 43868T (X92613) 
'----------Micromonospora coeru/ea DSM 43143T (X92598) 
'-------- Micromonospora nigra DSM 43818T (X92609) 
.------Micromonospora echinospora DSM 43816T (X92607) 
50 ~---- Micromonospora pallida DSM 438171 (X92608) 
...------Micromonospors inositola DSM 43819T (X92610) 
.-----Micromonospors endolithica DSM 44398T (AJ560635) 
'----Micromonospors chersina DSM 44151 T (X92628) 
~----Micromonospors rosaria DSM 803T (X92631) 
.-----------------'Micromonospors hennanusense' strain MMS6T (AY765354) 
.-------'Micromonospora terrae' strain MMS-DAT (AY862315) 
87 
'Micromonospors lacunae' strain MMS4T (A Y765353) 
93 
58 ,---'Micromonospors arsnincolae' strain MMS7T (AY862317) 
96 '---- 'Micromonospors grsteloupicolae' strain R2~; (AY862318) 
'------Micromonospora chalcea DSM 43026T (X92594) 
25 
46 ,.------ 'Micromonospors aquatica' strain MMS5T (AY862316) 
'----- Micromonospora aurantiaca DSM 43813T (X92604) 
,-----Micromonospora halophytica DSM 43171T (X92601) 
24 '-----Mlcromonospora purpureochromogenas DSM 43821T (X92611) 
.-------'Micromonospors stanfordense' strain MMSF (AY723730) 
,---------Micromonospora carbonacea DSM 43168T (X92599) 
.-------------------'Micromonospors cinerea' strain MMS3T (AY723731) 
'---------Micromonospors matsumotoense IMSNU 22oo3T (AF152109) 
OJ)()5 
Fig. 3.5. An unrooted neighbour-joining phylogenetic tree constructed from the 165 rONA sequences of the 16 validly published members 
of the genus Micromonospora and 8 potentially new species (indicated in orange) from this study. The tree was constructed with 1311 bp 
of alignable sequence. The GenBank sequence accession numbers are indicated in brackets. Nodes are labelled with the percentage 
bootstrap replications (out of 100) in which the node was found. The scale bar represents an average of 0.005 nucleotide substitutions per 
site. 
The phylogenetic tree (Fig. 3.5) shows that 5 of the South African environmental isolates group together (strains MMS6T, 
MMS-DAT, MMS4T, MMS7T, and R2~T). 
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(9) Micromonospora sp. strain MMS2 
Strain MMS2 was isolated from a sediment sample obtained from the main lagoon channel of the Klein Estuary. Spores are 
abundant, spherical, and are borne singly on short sporophores [Fig. 3.6 (a)J. The sugar constituents of the cell wall are 
arabinose and xylose. Two non-overlapping 16S rONA sequences were obtained. 
A BLAST search of the F38-F2 sequence (covering two-thirds of the 5' end of the 16S rRNA gene) [Fig 3.7 (a)] revealed 
98% homology to M. endolithica DSM 44398T (AJ560635) and M. chalcea DSM 43026T (X92594) over 978 bases, while the 
BLAST search of the R5 sequence (covering the 3'end of the 16S rRNA gene) [Fig. 3.7 (b)], revealed 96% homology to M. 
chemina DSM 441511 (X92628), M. auratinigra DSM 44815T (AB159779), M. matsumotoense IMSNU 22003T (AF152109), 
M. endolithica DSM 44398T (AJ560635), M. rosaria DSM 803T (X92631), and M. echinospora DSM 43816T (X92607). 
Sequencing primer F38 binds to position 8 of the E. coli 16S rONA sequence. Primer F2 binds to pOSition 338, and primer 
R5 binds to pOSition 1492. 
(a) 
SEQ F38-F2 ED Consensus MMS2: 981 bPi 
Composition 213 A; 241 C; 351 G; 176 T; 0 OTHER 
Percentage: 22% A; 25% C; 36% G; 18% T; O%OTHER 
Molecular Weight (kDa): ssDNA: 305.30 dsDNA: 604.9 
ORIGIN 
1 TAACA1'GCAG TCGAGCGGAA AGGCC1'TCGG GGTTACTCGA GCGGCGAACG GGTGAG1'1'AA 
61 CACGTGAGCA CCTGCCCCAG GCT1'1'GGGGA TAACCCCGGG AAACCGGGGC TAATACCGAA 
121 1'A1'GACCTTG CACCGCATGG TG1'T1'GG1'GG AAAGTTTTTC GGCTTGGGAT GGGCTCGCGG 
181 CC1'A1'CAGC1' TGTTGGTGGG G1'GA1'GGCC1' ACCAAGGCGA CGACGGG1'AG CCGGCCTGAG 
241 AGGGCGACCG GCCACACTGG GAC1'GAGACA CGGCCCAGAC TCCTACGGGA GGCAGCAGTG 
301 GGGAATAT1'G CACAATGGGC GGAAGCC1'GA TGCAGCGACG CCGCG1'GAGG GA1'GACGGCC 
361 1'1'CGGG1'1'G1' AAACC1'CTTT CAGCAGGGAC GAAGCG1'AAG TGACGGTACC TGCAGAAGAA 
421 GCGCCGGCCA ACTACGTGCC AGCAGCCGCG GTAAGACGTA GGGCGCGAGC GTTG1'CCGGA 
481 TTA1'1'GGGCG TAAGAGC1'CG TAGGCGGCTT GTCGCGTCGA CTGTGAAAAC CCGCAGCTCA 
541 ACTGCGGGCC TGCAGTCGAT ACGGGCAGGC TAGAGTTCGG TAGGGGAGAC TGGAATTCCT 
601 GGTGTAGCGG TGAAATGCGC AGATATCAGG AGGAACACCG GTGGCGAAGG CGGGTCTCTG 
661 GGCCGATACT GACGCTGAGG AGCGAAAGCG TGGGGAGCGA ACAGGATTAG ATACCCTGGT 
721 AGTCCACGCT GTAAACGTTG GGCGCTAGGT GTGGGGGGCC TCTCCGGTTC CCTGTGCCGC 
781 AGCTAACGCA TTAAGCGCCC CGCCTGGGGA GTACGGCCGC AAGGCTAAAA CTCAAAGGAA 
841 TTGACGGGGG CCCGCACAAG CGGCGGAGCA TGCGGATTAA TTCGATGCAA CGCGAAGAAC 
901 CTTACCTGGG TTTGACATGG CCGCAAAACT GTCAGAGATG GCAGGTCCTT CGGGGGCGGT 
961 CACAGGTGGT GCATGGCTGT C 
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(b) 
SEQ MMS2 RC-R5 ED: 261 bPi 
Composition 63 A; 70 C; 80 G; 48 T; 0 OTHER 
Percentage: 24% A; 27% C; 31% G; 18% T; O%OTHER 
Molecular Weight (kDa): ssDNA: 80.86 
ORIGIN 
dsDNA: 160.9 
1 GGGTCTGATG CTGAATTAAC CACGGGTGAG TGATGGAAGG CCGAAAAATT CCCAAAAAGC 
61 CGGATCGTCA GTTCGGATTC GGGGTTCTGC AACTCGACCC CGTGAAGTCG GAGTCGCTAG 
121 TAAATCGCAG ATCAGCAACG CTGCGGTGAA TACGTTCCCG GGCCTTGTAC AACACCGCCC 
181 GTCACGTCAC GAAAGTCGGC AACACCCGAA GCCGGTGGCC CAACCATTGT GGAGGGAGCC 
241 GTCGAATGTG GGCTGCGTGA C 
Fig. 3.7. Strain MMS2 partial 16S rONA sequences: (a) sequence obtained from sequencing primers F38 and F2; (b) reverse 
complementary sequence obtained from sequencing primer R5. 
(10) Micromonosporll sp. strain MLR 
Strain MLR was isolated from a vegetable patch in Napier, South Africa, by Marilize Ie Roes. Spores are abundant, 
spherical, and are borne singly on short sporophores [Fig. 3.6 (b)]. The sugar constituents of the cell wall are arabinose and 
xylose, present in equal amounts. 
A BLAST search of the F2 sequence (Fig. 3.8) revealed 98% homology to M. purpureochromogenes DSM 438211 
(X92611), M. Ch81ce8 DSM 43026T (X92594). and M. 8urantiac8 DSM 43813T (X92604). 
SEQ F2 MLR ED: 803 bPi 
Composition 173 A; 197 C; 285 G; 148 T; 0 OTHER 
Percentage: 22% A; 25% C; 35% G; 18% T; O%OTHER 
Molecular Weight (kDai: ssDNA: 249.84 
ORIGIN 
dsDNA: 495.1 
1 TGGGATTTGC CAATGGGCGG AGCCTGATCC AGCGACGCCG CGTGAGGGAT 
61 GGGTTGTAAA CCTCTTTCAG CAGGGACGAA GCGAAAGTGA CGGTACCTGC 
121 CCGGCC.~CT ACGTGCCAGC AGCCGCGGTA AGACGTAGGG CGCGAGCGTT 
181 ATTGGGCGTA AAGAGCTCGT AGGCGGCTTG TCGCGTCGAC CGTGAAAACC 
241 CCCCAGGCCT GCGGTCGATA CGGGCAGGCT AGAGTTCGGT AGGGGAGACT 
301 GTGTAGCGGT GAAATGCGCA GATATCAGGA GGAACACCGG TGGCGAAGGC 
361 GCCGATACTG ACGCTGAGGA GCGAAAGCGT GGGGAGCGAA CAGGATTAGA 
421 GTCCACGCTG TAAACGTTGG GCGCTAGGTG TGGGGGGCCT CTCCGGTTCC 
481 GCTAACGCAT TAAGCGCCCC GCCTGGGGAG TACGGCCGCA AGGCTAAAAC 
541 TGACGGGGGC CCGCACAAGC GGCGGAGCAT GCGGATTAAT TCGATGCAAC 
601 TTACCTGGGT TTGACATGGC CGCAAAACTC GCAGAGATGT GAGGTCCTTC 
GACGGCCTTC 
AGAAGAAGCG 
GTCCGGATTT 
TGGGGCTCAA 
GGAATTCCTG 
GGGTCTCTGG 
TACCCTGGTA 
CTGTGCCGCA 
TCAAAGGAAT 
GCGAAGAACC 
GGGGGCGGTC 
661 ACAGGTGGTG CATGGCTGTC GTCAGCTCGT GTCGTGGAGA TGTTGGGTTT AAGTCCCGCA 
721 ACGAGCGCAA CCCTCGTTCG ATGTTGCCAG CGCGTTTATG GCGGGGACTC ATCGAAGACT 
781 GCCGGGGTCA ACTCGGAAGA AAG 
Fig. 3.8. Partial16S rONA sequence of strain MLR obtained from sequencing primer F2. 
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3.3.5 Group B: Micromonospora Strains MMS·8 to ·12 and MMS-14 to -19 
Strain MMS17 was isolated from a sediment sample obtained from the main lagoon channel of the Klein Estuary. Strains 
MMS-8 to -12, MMS14, and MMS16 were isolated from a sediment sample obtained from the Stanford River, which feeds 
the Klein Estuary. Strains MMS15 and MMS18 were isolated from a sediment sample obtained from the Beacon Isle lagoon, 
Plettenberg Bay. South Africa. Strain MMS19 was isolated from near-shore ocean sediment. Phuket Thailand and is the 
only Micromonospora strain to grow at 45°C. There is no strain MMS13. 
Strain MMS8 produces black-greyaerial mycelia on modified 172F agar, while grey aerial mycelia are produced by MMS14 
(on YEME agar) and MMS15 (on 8M-Glucose agar). The substrate mycelia and the diffusible pigments of these 11 strains 
are not pH sensitive. The brown-red pigment typically seen during tyrosine degradation was produced by strains MMS8. 
MMS9, MMS11, MMS15, and MMS16. These 11 strains were placed in the genus Micromonospora on the basis of colony 
morphology and ARDRA. Physiological characteristics are listed in Tables 3.6 and 3.7. All of the environmental isolates in 
Group B utilized glycerol (1.0% w/v) as a sole carbon source. This is particulariy interesting. as M. purpureochromogenes is 
the only validly published member of the genus to use glycerol as a sole carbon source. 
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Table 3.S. Physiological characteristics of the Group B Micromonospora strains. 
, 
I 
C> ...... N ..... II') co .... co ~I co CJ) ...... ..... ..... ..... ..... ...... ...... ...... 
tI) tI) tI) tI) tI) tI) tI) tI) tI) tI) tI)! 
:i :i :i :i :i :i :i :i :i :i II Characteristics: :i :i :i :i :i :i :i :i :i :i 
Maximum NaCI Tolerance (%, w/v) 5.0 5.0 3.0 5.0 4.0 2.0 3.0 4.0 5.0 0.0 6.0 , 
Nitrate reduction - 5+ 5+ + + s+ + s+ + - - i 
H2S production s+ s+ + + + + + + + - + I 
L-Tyrosine degradation s+ + - s+ - - + + + ! 
Growth at: I 
4°C - - - - - - - - - I 
37°C i s+ s+ + s+ s+ + + 5+ s+ + 
45°C - - I - + i 
; Growth on: ! 
Potato slice + I + + + s+ - - - + + J 
Potato slice plus CaC03 + s+ + + s+ - - + - + i 
Czapek-solution~ar + + s+ w+ - + + w+ - + I 
ISP Medium No.4 w+ + + + - + I + + + 
Antibiotic Susceptibility: I 
Cephaloridine (100 J,t9/ml) + + + - -
- I 
lincomycin (100 Ilg/ml) - - - - + - + - I 
i Oleandomycin (100 Ilg/ml) + + - + + + + + + + + I 
i Penicillin G (10 I.U.) + + + + + + + + I -
! Rifampicin (SO Ilg/ml) - - - - - + - - + I 
Tobramycin (50 J,t9/ml) - - + + - - + - - I 
Vancomycin (50 Ilg/ml) - - - - - - - - - - - I 
I Organic Compound Utilization: I 
n-Butanol ++ ++ ++ ++ ++ i ++ ++ ++ i + + + i 
I meso-Erythritol ++ ++ + + ++ ++ ++ ++ ++ ++ + I 
I Ethanol ++ ++ ++ ++ ++ ++ ++ ++ + + + I 
Isoamylalcohol ++ ++ ++ + ++ ++ + ++ ++ + + 
u-Methyl-o-glucoside ++ ++ ++ ++ ++ ++ ++ ++ - + ++ 
Mucic acid ++ ++ ++ ++ + + - + i 
Sodium acetate ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ + i 
Sodium butyrate ++ ++ ++ + ++ ++ + + ++ ++ + I 
Sodium citrate ++ ++ ++ + ++ ++ ++ ++ ++ ++ + i 
Sodium formate ++ ++ ++ + ++ + ++ ++ - - - ! 
Sodium lactate ++ ++ ++ ++ ++ + ++ ++ ++ ++ ++1 
Sodium salicylate + ++ + + ++ ++ + + I - - -
Sodium L(+)-tartrate ++ ++ ++ + ++ ++ ++ + ++ + + I 
Abbreviations: -, no growth/utilization; W+, weakly positive; +, moderate growth/utilization; ++, good growth/utilization; 5+, strongly positive. 
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Table 3.7. Sole carbon and nitrogen source utilization of the Group B Micromonospora strains . 
0 .... N .... It) CD ..... co en 
co en ..... .... ..... ..... ..... ..... ..... .... ..... (I) (I) (I) (I) (I) (I) (I) Ii (I) (I) (I) Characteristic: ::& ::& ::& ::& ::& ::& ::& ::& ::& ::& ::& ::& ::& 1::& ::& ::& 1 ::& ::IE ::IE ~ 
Carbon Sources: 
I 
1 o(+)-Glucose + + + + ++ + - + + + + I 
Adonitol ++ ++ : + + ++ + + + + + + I 
L( + )-Arabinose + + ! ++ ++ ++ ++ + +++ + + I 1 
i Glycerol + + ++ + ++ ++ + + + + + 
I 
: mya-Inositol + + ++ + - ++ ++ +++ - - + 
a-Melibiose + ++ +++ + ++ +++ + +++ + + ! + 
I o{ + )-Melezitose ++ ++ ++ ++ ++ + + + + + + 
J 
L{ + )-Rhamnose ++ ++ ++ + + + + + + + + 
• D{ - )-Ribose + + + - + + - - + 
Sucrose ++ +++ +++ + +++ +++ 1 ++ +++ + + + I 
Nitrogen Sources: 
1 
L-Arginine + + + 1 ++ - ++ - - I + 
DL-Omithine +++ +++ +++ +++ +++ I +++ ++ + +++ + + 
L-Serine ++ +++ +++ +++ +++ +++ +++ +++ +++ + + 
L-Threonine ++ + +++ ++ +++ +++ + + + -
Abbreviations: -, no growth/utilization; +, weak growth/utilizaUon; ++, moderate growth/utilization; +++, good growth/utilization. 
Some strains were tested on other media not listed in the tables. The results are as follows. 
(i) Aficromonospora sp. strain MMS10 
Strain MMS10 has an orange-coloured mycelium, however, once sporulation occurs, a green layer of spores develops. This 
can be seen on the medium testing for cellulose degradation, ISP Medium No.4, and on Czapek-solution agar. This has not 
been reported for any other Micromonospora strain and since the morphological features of the members of this genus play 
an important role in discerning between species, both strains MMS10 and MMS12 might be considered new species. It must 
be noted that that the mycelial colour of M. o/ivasterospora is olive-green before and after sporulation. As can be seen in 
Table 3.6 and 3.7, strains MMS10 and MMS12 are different from each other. Strain MMS10 appears black on L-arabinose 
agar, and does not produce a diffusible pigment on ISP Medium NO.5. The strain grows weakly on Middlebrook 7H9 agar 
and does not grow at pH 4.3. Melanin is not produced on ISP Media No.6 and No.7. Starch is hydrolysed. Gelatin is 
degraded but cellulose is not. 
(ii) Aficromonospora sp. strain MMS12 
Strain MMS12 is orange-coloured, turning green upon sporulation on 8M-Glycerol agar, erythritol and sodium lactate agars. 
This strain has a distinctive ocean smell (such as a coastal seaweed smell) on all media. A diffusible pigment is not produced 
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on ISP Medium No.5, nor is melanin produced on ISP Media No.6 and NO.7. Good growth occurs on Middlebrook 7H9 
agar but no growth occurs at pH 4.3. Starch is hydrolysed. Gelatin is degraded but cellulose is not. 
(iii) Micromonospora sp. strain MMS14 
A diffusible pigment is not produced on ISP Medium No.5, nor is melanin produced on ISP Media No.6 and NO.7. Strain 
MMS14 grows very weakly on Middlebrook 7H9 agar and does not grow at pH 4.3. Starch is hydrolysed. Gelatin is degraded 
but cellulose is not. 
(iv) Micromonospora sp. strain MMS17 
A diffusible pigment is not produced on /SP Medium No.5, nor is melanin produced on /SP Media NO.6 and NO.7. Strain 
MMS17 grows very weakly on Middlebrook 7H9 agar and does not grow at pH 4.3. Starch is hydrolysed. Gelatin is degraded 
but cellulose is not. 
3.3.6 The 7 Streptomycetes 
These 7 strains were placed in the genus Streptomyces by morphology and ARDRA. Mycolic acids were absent. Table 3.8 
shows the important morphological features of these 7 streptomycetes. Tables 3.9 and 3.10 list the physiological characters 
of the strains. It is interesting to note that members of the genus Streptomyces can tolerate much higher sodium chloride 
concentrations than members of the genus Micromonospora. The thin-layer chromatography (TLC) plate of the whole cell 
sugars of some of the Streptomyces strains is shown in Fig. 3.13 (c). The genus Streptomyces does not have characteristic 
sugars useful for descriptive purposes. All 7 strains produced a variety of coloured diffusible pigments on the various agar 
plates used for testing sole carbon and nitrogen source utilization. 
Table 3.8. Morphological characteristics of the 7 Streptomyces strains. 
On ISP Medium NO.4: By Cryo Electron Microscopy: 
Aerial Substrate 
Diffusible Pigment 
Spore Chain Spore Surface Colour on ISP Medium 
Streptomyces Mycelium Mycelium 
Morphology: Ornamentation: No.5: 
Strains: Colour: Colour: 
BAM 1 Blue Navy blue Spira/es Spiny Peach 
BAM3 Blue Blue-green Spirales Spiny Green 
Dark brown to red-
BAM4 Blue Red-orange Rectif1exibiles Smooth 
orange 
BAM7 Blue Blue-green Spira/es Spiny Green 
SVM65 Blue Yellow-brown Spirales Hairy Yellow 
PB Blue Dark pink Spira/es Spiny Pink-red 
HMS88 Yellow Yellow-brown Rectif1exibiles Smooth Pink 
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(a) (b) 
(c) 
(d) 
Fig. 3.6. Scanning electron micrographs of Micromonospora sp. strains MMS2 (a) and MLR (b), and of 'Streptomyces noordhoekensis' strain 
BAM4T (c) and Streptomyces sp. strain HMS88 (d). 
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(a) 
(c) (d) 
(e) (f) 
Fig. 3.9.Scanning electron micrographs of Streptomyces sp. strains BAM1 (a, b) and PB (c, d) showing on the left, the Spira/es spore chain 
morphology, and on the right, a closer view of the spiny spore surface ornamentation. The features of strains HMS88 (top), BAM1 (left), and PB 
(right) are shown in photographs of the substrate mycelial colour (e) and the aerial mycelia color (0 of the strains grown on /SP Medium NO.4 for 
2 weeks at 30°C. 
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(1) 'Streptomyces noonlhoekensis' strain BAM4T 
Streptomyces noordhoekensis (noord'hoek.ensis L. masc. noordhoekensis, of Noordhoek, a coastal suburb in Cape Town) 
was isolated from a beach sand sample. The features seen by electron microscopy are shown in Fig. 3.6 (c). On ISP 
Medium No.5, the substrate mycelium of strain BAM4T changes colour from brown to yellow-brown upon addition of 50 mM 
HC!. This strain produces a dark brown diffusible pigment on Bennett's agar, tyrosine, and egg yolk medium agars, as well 
as a light brown-orange pigment on ISP Medium NO.4. 
A BLAST search revealed that the streptomycetes with highest 16S rONA sequence homology to strain BAM4T are: S. 
/ateritius JCM 43891 (AF454764), with 99% homology (1405 over 1408 bases); and S. venezuelae JCM 4526T (AB045890), 
also with 99% homology (1408 over 1412 bases). The percentage pairwise identities in DNAMAN are 98.39% (over 1410 
nucleotides) and 94.94% (over 1412 nucleotides), respectively. Because of the high 16S rONA homology, DNA-DNA 
reassociation (hybridisation) studies will have to be performed to prove that strain BAM4T is a novel species, despite the 
many differences in physiological characteristics. BAM4T has blue aerial mycelia, a red-orange substrate mycelium, smooth 
spores, and a Rectiflexibiles spore chain morphology. S. lateritius differs from BAM4T in that it has red aerial mycelia and a 
Spirales spore chain morphology, while S. venezuelae differs from BAM4T by having yellow aerial mycelia. Strain BAM4T is 
differentiated from S. /ateritius by the following physiological tests: strain BAM4T was sensitive to penicillin G (10 LU.); it 
utilized L-histidine as a sole nitrogen source but did not utilize L-rhamnose as a sole carbon source. Strain BAM4T is 
differentiated from S. venezue/ae, which is a subjective synonym of S. vio/aceus, by the following physiological tests: strain 
BAM4T did not have lecithinase activity; was resistant to oleandomycin (100 IJ.g/ml) , and was sensitive to rifampicin (50 
J.Ig/ml) and penicillin G (10 LU.); it grew in the presence of 7.0% (w/v) NaCI; it utilized L-histidine as a sale nitrogen source 
but did not utilize L-phenylalanine; it did not utilize raffinose and D-melibiose as sole carbon sources. 
(2) Streptomyces sp. strain HMS88 
Strain HMS88 was isolated from a sediment sample obtained from the Stanford River, which feeds the Klein Estuary. 
Streptomyces strains isolated from marine environments often have yel/owaerial mycelia and a smooth spore surface (17). 
Fig. 3.6 (d) shows the features seen by electron microscopy. Fig. 3.9 (e) and (1) show photographs of strain HMS88 on ISP 
Medium NO.4. This strain produces a pink pigment on ISP Medium No.4, which diffuses throughout the agar plate. 
A BLAST search of the F2 sequence (Fig. 3.10) of strain HMS88 revealed 97% homology to the following Streptomyces 
strains over 860 bases: S. caviscabies AlCC 51928T (sequence accession number: AF112160); S. cyaneus ISP 5108T 
(AJ399460); S. flavogriseus CBS 101.34T (AJ494864); S. griseus (AY207580); and S. setonii ATCC 2549'JT (063872; a 
subjective synonym of S. anulatus). Strain HMS88 has yellow aerial mycelia, a yellow-brown substrate mycelium, 
Rectiflexibiles spore chain morphology and the spore surface is smooth. S. griseus and S. setonii share those features but a 
97% homology is low enough to suggest that strain HMS88 may be a new species. 
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SEQ HMS88 F2 ED: 960 bPi 
Composition 230 A; 239 C; 310 G; 181 T; 0 OTHER 
Percentage: 24% A; 25% C; 32% G; 19% T; O%OTHER 
Molecular Weight (kDa): ssDNA: 298.07 
ORIGIN 
dsDNA: 591.9 
GGAAATTGCC AATGGGCGAA GCCTGATCCA GCGACGCCGC GATGAGGGAT GACGGCCTTC 
61 GGGTTGTAAA CCTCTTTCAG CAGGGAAGAA GCGAAAGTGA CGGTACCTGC AGAAGAAGCG 
121 CCGGCTAACT ACGTGCCAGC AGCCGCGGTA ATACGTAGGG CGCAAGCGTT GTCCGGAATT 
181 ATTGGGCGTA AAGAGCTCGT AGGCGGCTTG TCACGTCGGA TGTGAAAGCC CGGGGCTTAA 
241 CCCCGGGTCT GCATTCTATA CGGGCTAGCT AGAGTGTGGT AGGGGAGATC GGAATTCCTG 
301 GTGTAGCGGT GAAATGCGCA GATATCAGGA GGAACACCGG TGGCGAAGGC GGATCTCTGG 
361 GCCATTACTG ACGCTGAGGA GCGAAAGCGT GGGGAGCGAA CAGGATTAGA TACCCTGGTA 
421 GTCCACGCCG TAAACGTTGG GAACTAGGTG TTGGCGACAT TCCACGTCGT CGGTGCCGCA 
481 GCTAACGCAT TAAGTTCCCC GCCTGGGGAG TACGGCCGCA AGGCTAAAAC TCAAAGGAAT 
541 TGACGGGGGC CCGCACAAGC AGCGGAGCAT GTGGCTTAAT TCGACGCAAC GCGAAAAACC 
601 TTACCAAGGC TTGACATATA CCGGAAAGCA TCAGAGATGG TGCCCCCCTT GTGGACGGTA 
661 TACAGGTGGT GCATGGCCTG TCCTCAGCTC GTG'rCTGGAG ATGTTGGGTT AAGTCCCGCA 
721 ACAAGCGCAA CCCTTGCTCT GTGTTGCCAC CATGCCCTTC GGGGTGATGG GGACTCAAGG 
781 AGACTGCCGG GGTCAACTCG GAGGAGGTGG GGAAACAACA AGTCCTCATG CCCCTTTGTC 
841 TGGGGCCTGA CACGTGCTAC AATGCCGGTA AATGGGTGCG AGCCCGGGGG GAACCAATTC 
901 AAAACCGGCC CCCATCCGAT TGGGGTCGCA CTCGCCCCTG AACCGGATTG TAAAAAAAAA 
Fig. 3.10. Partial16S rONA sequence of strain HMS88 obtained from sequencing primer F2. 
(3) Stf'9ptomyc8$ sp. strain BAM7 
Strain BAM7 was isolated from Noordhoek beach. Fig. 3.11 (a) and (b) show the features of this strain revealed by electron 
microscopy. On ISP Medium No.5, the substrate mycelium of strain BAM7 changes colour from green to purple upon 
addition of He!. 
A BLAST search of the F2 sequence (Fig. 3.12) revealed that the streptomycetes with highest homology to BAM7 are: S. 
olivochromogenes DSM 40451 T (AY094370) and S. cyeneus NRRL B·2296T (AF346475). both showing 99% homology (542 
over 547 bases). Some members of the S. cyaneus species group have blue aerial mycelia, spiny spores, and Spira/es 
spore chain morphology (13). BAM7 differs from S. cyaneus as it has a blue.green substrate mycelium and produces a 
green diffusible pigment, whereas S. cyaneus has neither feature. All strains of S. cyaneus produce melanin on /SP Medium 
NO.6 and utilize D-melibiose and raffinose as sole carbon sources (13). BAM7 shares these features except that D-melibiose 
is weakly utilized. S. o/ivochromogenes is a subjective synonym of S. diastaticus, having grey aerial mycelia and does not 
produce melanin nor has it a green substrate mycelium. 
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(a) 
(c) (d) 
Fig. 3.11 . Scanning electron micrographs (a, b) of Streptomyces sp. strain BAM7 showing the Spira/es spore chain morphology and spiny spore 
surface ornamentation. (c, d) Scanning electron micrographs of Streptomyces sp. strain BAM3; this strain is also spiny with a Spira/es spore 
chain morphology. 
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SEQ BAM7 F2 ED: 675 bpi 
Composition 171 A; 161 C; 219 G; 124 T; 0 OTHER 
Percentage: 25% A; 24% C; 32% G; 18% T; O%OTHER 
Holecular Weight (kDa): ssDNA: 209.80 
ORIGIN 
dsDNA: 416.2 
1 ATGACATGGG CGAAAGCTGA TGCAGCGACG CCGCGTGAGG GATGACGGCC TTCGGGTTGT 
61 AAACCTCTTT CAGCAGGGGA AGAAGCGAAA GTGACGGTAC CTGCAGAAGA AGCGCCGGCT 
121 AACTACGTGC CAGCAGCCGC GGTAATACGT AGGGCGCAAG CGTTGTCCGG AATTATTGGG 
181 CGTAAAGAGC TCGTAGGCGG CTTGTCACGT CGGGTGTGAA AGCCCGGGGC TTAACCCCGG 
241 GTCTGCATTC GATACGGGCT AGCTAGAGTG TGGTAGGGGA GATCGGAATT CCTGGTGTAG 
301 CGGTGAAATG CGCAGATATC AGGAGGAACA CCGGTGGCGA AGGCGGATCT CTGGGCCATT 
361 ACTGACGCTG AGGAGCGAAA GCGTGGGGAG CGAACAGGAT TAGATACCCT GGTAGTCCAC 
421 GCCGTAAACG GTGGGAACTA GCGTGTTGGC GACATTCCAC GTCGTCGGTG CCGCAGTCTA 
481 ACGCATTAAG TTCCCCGTCT GGGGAGTACG GCCGCAAGGC TAAAACTCAA AGGAATTGAC 
541 GGGGGCCCGC AACAATGCCG ATGGAAGTAC ACTGTGGCTT AATTCGAACG CAAACGACGA 
601 AAGAACCTTA CCAACGGGCT TGACACATAC AACCCGCGAA AAGCTCATTC TCAGAATTCG 
661 TAGGCCACAC GCTTG 
Fig. 3.12. Partial16S rONA sequence of strain BAM? obtained from sequencing primer F2. 
(4) Streptomyces sp. strain PB 
Strain PB was isolated from the southern shore of Bazaruto Island, off the coast of Mozambique. The features of strain PB 
revealed by electron microscopy are shown in Fig. 3.9 (c) and (d). Fig. 3.9 (e) and (f) show photographs of strain PB, or 
'Plum Bug" on ISP Medium NO.4. On ISP Medium No.5, the substrate mycelium of strain PB is pH sensitive, changing 
colour from plum to red upon addition of HCI. This strain produces a plum-coloured pigment on ISP Medium No.4, and a 
dark red diffusible pigment on glucose, galactose, and mannitol agars. Strain PB does not share morphological features in 
common with other blue streptomycetes, thus this strain is a potentially novel species. 
(5) Streptomyces sp. strain BAM1 
Strain BAM1 was isolated from Noordhoek beach. Fig.3.9 (a) and (b) show the features seen by electron microscopy. Fig. 
3.9 (e) and (f) show photographs of strain BAM1 on ISP Medium NO.4. Strain BAM1 produces a purple-blue diffusible 
pigment on Bennett's agar; a dark violet pigment on ISP Medium No.4, casein, xanthine, and tyrOSine agars, and in the 
medium used for the nitrate reduction test. Strain BAM1 is a potentially novel species as there is no known streptomycete 
having both blue aerial and substrate mycelia. 
(6) Streptomyces sp. strain BAM3 
Strain BAM3 was isolated from Noordhoek beach. Fig. 3.11 (c) and (d) show the features seen by electron microscopy. On 
ISP Medium No.5, the substrate mycelium of strain BAM3 changes colour from green to purple upon addition of HC!. Strain 
BAM3 is not a strain of S. cyaneus: it has a blue-green substrate mycelium and produces a green diffusible pigment, 
whereas S. cyaneus has neither feature. Furthermore, although strain BAM3 produces melanin on ISP Medium No.6 and 
utilizes raffinose as a sale carbon source, it differs from the S. cyaneus species group in that it does not utilize o-melibiose as 
a sole carbon source. S. viridochromogenes has blue aerial mycelia, spiny spores, and Spira/es spore chain morphology. 
However, BAM3 differs from this species as its green diffusible pigment is not pH sensitive, as well as having other 
61 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
differences in physiological characters. S. viridochromogenes is resistant to rifampicin (50 Jlg/ml). sensitive to penicillin G (10 
I.U,). utilizes meso-inositol, L-rhamnose, and D-melibiose but does not utilize sucrose and L-phenylalanine (13). 
(7) Streptomyces sp. strain SVM65 
Strain SVM65 was isolated from a soil sample obtained from a nature reserve at Silvermine, an area near Noordhoek. Fig. 
3.13 (a) and (b) show the features seen by electron microscopy. This strain produces a lime green pigment on ISP Medium 
No.4, which diffuses throughout the agar plate. Strain SVM65 does not share morphological features in common with other 
blue streptomycetes, thus this strain is a potentially novel species. 
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GMR PB ,BAM1 'GAX IBAM3 BAM7GMR SVM65GAX 
I 
(c) 
Fig. 3.13. (a, b) Scanning electron micrographs of Streptomyces sp. strain SVM65 showing the Spira/es spore chain morphology and hairy spore 
surface ornamentation. (c) Determination of the whole cell sugar pattern of Streptomyces sp. strains PB, BAM1 , BAM3, BAM?, and SVM65. The 
1 % sugar standards are: GMR, glucose, mannose, and ribose; GM, galactose, arabinose, and xylose. 
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Table 3.9. Physiological characteristics of the 7 Streptomyces strains. 
In 00 
..... 
-.to C") t- CD 00 
:E :e :e :e :e Q) 
« « « « m G> :e Characteristics: m m m m a.. :I: I 
Diffusible pigment on ISP Medium NO.5 + + + + + + + I 
Aesculin hydrolysis vs+ vs+ + vs+ vs+ vs+ vs+ I 
Arbutin hydrolysis + + + + + + + 
Hippurate hydrolysis - - - - -
Pectin hydrolysis + + + + + 
- i 
i Nitrate reduction + + - - + - + ! 
• H2S production + + I + + + + + I 
Growth in the presence of NaCI (%, w/v): 
7.0 + + + + + + + ! 
11.0 - - - + - + : 
Adenine degradation + + + + + + + 
• Allantoin degradation - - + - - i 
Casein degradation + + + + + + + : 
Cellulose degradation - - - - - - w+ 
Gelatin d~radation + + + + + + + i 
Guanine degradation - + - - + - ! 
Hypoxanthine degradation + + - - + + - I 
• Starch degradation + + + + i + + ! 
Tween 80 degradation + + + + + + + 
l-Tyrosine degradation + + 
- -
+ 
-
Urea degradation w+ - - - + - - I 
Xanthine degradation 
-
+ + - - - I 
i Xylan degradation - - - - -
I Melanin on ISP Medium NO.6 + + + + - I 
Melanin on ISP Medium No. 7 + 
- - - - -
I 
Growth at 4"C - - - -
Growth at 37°C + + + + + + + ! 
Growth at pH 4.3 - - + + + + -
Growth in the presence of 0.1 % 2-Phenylethanol - - - I 
• Antibiotic Susceptibility: 
Cephaloridine (100 J!g/ml) - - - + - - + I 
Gentamicin (100 f.lg/ml) - - - - - - -
Kanamycin (10f.lg/ml) - - - -
Lincomycin (100 Ilg/ml) + - - + + + + 
Neomycin (50 f.lg/ml) - - - - - - -
Oleandomycin (100 f.lg/ml) + + + + + + + 
Penicillin G (10 I.U.) + - + + + - + 
Rifampicin (50 f.lg/ml) - + + + + 
Streptomycin (100 J!g/ml) - - - - - - -
Tobramycin (50 f.lg/ml) - - - - - - + 
Vancomycin (50 !lg/ml) - -
Lecithinase activity + - + + + + - i 
Lipase activity + - - - + 
i Protease activity I + 
- + + - - + 
.. Abbreviations: +, posItive resulUgrowth; -, negative resulUno growth; vs, very strong growth; w, weak growth. 
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Table 3.10. Streptomyces sole carbon and nitrogen source utilization. 
i Characteristic: HMS88 SVM65 BAM1 PB BAM4 BAM7 BAM3 
Carbon Sou rees: 
L( + )-Arabinose ++ + + ++ + + ++ 
o( + )-Cellobiose + + + ++ ++ + ++ 
D( - )-F ructose + ± + i ++ != + + o( + )-Galactose + + + + + ++ 
Glycerol + + - - ++ + + 
• meso-Inositol - + + ++ ± ++ -
i D-Lactose ± ++ + ++ ± + ++ I 
! Maltose + ± - + ± .. 
D-Mannitol + + + + - + ++ 
0(+ )-Melezitose - ++ .. I ± I 
• D(+)-Melibiose ± .. ++ ± 
• Raffinose - + + ++ - + ++ 
L( + )-Rhamnose + ± - + + ! 
Salicin I ± ± .. - ± + 
• Sodium benzoate - - - - - - -
Sodium citrate ± ± - ± -
I Sodium malonate - - - .. - .. 
• Sodium propionate ± ± - .. ± ± - I 
o-Sorbitol .. -
L( - )-Sorbose .. .. .. -
Sucrose - + + + .. ++ ++ 
Trehalose ++ + + ++ ++ ++ + 
Xylitol 
-
.. .. 
-
.. .. 
-
o(+)-Xylose ++ ± - ++ ± + - ! 
Nitrogen Sources: 
OL-a-amino-n-butyric acid ± ± - - + ± + 
4-amino-n-butyric acid + + ++ + ± + + 
I L-Arginine + ++ ++ ++ + + + 
• L-Asparagine + + + + + + + 
I L -Cysteine .. .. .. .. - ± ! 
! L-Histidine + ± ++ ++ + + + 
· 
L -Hydroxyproline .. + + + + + ++ I 
I L-Methionine - + ++ ± ± + 
I oL-Ornithine 
- -
++ + - + + 
• 
L -Phenylalanine + + ++ + .. ± + 
I Potassium nitrate + +~~ + + ± ++ ! L-Serine + ++ R + + • L-Threonine L± + + + L-Valine ± + + ++ 
Abbreviations: -, no growthlutihzatlon; ±, weak growthlutllization; +, moderate growth/utilization; ++, good growthlutlhzatlon. .. .. .. " 
3.3.7 Six Other Strains of Interest: 3 Streptomyces and 3 Pseudonocsrdis Strains 
The 3 Pseudonocardia strains were isolated from the River Kwai, Thailand, while Streptomyces sp. strains LMP-TD and 
LMP-BRP were iso/a ted from the is/and of Phuket, Thailand. Streptomyces sp, Kit2004 was isolated from the Beacon Isle 
lagoon, South Africa, As these strains were isolated from previously unexplored environments, they should be further 
investigated to assess their potential novelty, especially since the streptomycetes show promising antimicrobial activity (see 
Chapter 5), 
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(b 
(d) 
Fig. 3.14. Photograph of the colour of the aerial mycelia of (a) Streptomyces sp. strain LMP-TO (left half of the agar plate) and Streptomyces sp. 
strain Kit2004 (right), grown on ISP Medium No.4 for 2 weeks at 28°C. (b) Photograph of the aerial mycelial colour of Streptomyces sp. strain 
LMP-BRP grown on Bennett agar. (c) The 3 Pseudonocardia sp. strains grown on YEME agar: strain RKVB-VW (left), strain RKVB-LW (middle), 
and strain RKVB-3CBM2G (right). Digital photographs taken through the eye lens of a light microscope: (d) The tightly curled spirals at the ends 
of the long mycelia of strain LMP-TO can be seen; (e) The dense mycelia of strain RKVB-LW. The magnification of the light microscope was 
1000x. 
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The genus level of these 6 strains was determined by ARDRA. Photographs of these 6 strains are shown in Fig. 3.14 (8), 
(b), and (c). Photographs of the aerial mycelia of strains LMP-TD and RKVB-LW, grown on ISP4 and YEME agar plates, 
respectively, seen through a light microscope, are shown in Fig. 3.14 (d) and (e). Streptomyces sp. strain LMP-TD has a 
brown-red aerial mycelium and brown substrate mycelium on ISP Medium No.4. The spore chain morphology, seen through 
a light microscope, was Spira/es. Streptomyces sp. strain Kit2004 has a green aerial mycelium and dark brown-green 
substrate mycelium on ISP Medium No.4. A dark green diffusible pigment is also produced. The spore chain morphology is 
Rectiflexibiles. Streptomyces sp. strain LMP-BRP grew poorly on /SP Medium No.4 but grew very well on other media such 
as Bennett's and modified 172F agars. On ISP Medium No.4 the aerial mycelium is orange and the substrate mycelium is 
yellow-brown. The spore chain morphology is Rectiflexibiles. As can be seen in Fig. 3.14 (b) this strain has a dark red 
substrate mycelium and multicoloured aerial mycelia on other agar plates, such as YEME, Bennett's agar, and modified 
172F agar. 
Electron microscopy will need to be performed on the 3 Pseudonocardia strains to be able to see details of the mycelium 
and the spores. All 3 strains have an orange substrate mycelium; the texture of each strain varies, as does the extent of 
sporulation (surface area covered by the white aerial mycelia). 
3.4 Conclusion 
The Klein Estuary, or Hermanus Lagoon, is concluded to be an eminently suitable ecosystem from which to isolate novel 
aetinomycetes for screening programs. Strains of the rare actinomycete genus Micromonospora were easily isolated on 
YMEM and modified 172F media, supplemented with nalidixic acid and cycloheximide as selective inhibitors. At this time, 
and as a result of this study, there are 34 actinomycete isolates that warrant further investigation. There are potentially 7 
novel Streptomyces strains and potentially 21 novel Micromonospora strains. Nine (9) new species are proposed: 
'Micromonospora aquatica', 'Micromonospora areninco/ae', 'Micromonospora cinerea', 'Micromonospora grate/oupico/ae', 
'Micromonospora hennanusense', 'Micromonospora lacunae', 'Micromonospora stanfordense', 'Micromonospora terrae', and 
'Streptomyces noordhoekensis'. The application of the Identification Key to environmental Micromonospora isolates proved 
very successful. None of the strains tested grew on vancomycin (50 f.1g1ml) plates. Hippurate hydrolysis, guanine 
degradation, growth at 4 and 45°C, growth at pH 4.3, and sensitivity to rifampicin (50 f.19/ml) are physiological tests that have 
been developed for Micromonospora species delineation. 
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Chapter 4 
Micromonospora Antibiotic Biosynthetic Capability 
4.1 Introduction 
4.1.1 Micromonospora Antibiotic Classes In Brief 
The genus Micromonospora displays diverse secondary metabolite capabilities. Members of Micromonospora produce 
compounds belonging to antibiotic classes such as aminoglycosides. macrolides. ansamysins. and everninomicins (see 
Table 4.1 and Chapter 5 for more in depth information). 
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Table 4.1. Validly published Micromonospora species, their secondary metabolites, and important infonnation on the strains used in this 
study. 
No.: Lista: Speciesb: 
AL 1980 M. auran(iaca 
2 VL2004 M. aura(inigra 
3 AL 1980 M. carbonacea 
M. cha/cea 
4 AL1980 (Type Species) 
5 VL 1992 M. chersina 
6 AL 1980 M. coerulea 
7 AL 1980 M. echinospora 
Strains Used in This Study 
And Important Commentsc: 
M. auran(iaca NRRL 8-160911 
~ Preferred growth medium: m172F 
Agar. 
Information on this species obtained from the 
publication. 
M. c8rbon8ce8 subsp. c8rbon8ce8 NRRL 
2972T 
Synonym: 
M. carbonacea subsp. auran(iaca NRRL 
299?T 
M. chalcea subsp. chalcea NRRL 8-2344T 
~ Steroid conversion. 
~ 'fmrO-' and 'fmrT-type' Negative 
Control (NmS). 
~ Preferred growth medium: m172F 
Agar. 
M. chersina DSM 441511 
M. coeru/ea DSM 43143T 
M. echinospora subsp. echinospora NRRL 
2985T 
~ Gentamicin. 
~ 'fmrO-type' Positive Control. 
~ Preferred growth medium: 8M 
Agar. 
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Secondary Metabolite 
Capabilities 
Of the Species 
(Antibiotic Class)d: 
No antibiotic. 
No antibiotic. 
Eveminomicin Antibiotic 
Complex 
(Eveminomicin) 
Neomycin 
(Aminoglycoside) 
T etrocarcin Antitumor and 
Antimalaria Complex 
(Tetrocarcin) 
Neorustmicin B 
(Macrolide) 
Macquarimicin A 
(Cytotoxic Agent) 
:1Q-membered Enediyn€ 
No antibiotic. 
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M. echinospora NRRL 2953T 
» Gentamicins and the restriction 
endonuclease Mpul. Gentamicin Antibiotic Complex 
» 'fmrO-type' Positive Control. (Aminoglycoside) 
M. echinospora subsp. echinospora NRRL 
B-12180 Lipannacin A and Tiacumicin C 
» No antibiotic product. (Macrolide) 
» 'fmrO-type' Negative Control. 
S~non~m: 
M. echinospora subsp. ferruginea NRRL 
2995T 
» Gentamicin. 
Heterotypic S~nonyms: 
M. purpurea 
M. rhodorangea Antibiotic G-418 
(Aminoglycoside) 
M. endolithica strain AA-459T 
» Preferred growth medium: BM 
8 VL2004 M. endolithica 
Agar. 
No antibiotic. 
» Preferred temperature range for 
growth: 28°C - 37°C. 
M. gal/ica 
9 AL1980 (No strain available: N/A N/A 
Lost) 
M. halophytica subsp. halophytica NRRL Halomicin Antibiotic Complex 
2998T (Ansamysin) 
10 AL1980 M. halophytica » Halomicin and vitamin B12. 
» Preferred growth medium: m172F K 13: angiotensin I converting 
Agar. enzyme inhibitor. 
M. inositola NRRL B-16095T 
» XK-41 Complex. XK-41 Antibiotic Complex 
11 AL 1980 M. inositola 
» Preferred growth medium: BM (Macrolide) 
Agar. 
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M. matsumotoense DSM 44100T 
12 VL2000 M. matsumotoense No antibiotic. 
Basonvm: 
Catellatospora matsumotoense 
M. nigra NRRL 3097T 
~ Halomicin and possibly 
everninomicin. Halomicin Antibiotic Complex 
13 AL1980 M. nigra (Ansamysin) 
M. nigra NRRL 8-16696T 
~ No antibiotic. 
M. olivasterospora NRRL 8178T 
~ Fortimicins. Fortimicin Antibiotic Complex 
14 1983 M. o/ivasterospora ~ 'fmrO-type' Positive Control. (Aminoglycoside) 
~ Preferred growth medium: BM Fortimicin A '" Astromicin. 
Agar. 
M. echinospora subsp. pal/ida NRRL 2996T 
~ Gentamicin. Gentamicin Antibiotic Complex 
15 AL1980 M. pal/ida 
~ Preferred growth medium: BM (Aminoglycoside) 
Agar. 
M. purpureochromogenes NRRL 8-16094T 
~ Possible product: Gentamicin. 
~ Preferred growth medium: 8M 
M. Agar. 
16 AL1980 No antibiotic. 
purpureochromogenes 
Heterotypic Synon,ym; 
M. brunnea 
M. rosaria NRRL 3718T Rosaramicin 
~ Rosaramicin (Macrolide) 
17 1986 M. rosaria 
~ Preferred growth media: YEME 
and m172F agars. 
Sch23831 
(Ansamysin) 
. . .. Abbreviations: AL, approved list; VL, validation list; BM, Bennett's Agar; N/A. not applicable; Nms, sensItive to neomyCin . 
'Information obtained from reference 5. 
blnformation obtained from reference 9. 
"Information obtained during the course of this study, and from the NRRL (14), DSMZ (3), and reference 5. 
dinformation obtained from the NRRL (14), and references 4 and 5. 
"Information obtained from reference 11 . 
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Of greatest interest in this study are the aminoglycosides. Many Micromonospora strains produce aminoglycoside 
antibiotics and thus if a new Micromonospora species is isolated, the strain may produce an aminoglycoside-type antibiotic. 
Of most significance is that aminoglycoside biosynthesis has been well documented in the literature, which lends a greater 
understanding to how aminoglycoside antibiotics are produced. In line with the interests of this laboratory, viz. the search for 
novel antitubercular antibiotics, it must be noted that two aminoglycosides (kanamycin and streptomycin) are used to treat 
tuberculosis. However, M. tuberculosis has evolved resistance to these drugs. Thus the search for novel antitubercular drugs 
could begin with searching for novel aminoglycoside antibiotics. 
In a 1976 review article (20), Rinehart et 81. divided aminoglycoside antibiotics into 5 distinct groups. With the discovery of 
fortimicin in 1977, it was found that this aminoglycoside was a unique member of the antibiotic class. While all other 
aminoglycosides are pseudotrisaccharides or pseudotetrasaccharides, fortimicin is a unique pseudodisaccharide (8) . 
Aminoglycoside antibiotics can now be divided into 6 groups based on differences in their chemical structures (Table 4.2). 
Table 4.2. The 6 groups of the aminoglycoside antibiotic class. 
Aminoglycoside Group Designated as: 
1 4, 5-disubstituted deoxystreptamine 
2 4, 6-disubstituted deoxystreptamine 
3 Monosubstituted deoxystreptamine 
Aminoglycosides derived from Streptidine, Bluensidine, and 
4 
Actinamine. 
5 Monoaminocyclitol 
6 1, 4-diaminocyditol 
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Examples of Antibiotics Belonging to the 
Group: 
Neomycins 
Kanamycins 
Tobramycin 
Nebramycins 
Gentamicins 
G-418 
Sagamicin 
G-S2 
Hygromycin B 
Apramycin 
Spectinomycin 
Bluensomycin 
Streptomycin 
Hygromycin A 
Fortimicin 
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4.1.2 Aminoglycoside Antibiotic Biosynthesis and Resistance Genes 
In order for antibiotic producers to avoid 'suicide', they must have a 'self-defence mechanism' against their own antibiotics. 
Antibiotic biosynthetic genes are clustered in specific regions in the genome, and the genes conferring resistance to an 
organism's own antibiotics are located in or near the biosynthetic gene clusters (17). 
In a 1993 study by Ohta et al. (17), arninoglycoside producing strains were found to possess resistance genes belonging to 
one of two 'types', based on differences in their aminoglycoside resistance profiles and DNA homologies. The strains used in 
the study were representatives of the genera Micrornonospora and Streptomyces, and species Saccharopolyspora hirsuta 
and Dactylosporangium matsuzakiBnse. The aminoglycoside producing strains were inoculated onto media containing 
different concentrations of aminoglycoside antibiotics (fortimicin, gentamicin, neomycin, kanamycin, and streptomycin) in an 
attempt to assess the sensitivity of aminoglycoside producing strains to various aminoglycosides. As expected, strains were 
not sensitive to their own products, e.g., the fortimicin producers were resistant to fortimicin in the agar media. Furthermore, 
it was found that all of the strains tested were highly resistant to kanamycin, but highly sensitive to streptomYCin. 
They had found a link between the genotype and the phenotype of the strains (Table 4.3). The first resistance type was 
deSignated the 'fmrT-type', showing resistance to neomycin, fortimicin and kanamycin, and sensitivity to gentamiCin and 
streptomycin. The second resistance type, designated the 'fmrO-lype' showed resistance to gentamicin, fortimicin, and 
kanamycin, and sensitivity to neomycin and streptomycin. Importantly, they found that the 'fmrO-type' resistance genes are 
located adjacent to the biosynthetic gene clusters in the strains examined (17). 
Resistance 
Genotype: 
'fmrO-type' 
(GmR.KmR; 
NmS-SmS) 
'fmrT-type' 
(NmR.KmR; 
Gms-SmS) 
Table 4.3. The resistance profiles of the two types of aminoglycoside resistance genes. 
Resistance Phenotype: 
Resistant to: Gentamicin, Fortimicin and 
Kanamycin. 
SenSitive to: Neomycin and Streptomycin. 
Resistant to: Neomycin, Fortimicin and 
Kanamycin. 
Sensitive to: Gentamicin and Streptomycin. 
Examples of Strains With This Resistance 
Type: 
Micromonospor8 o/iv8sterospora 
Micrornonospora echinospora 
Micromonospor8 pa/lida 
Streptomyces tenebrarius 
Streptomyces tenjimariensis 
Saccharopolyspora hirsuta 
Abbreviations: R, resistant; s, sensitive; Gm, Gentamicin; Km, Kanamycin; Nm, Neomycin; Sm, Streptomycin. 
One way to predict the antibiotic class before attempting purification is to screen for the presence of Specific biosynthetic 
genes. By using peR primers, specifically designed to amplify a particular biosynthetic gene, or the resistance genes, 
belonging to the aminoglycoside biosynthetic cluster, an amplified fragment would indicate the presence of this gene in the 
bacterium's genome, providing presumptive evidence of the ability to synthesize an aminoglycoside type antibiotic. This 
strategy acts as a tool to assess rapidly whether or not any strain under investigation has the genes for an aminoglycoside-
type antibiotic. This saves on time and effort as knowing the class of antibiotic allows one to consult the literature for a 
purification procedure that will work for that specific antibiotic type. 
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It must be noted that targeting resistance genes for PCR amplification presents some limitations: not all resistance genes 
are located in the biosynthetlc cluster, and strains may possess acquired resistance to antibiotics due to gene transfer 
between strains in their natural environment (i.e. strains may exhibit antibiotic resistance, but lack the genes for antibiotic 
biosynthesis). 
4.1.3 This Study 
In this study, the aim was to attempt to ascertain what type of antibiotic the Micromonospora strains under investigation 
have the potential to produce in an effort to make the purification step easier. Various genes were analysed and PCR 
primers, specific for the amplification of ansamysin, glycopeptide, and aromatic antibiotic biosynthetic genes, were used. 
Primers were designed to amplify the 'fmrO-' and 'fmrT-type' aminoglycoside resistance genes, and an antibiotic 
susceptibility plate assay was used to confirm the PCR results. 
4.2 Materials and Methods 
4.2.1 Phylogenetic Analysis 
Phylogenetic trees were constructed from 16S rRNA gene sequences, gyrB gene sequences, and aminoglycoside 
resistance gene sequences. Species of the genus Micromonospora used were those on the Approved Lists of Bacterial 
Names prior to May 2004 (5). Multiple sequence alignments were performed using DNAMAN, Version 4.13 (Lynnon BioSoft). 
All sequences were edited to produce the longest sequence region common to all sequences in each data set The GenBank 
sequence accession numbers are indicated in brackets after the type strain names. Bootstrapping analysis was used to test 
the Significance of phylogenetic affiliations. The trees were generated by the neighbour-joining method (21), with pairwise 
distances calculated by the Kimura two-parameter estimation, and the percentage bootstrap values obtained by using 
CLUSTALX, Version 1.81 (24) and MEGA2, Version 2.1 (12). 
4.2.2 DNA Extraction 
DNA was extracted according to the method of Cook and Meyers (2) and by the Freeze-Thaw Method (Goodwin, 
unpublished). Cultures were grown in ISP Medium No.2 broth (23), Bennett's broth or 172F broth (see 3.2.2). Broth cultures 
were incubated with shaking for 4 - 6 days at 30°C and 37°C. The Freeze-Thaw Method was performed as follows: 1 ml of 
broth culture was pipetted into a 1.5 ml microfuge tube, centrifuged for 1 - 2 min, and the supernatant discarded. The cell 
pellet was washed in 500 1-11 of 10 mM Tris-HCI-1 mM EDTA (TE) buffer (pH 7.6) and resuspended in 500 III TE buffer (pH 
7.6). The sample was first exposed to -70°C for several hours and then to +70°C for 10 min. This was repeated for three 
cycles. After the third cycle, the sample was placed in a 100DC water bath for 10 min, allowed to cool and centrifuged for 1 
min. Four hundred (400) t.tl of the supernatant was transferred to a 1.5 ml microfuge tube. The DNA was stored at -20°C. 
4.2.3 PCR Amplification and Agarose Gel Electrophoresis 
The primers used in this study for the amplification of various genes are listed in Table 4.4. All synthetic oligonucleotides 
were supplied by the Oligonucleotide Synthesising Service of the Molecular and Cell Biology Department, University of Cape 
Town, Cape Town, South Africa. 
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Super-Therm thermostable DNA polymerase (Taq), 10X Reaction Buffer, and 25 mM MgCI2 were supplied by JMR 
Holdings, USA. dNTPs were supplied by Roche. Each PCR reaction tube contained the following (giving a total of 50 III 
reaction mix): 4 !JI MgCI2 (25 mM), 5 !JI10X Reaction Buffer, 2.5 III of each primer (10 !lM each primer), 0.3 !JI dNTPs (100 
mM), 0.3 III Taq polymerase (5 UlIll), 33.4 III H20, and 2 III DNA. The cycle profile was as follows: initial denaturation (96°C 
for 2 min); 30 cycles of denaturation (96°C for 455), annealing (56°C for 30 s for the 16S rRNA gene and ARO-PKS; S6nC 
or 54°C for oxyB; 50°C or 48°C for grm; 60aC or 64°C for fmr; 52°C for ANSA), and extension (72°C, for 2 min for the 16S 
rRNA gene and ANSA; 90 s for ARO-PKS; 75 s or 90 s for fmr, 75 s for oxyB and grm); and a final extension (72°C for 5 
min) followed by a cooling step WC for 10 min). 
PCR products were analysed on agarose gels according to Sam brook et al. (22). The bands were visualized on a 254 nm 
transilluminator (UVP©) and photographs taken. A standard 'APst DNA ladder was used as the marker. 
The oxyB primers were designed to specifically target the monooxygenase B gene, involved in the biosynthesis of 
glycopeptide antibiotics (19). The ARO-PKS primers amplify across the junction of the tandem KSa and KSI3 genes in the 
biosynthetic cluster of aromatic polyketide antibiotics speCifically using Type II polyketide synthases (PKS) in their 
biosynthesis. However, these primers may also amplify spore pigment genes as there is an evolutionary link between 
biosynthetic genes encoding aromatic poIyketide antibiotics and those encoding spore pigments (1). The only way to know 
which has been amplified is to sequence the PCR product. The ANSA primers amplify the gene encoding AHBA synthase, 
the unique starter molecule that generates the ansamysin antibiotic (6, 13). The grm primers amplify 'fmrO-type' 
aminoglycoside resistance genes and the fmrprimers amplify 'fmrT-type' aminoglycoside resistance genes. 
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Table 4.4. List of peR primers used for the amplification of specific genes. 
Primer Sequences: 
(Listed as Forward and Reverse primers, respectively; I = inosine.) 
16S rRNA gene (F1 and R5 modified from primers 101 and rP2, respectively. of 
Weisburg, et a/. [25]) 
F1 : 5'-AGAGTTTGATCITGGCTCAG-3' 
R5: 5' -ACGGITACCTTGTT ACGACTT - 3' 
oxy8 (designed by Dr Paul Meyers) 
Targets the glycopeptide monooxygenase (oxyB) gene. 
Foxy: 5' -CTGGTCGGCAACCTGATGGAC-3' 
Roxy: 5' -CAGGTACCGGATCAGCTCGTC-3' 
ARO·PKS (designed by Dr Paul Meyers) 
Targets PKS Type II KSI-KSII tandem genes. 
ARO-PKS-F: 5' -GGCAGCGGITTCGGCGGITTCCAG-3' 
Binds in the 3' half of the ketosynthase (KS) gene: KSIIKSa. 
ARO-PKS-R: 5' -CGITGTTIACIGCGT AGAACCAGGCG-3' 
Binds in the 5' half of the chain-length-factor gene: KSIIIKSI3. 
grm (=fmrO) (grm1 and grm2, respectively, of Ohta, et at. [15]) 
grm-F: 5' -CAGGCCATCACCAAGAGCCGGCGCTACCAG-3' 
grm-R: 5' -GT AAA TCAGCTCGTTGCCGATCTCCAGTCG-3' 
fmr (=fmrn (redundant primers, designed by Candice Goodwin and Dr Paul 
Meyers) 
frnrT-F: 5'-ATGCC(GC)TGGGG(GC)AGCCTGCTGCGCGG-3' 
frnrT-R: 5'-G(CA)CG(CG)CGGGTCCA(CG)GAGGT(CG)(GT)CCAG-3' 
ANSA (redundant primers. designed by Dr Paul Meyers) 
Targets the ansamysin 3-amino-S-hydroxybenzoic acid (AHBA) synthase gene. 
ANSA-F: 5' -CC(CG)GC(GC)TTCAC(CG)TTCATCTC-3' 
ANSA-R: 5' -AI(GC)(CT)GGAICA T1GCCATGTAG-3' 
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Expected Fragment 
Size: 
1500 bp 
591 bp 
492-630 bp 
(But mostly in the 
region of 500 bp.) 
734 bp 
284bp 
741 bp 
% Agarose 
Used: 
1.2 
1.2 
1.2 
2.0 
2.0 
1.5 
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4.2.4 Aminoglycoside Antibiotic Susceptibility Assay on Solid Agar Media 
8M-Glucose Agar (see 3.2.2) was used as a basal medium, and the antibiotics were added to the medium after 
autoctaving. The following antibiotics and concentrations were used: gentamicin (100, 50, 20, 10, and 5 J.1g1ml) (Sigma), 
kanamycin (10 and 2 fJ.g/ml) (Sigma), neomycin (20, 10, 7.5, 5, and 4 J.1g/mf) (Intramed), and streptomycin (100 fJ.g/ml) 
(Calbiochem). Plates were incubated for 7 days at 28-30°C. Growth at any of these concentrations was taken as resistance 
to the antibiotic. 
4.2.5 Strains Used in This Study 
DNA was extracted from the following strains for this study: Micromonospora halophytica subsp. ha/ophytica NRRL 2998T, 
Micromonospora nigra NRRL 3097T, M. nigra NRRL B-16696T, Micromonospora o/ivasterospora 8178T, Micromonospora 
echinospora subsp. pal/ida 2996T, 'Streptomyces tenebrarius' NRRL B-12390T, and Saccharopo/yspora hirsuta NRRL B-
5792T were kindly provided by Dr David P. Labeda, curator of the Actinobacterial Culture Collection at the U.S. Department 
of Agriculture Agricultural Research Service, Peoria, Illinois, United States of America. The other strains used in this study 
are listed in Chapter 2 (2.2.1). 
4.3 Results and Discussion 
4.3.1 Phylogenetic Analysis 
Phylogenetic relationships deduced from the nucleotide sequences of 16S rRNA genes often do not agree with the DNA 
reassociation values determined by DNA hybridisation, which is the criterion used to define a species (26). This is because 
the resolution of 16S rONA sequence analysis is low for ctosely related organisms. To resolve the phylogenetic relationships 
of closely related strains, it is necessary to use other gene sequences that provide a higher resolution than that· of the 168 
rRNA gene (26). 
DNA gyrase (gyrB encodes the DNA gyrase 8 subunit) is the enzyme responsible for introducing negative supercoils into 
bacterial chromosomal DNA, playing a crucial role in chromosome replication, and thus is essential for a bacterium's 
survival. Furthermore, protein-encoding genes have been reported to evolve much faster than rRNAs, and horizontal transfer 
of these genes may be as rare as that of rRNA genes (26). Kasai et al. (9) performed a phylogenetic analYSis on the genus 
Micromonospora using gyrB sequences in order to provide a higher resolution than an analysis using 16S rRNA gene 
sequences (there is no gyrB sequence available for M. matsumotoonse). 
A 16S rONA phylogenetic tree was constructed and the secondary metabolite capabilities of the Micromonospora species 
were highlighted to determine whether there is a link between taxonomic position and the type of antibiotic produced (Fig. 
4.1). It was interesting to note that the macrolide producers formed a clade of their own, however, of more interest were the 
aminoglycoside producers. Referring to Table 4.2, neomycin, gentamicin, and fortimicin are classified as belonging to three 
different groups of aminoglycoside antibiotics, viz. 4, 5-disubstituted deoxystreptamine, 4, 6-disubstiMed deoxystreptamine, 
and 1, 4-diaminocyctitol, respectively. It is interesting that both the 16S rRNA and gyrB (Fig. 4.2) phylogenetic trees reflect 
this: M. echinospora and M. pal/ida both produce gentamicin and group together (most noticeable in the gyrB tree). M. 
olivasterospora, the producer of the unique fortimicin, is isolated in a deep branch in both trees. M. cha/rea, the neomycin 
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producer, is phylogenetically unrelated. Thus, having their secondary metabolites belonging to three structurally different 
aminoglycoside groups, could explain why the species' phylogenetic pOSitions are separate, as opposed to a single clade 
consisting of all the aminoglycoside producers. 
32 
54 
M. chersina DSM 44151 ' (X92628) 
M. rosaria DSM 803T [MRL) (X92631) 
M. inositola DSM 43819T [MRL) {X92610) 
M. echinospora DSM 43816T [AGS) (X92607) 
M. pa/lida DSM 43817' [AGS) (X92608) 
"---M. nigra DSM 43818' [ASM) (X92609) 
'-----M. coerulea DSM 43143' [NAB) (X92598) 
.-----M matsumotoense IMSNU 22003' [NAB] (AF152109) 
M. purpureochromogenes DSM 43821 ' AB] (X92611) 
M. halophytica DSM 43171 ' [ASM) (X92601) 
M aurantiaca DSM 43813T AB) (X92604) 
M. chalcea DSM 43026' [AGS) (X92594) 
M. olivasterospora DSM 43868 T [AGS ) (X92613) 
M. carbonacea DSM 43168' [ENM] (X92599) 
'---____________________ Streptomyces africanus NRRL B-24143' (AY208912) 
0.01 
Fig. 4.1 . An unrooted phylogenetic tree of 14 of the validly published members of the genus Micromonospora based on 16S rRNA gene 
sequences, and showing the secondary metabolites produced. The tree was constructed with 1412 bp of alignable 16S rRNA gene 
sequence. with Streptomyces africanus NRRL B-24143T as the outgroup. The GenBank sequence accession numbers are indicated in 
brackets. The abbreviations of the antibiotic classes to which the secondary metabolites belong are indicated in square brackets: 
aminoglycoside (AGS). ansamysin (ASM). enediyne polyketide ' ). eveminomicin (ENM). macrolide (MRL). and no antibiotic product 
(NAB). Nodes are labelled with the percentage bootstrap replications (out of 1(0) in which the node was found. The scale bar represents 
an average of 0.01 nucleotide substitutions per site. 
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100 1'- ----- M. cha/cealFO 13503T [AGS] (AB014148) 
r---------~ ~ I M. aurantiaca IFO 16125 [NAB] (AB015621) 
51 I IL-_________ M. chersina IFO 15963 T IB1 (AB015622) 
,--_8_9--111 M. nigralFO 16103T [ASM] (AB014156) 
I ~ M. purpureochromogenes IFO 13324T [NAB] (AB014161) 
~ 72 1 M. ha/ophyticalFO 14112T [ASM] (AB014157) 1----------------- M. coeru/ea IFO 13504T [NAB] (AB014151) 89 M. CarDonacealFO 14108T [ENM] (AB014147) 
,-------------- M. inosito/a ATCC 21773 T [MRL] (AB014158) 
,--------------------- M. olivasterospora IFO 14304T [AGS] (AB014159) 
,------------M. rosarialFO 13697T [MRL] (AB014163) 
,--------- M. echinospora IFO 13149T [AGS] (AB014154) 
~--------~ 
100 LI --------- M. pallidalFO 16070T [AGS] (AB014153) 
0.01 
Fig. 4.2. An unrooted phylogenetic tree of 13 of the validly published members of the genus Micromonospora based on gyrB gene 
sequences and showing the secondary metabolites produced. The tree was constructed with 1179 bp of alignable gyr8 gene sequence. 
The GenBank sequence accession numbers are indicated in brackets. The abbreviations of the antibiotic classes to which the secondary 
metabolites belong are indicated in square brackets: aminoglycoside (AGS), ansamysin (ASM), enediyne polyketide . , eveminomicin 
(ENM), macrolide (MRL), and no antibiotic product (NAB). Nodes are labelled with the percentage bootstrap replications (out of 100) in 
which the node was found. The scale bar represents an average of 0.01 nucleotide substitutions per site. 
Having examined the phylogenetic trees, It was thought that If a new strain's 16S rONA sequence was added to the 
phylogenetic tree, the strain's phylogenetic position may reveal the type of antibiotic the strain may be capable of prodUCing. 
However, as revealed in Chapter 3 (see Fig. 3.5), it was found that our laboratory's strains funned a clade of their own, and 
the antibiotic type cannot be predicted. Perhaps the finding may be different if the gyrB genes were sequenced for the 
strains, as well as for M. matsumotoense. 
68 r--------- Streptonyces tenebrarius NCIB 11028 karrB (M64625) 
100 L-_____ Saccharopo/yspora hirsuta Strain CL 102 karrC (M64626) 
'---____ Streptonyces tenjirrariensis ATCC 31602 frrrT [karrl'1 ] (013170) 
,..--__________ MicrormnospoflJ O/ivilsterosporll AlCC 21819T frrrO (013171) 
Microrronospora rosea grm (M55521) 
100 Microrronospora purpurea grm (M55520) 
t-
0 .1 
Fig. 4.3. Phylogenetic analysis of the aminoglycoside resistance genes of 6 strains of 3 actinomycete genera. The resistance genes are 
classified into 2 groups on the basis of DNA homology: 'fmrT-type' (in blue) and 'fmrO-type' (in red). The GenBank sequence accession 
numbers are indicated in brackets. Nodes are labelled with the percentage bootstrap replications (out of 100) in which the node was found. 
The scale bar represents an average of 0.1 nucleotide substitutions per site. 
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Fig. 4.3 shows the phylogenetic analysis of the aminoglycoside resistance genes of representatives of the two 
aminoglycoside resistance types. The tree is neatly divided into two clades, the 'fmrO-type' clade in red, and the 'fmrT-type' 
clade in blue. The gene abbreviations are as follows: kam, kanamycin-apramycin resistance methylation; fmr, fortimicin-
resistance gene; grm, gentamicin resistance-encoding methyltransferase (7, 16). 
4.3.2 Selective Amplification of Antibiotic Biosynthetic and Resistance Genes by PeR 
The results of the various peRs are summarized in Table 4.5, shOwing the peR screening of 14 environmental 
Micromonospora isolates. Appropriate control strains were used for the different peRs. Strains from our laboratory, 
'Amycolatopsis umgenif strain No. 16 and 'Streptoallomorpha po/yantibiotica' strain SPR were used as the positive controls 
for the oxyB and AR()"'PKS peRs, respectively. Micromonospora halophytica and Micromonospora nigra NRRL 30971", the 
ansamysin producers, were used as positive controls for the ANSA peR. The non-producing strain, M. nigra NRRL B-
16696T, was used as the negative control for the ANSA PCR. Micromonospora olivasterospora and Micromonospora pal/ida 
were used as the positive controls for the grm PCR, and 'Streptomyces tenebrarius' and Saccharopolyspora hirsuta were the 
positive controls for the fmr PCR. 
An amplified PCR product indicates the presence of a specific gene in the bacterium's genome, thus providing presumptive 
evidence of the ability to synthesise the speCific antibiotic type, or to have resistance to aminoglycoside antibiotics (grm and 
fmr). 
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Tabie 4.5. Table of PeR results for the selective amplification of antibiotic biosynthetic and resistance genes. 
PCR: oxyB ARO-PKS gnn fmr ANSA 
Strain: 
MMS1 
MMS2 + + + 
MMS3 + 
MMS4 + + + 
MMS5 + + 
MMS6 + + 
MMS7 + + 
R211 + 
MLR 
MMS-DA + 
MMS10 
MMS12 
MMS14 + 
MMS17 + 
M. nigra 3097T + + 
M. nigra NRRL 8-16696T 
M. halophytica N.T. N.T. N.T. + 
M. oliv8sterospora N.T. N.T. + N.T. 
M. pallida N.T. + + 
'Streptomyces tenebrarius' N.T. N.T. + N.T. 
Saccharopo/yspora hirsuta N.T. N.T. + N.T. 
Abbreviations: -, PeR result is negative; +, peR result is positive; N.T., not tested. 
It is interesting to note that two of the Micromonospora control strains were positive for the ARO-PKS PCR. M. pallida may 
thus have the biosynthetic capability to produce an aromatic polyketide antibiotic and an aminoglycoside antibiotic. M. nigra 
NRRL 3097T was positive for the ansamysin and ARO-PKS PCRs, however M. nigra NRRl 8-16696T, mutated to lose the 
ability to produce halomicin, an ansamysin, was negative for both the ANSA and ARO-PKS antibiotic type PCRs, suggesting 
that this strain has also lost the ability to produce the aromatic polyketide (antibiotic or spore pigment). 
The ARO-PKS primers do not distinguish between the Type II Polyketide antibiotic subclasses and thus the PCR products 
should be sequenced to detenmine to which subclass the aromatic polyketide antibiotic belongs, and to rule out the possibility 
of the primers having amplified a spore pigment gene. 
The gnn positive controls were positive for the gnn PCR and negative for the fmr PCR, while the fmr positive controls were 
negative for the grm peR, showing that the primers do discern between the two aminoglycoside resistance types. 
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Interestingly, strains MMS2 and MMS4 were positive for both the grm and fmr PCRs. Since it has not been documented 
that a strain can possess genes for both resistance types, one of the genes amplified may not be associated with a 
biosynthetic cluster. Since many workers have found that the genes targeted by the grm PCR primers are adjacent to the 
biosynthetic cluster, the explanation may lie with the specificity of the fmr primers. The strains may have acquired the 'fmrT-
type' resistance genes from other bacteria in the Hermanus lagoon via conjugation, or transduction via phages (10). 
Fig. 4.4 shows some of the positive results obtained for the grm PCR. It would be interesting to sequence the PCR products 
and expand the phylogenetic tree, shown in Fig. 4.3, to determine if all the grm positives form a clade with the existing 'fmrO-
type' resistance genes. 
734bp 
Fig. 4.4. Agarose gel photograph showing the results of the grm PCR amplification . The red arrow indicates the position of the expected 
fragment produced by PCR amplification. Lanes 1 and 10: "Pst Ladder (marker); Lane 2: Micromonospora sp. strain MMS2; Lane 3: 
Micromonospora sp. strain MMS4; Lane 4: Micromonospora sp. strain MMS6; Lane 5: Micromonospora sp. strain MMS7; Lane 6: No DNA 
control; Lane 7: Micromonospora sp. strain MMS1 ; Lane 8: Micromonospora sp. strain MMS5; Lane 9: Micromonospora sp. strain MMS-
DA. 
4.3.3 Amlnoglycoside Antibiotic Susceptibility Plate Assay 
The results of the assay are shown in Tables 4.6 and 4.7. 
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Table 4.6. Comparison of the aminoglycoside antibiotic susceptibility plate assay results with the grm and fmrPCR resultsB. 
I Antibiotic Resistance Type 
Concentration Sm Km Gm Nm Suggested By PCR 
(Ilg/ml ): The Plate Confirms? 
Strain: 100 2 10 5 10 20 50 100 4 5 7.5 10 20 Assay: 
MMS1 - + + 1- - +1 + I + + fmrT x 
I 
MMS2 - + + + + - - + + + fmrO AND fmrT .;' I 
I Sensitive to ALL 
I MMS3 I I - Aminoglycoside ,/ - - - 1- - - -
Antibiotics. 
IMMS4 - + + ++ - - - - + + + fmrO AND fmrT ,/ 
MMS5 - + + - - + + 1 + + fmrT x 
MMS6 - + + ++ ! - - - - + + + + fmrO AND fmrT ,/ AND x 
MMS7 - + + + - - - - + + + fmrO AND fmrT ,/ AND x 
R21l - + + - - - - - + + + fmrT x 
MLR - i+ i-I - - - + + - fmrT x 
i MMS-DA - - - - - + + + IIi x 
FS10 
Sensitive to ALL 
- - - - - - - - Aminoglycoside ,/ 
I 
Antibiotics. 
i 
MMS12 - + - - _I - + + + fmrT x 
I 
i MMS14 - - - - - + - fmrT ,/ 
I MMS17 - :b - - - + + + - + fmrT )( I M. nigra - + - fmrT x 
M. o/ivasterospora - + + + + + + + - fmrO ,/ 
M. pal/ida - + - - + - + - + fmrT x 
'Streptomyces 
fmrT ,/ - + + - - - - + + + + 
! 
+ 
tenebrarius' 
Saccharopo/yspora 
+ I + fmrT ,/ I hirsuta - + + - -1- - + 
+ + 
• 
"See Table 4.5. 
Abbreviations: Sm, streptomycin; Km, kanamycin; Gm, gentamicin; Nm, neomycin; +, growth; -, no growth. 
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Table 4.7. Plate assay results for the other MMS strains investigated, and for the other validly published members of the genus 
Micromonospora. 
Antibiotic Resistance Type 
Sm Km Gm Nm 
Concentration (I!g/ml): Suggested by the Plate 
Strain: 100 2 10 5 10 20 50 100 4 5 7.5 10 20 Assay: 
MMSB - + + - - - - - + + + + + fmrT 
MMS9 - + + - - - - - + + - - - fmrT 
MMS11 - + + - - - - - + + + - - fmrT 
MMS15 - + + - - - - - + + + + + fmrT 
MMS16 - + + - - - - - + + - - - fmrT 
MMS18 - - - - - - - - + - - - - fmrT 
Sensitive to ALL 
MMS19 - - - - - - - - - - - - -
Aminoglycoside Antibiotics. 
M. aurantiaca - + + - - - - - + - - - - fmrT 
M. carbonacea - + + - - - - - + + + + + fmrT 
M. chalcea - + + - - - - - + + + + + fmrT 
M. chersina - + - - - - - - - - - - - Neither. 
Sensitive to ALL 
M. coerulea - - - - - - - - - - - - -
Aminoglycoside Antibiotics. 
M. echinospora - + + - - - - - - + - - - fmrT 
M. halophytica - + + - - - - - + - - - - fmrT 
M. inosffola - + + - - - - - - - - - - Neither. 
Sensitive to ALL 
M. matsumotoense - - - - - - - - - - - - -
Aminoglycoside Antibiotics. 
M. Sensitive to ALL 
- - - - - - - - - - - - -
purpureochromogenes Aminoglycoside Antibiotics. 
M. rosaria - + + - - - - - + + - - - fmrT 
. . Abbreviations: Sm, streptomycin; Km, kanamycin; Gm, gentamiCin; Nm, neomyCin . 
It can be seen in Table 4.6 that the plate assay revealing a 'fmrO-type' corresponds exactly with the grm PCR results 
(except for M. pal/ida). Strains MMS3 and MMS10, which were negative for both the grm and fmr PCRs, were sensitive to all 
of the antibiotics tested, suggesting that they have no resistance mechanisms against aminoglycoside antibiotics. Generally, 
kanamycin (2 I!g/ml) and streptomycin (100 I!g/ml) proved useful as positive and negative control plates, respectively, for 
this assay (see 4.1.2). As noticed with the PCR experiments, 'fmrT-type' resistance seems to be widely spread in the plate 
assay. Researchers have not looked for 'fmrT-type' resistance genes in species of Micromonospora. As can be seen in Fig. 
4.3, the 'fmrT-type' clade is formed from sequences of Saccharopolyspora and Streptomyces species. Thus, the fmr PCR 
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primers were designed using non-Micromonospora sequences. If Micromonospora strains do have 'fmrT-type' 
aminoglycoside resistance genes, then the finding of Micromonospora strains having both the fmrO and fmrT resistance 
types may not be surprising. The fmr PCR products of the Micromonospora strains should be sequenced and compared with 
those sequences used to design the primers, and the phylogenetic tree should be expanded. If the Micromonospora 
sequences are phylogenetically related to the Saccharopolyspora and Streptomyces sequences, and they all share 
conserved regions, then the Micromonospora strains do possess the 'fmrT-type' aminoglycoside resistance gene. If not, the 
strains may possess resistance genes acquired from elsewhere and are not indicative of a resistance gene related to an 
antibiotic biosynthetic cluster. Although the fmr PCR does not seem to be reliable (because the results do not correlate with 
the plate assay findings), the grm PCR presents reasonable results as it verified the plate assay results in all but one case 
(M. pel/ide). If both the grm PCR and the plate assay point to the 'fmrO-type', then the strains show resistance to their own 
antibiotic type and thus it is recommended that purification protocols for gentamicin-type aminoglycoside antibiotics be used 
(e.g. for strains MMS2, MMS4, MMS6, and MMS7). 
If one looks at the neomycin results, one can see a strange phenomenon: some strains grow at intermediate concentrations 
of the antibiotic but not at the highest or lowest concentration. The experiment was performed three times and the same 
result was observed each time. Piendl at a/. (18) investigated the involvement of 168 rRNA in aminoglycoside resistance by 
aminoglycoside producers and stated that "in systems programmed by mRNA, inhibition of protein synthesis observed in the 
presence of low or high concentrations of aminoglycosides may be obscured at intermediate drug concentrations due to 
stimulated incorporation of amino acids associated with misreading of mRNA codons: 
4.4 Conclusion 
The grm primers and the plate assay seem worthy of being used to predict the ability to synthesize a gentamicin-type 
aminoglycoside antibiotic. This should be taken into account when deciding on antibiotic purification protocols to be used. 
Furthermore, the positive grm PCR products should be sequenced and the phylogenetic affiliations examined to better 
understand this type of resistance gene. The problems with the fmr PCR and plate assay should be further examined by 
sequencing the fmr PCR products and comparing the sequences to those used to design the primers. Conserved regions 
between the sequences should be seen, indicating that the 'fmrT-type' resistance gene has been amplified in 
Micromonospora strains. 
Many strains were positive for the ARO-PKS primers and thus the PCR products should be sequenced to determine which 
subclass of aromatic polyketide antibiotic is produced and purification protocols sought. 
Table 4.8 summarizes the PCR screening results, suggesting the type of antibiotic that the strains may produce and the 
purification procedures to be used. It must be carefully noted that bacteria may have antibiotic biosynthetic genes that are 
not expressed. This means that a primer may amplify a biosynthetic gene but the gene is not expressed and thus the 
bacterium will not produce the antibiotic. Relying on PeR results alone may be a gamble but a worthy one as time and effort 
could be saved on antibiotic purification. 
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Table 4.B. A summary of strains showing antibiotic biosynthetic capabilities and aminoglycoside resistance genotypes. 
MMS3, MMS-
Strains MMS5: MMS2 and MMS4: MMS6 and MMS7: MMS14 DA, MMS17, 
R2J,1: 
Positive for ANSA and ARO-PKS. grm, and 
ARO-PKS and grm. fmr ARO-PKS 
which PCRs? ARO-PKS. fmr. 
Aromatic. gentamicin- Aromatic and 
Antibiotic Ansamysin Neomycin-type 
type, and neomycin-type gentamicin-type Aromatic 
Type Possibly and Aromatic Aminoglycoside 
Aminoglycoside Aminoglycoside antibiotics. 
Produced? antibiotics. antibiotic. 
antibiotics. antibiotics. 
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Chapter 5 
5.1 Introduction 
5.1.1 Antibiotic Classes from Micromonospora 
(i) Aminoglycosides 
Antibiotic Isolation and 
Partial Purification 
Several important aminoglycoside antibiotics are produced by Streptomyces species and by Micromonospora species. For 
example, streptomycin, kanamycin, neomycin, and tobramycin are produced by Streptomyces species, while the 
gentamicins, fortimicins, sagamicin, and antibiotics G-52 and G-418 are produced by Micromonospora species. Neomycin B 
is produced by both Streptomyces and Micromonospora (18). Although there is considerable variation in structure among 
aminoglycosides, the common feature is that they all contain a cyclohexane ring and amino sugars (Fig. 5.1). Their mode of 
action is the inhibition of protein synthesis in at least two ways: the antibiotic binds to the 30S ribosomal subunit and prevents 
the elongation of the protein chain, as well as preventing the recognition of the triplet code on mRNA (11). Aminoglycosides 
are bactericidal and tend to be most active against Gram-negative pathogens, and thus are used to treat infections caused 
by Proteus spp. and Pseudomonas spp. (18). Antibiotic G-418 is of particular interest because of its excellent antiparasitic 
activity against both protozoa and helminths (18). 
Aminoglycosides are water-soluble, basic antibiotics, which are purified by means of ion-exchange chromatography. 
Hydrolytic patterns of the base form of the antibiotics are revealed by acid hydrolysis and the antibiotics give a positive 
ninhydrin result (17). One of the most common solvent systems used for separation of components by silica TLC is by using 
the lower (organic) phase of a solvent mixture of chloroform: isopropanol: 17% ammonium hydroxide in a ratio of 2: 1: 1 (vlv) 
(10). 
NH 
N II IIH~NHCNH' H,NCNH 
OH 
H HO OH 
o \ 
~o Cyc/ollexane ring CHO H,c HO 
o 
H,OH . H~O CH,N - Ammo sugar 
OH 
Streptomycin 
Fig. 5.1. Representative aminoglycoside antibiotics (12). 
92 
~"C~~ CH, 0 0 . 
OH~ 
OH 
NH, 
NH, 
G",ntamicin C., 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
(ii) Macrolides 
Macrolides contain a 12- to 22-carbon macrocyclic lactone ring, linked to a sugar and aminosugar. The sugar residues are 
important for activity (11). Macrolides are usually bacteriostatic and bind to the 23S rRNA of the 50S ribosomal subunit, 
inhibiting peptide chain elongation during protein synthesis (12). The macrolides are relatively broad-spectrum antibiotics, 
effective against Gram-positive and Gram-negative bacteria (12). The most well-known example of a macrolide antibiotic is 
erythromycin (Fig. 5.2), produced by Saccharopolyspora erythraea; it was used against penicillin-resistant staphylococci, and 
is now the drug of choice against legionnaire's disease (11). Examples of macrolides produced by Micromonospora species 
are the megalomicins, rosaramicin, the M-4365 complex, and erythromycin B (18). An inhibitor of starfish embryonic 
development, micromonospolide A, is a new macrolide from an uncharacterised Micromonospora species (9). 
Macrolides are mostly basic, but some are neutral; some are soluble in water, while others are insoluble in water but 
soluble in ethanol (16). Furthermore, the affinity of binding of macrolides to ribosomes is enhanced by the presence of 
ethanol (16). Macrolides are commonly purified by organic extraction with chloroform. They give a negative ninhydrin result 
(13). 
AMJ.'I;OSVGAR 
o 
lACT01'."E 
Fig. 5.2. Erythromycin, highlighting the important structural features of macrolide antibiotics (11). 
(iii) Ansamysins 
The ansamysins possess an aliphatic chain (the ansa bridge) that is connected to an aromatic nucleus at two, nonadjacent 
positions (18) (Fig. 5.3). The halomicins and rifamycins, produced by Micromonospora species, are members of one of the 
two ansamysin subgroups in which the ansa bridge is attached to a 
substituted naphthalene or naphthoquinone moiety (18). The ansamysins 
are often brightly coloured antibiotics (orange or red in colour, for 
example) and are solvent extractable (18). The halomicins and rifamycins 
are active against Gram-positive bacteria and very importantly, 
Mycobacterium tuberculosis, but are not active against Gram-negative 
bacteria (18). The mode of action is by binding non-covalently to RNA 
polymerase and inhibiting RNA synthesis, thus impairing protein synthesis 
(11 ). 
Fig. 5.3. The structure of an ansamysin antibiotic (11). 
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(iv) Everninomicins 
Eveminomicins (Fig. 5.4) are a class of oligosaccharide antibiotics produced by Micromonospora carbonacea, which 
possess highly potent activity against Gram-positive bacteria and are solvent extractable. Most importantly, they demonstrate 
antibacterial activity against multiply-resistant strains of methicillin-resistant Staphylococcus aureus and vancomycin-
resistant enterococci (2). 
....,* ... =-'" 1 
"'-
o 0 
DI 
Fig. 5.4. The structures of the eveminomicins (18). 
-1L 
EV[IL'I_CIH B OM 
[V£JIN IN~ICIN C H 
E\'DINIHC)YION 0 H 
(v) Other Micromonospora Antibiotics 
The cyclic enediynes, and tetrocarcins, new classes of antitumour antibiotics, are receiving increasing attention because 
they exhibit remarkable antitumour activity, and in the case of the enediynes, are DNA-cleaving agents (15). These 
antibiotics show extremely strong inhibition of the growth of Gram-positive bacteria, such as Bacillus subti/is (6). Dynemicin A 
(Fig. 5.5), a novel, violet-coloured antibiotic produced by Micromonospora chersina, is unique among the cyclic enediynes as 
it contains both a cyclic enediyne ring and anthraquinone chromophore (5, 15). 
Dyncmicin A R-H 
Fig. 5.5. The structure of dynemicin A (6). 
An uncharacterised Mlcromonospora species also produces the galbonolides, antifungal polyketide natural products (14). 
The orange mycelial pigments of Micromonospora strains are extractable in organic solvents and appear to possess 
antimicrobial activity of their own (7). 
5.1.2 This Study 
The antimicrobial activities of all 34 environmental isolates were investigated by performing sloppy-agar overlays and 
testing for activity against 5 specifically chosen test bacteria. Micromonospora strains showing potential as antibiotic 
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producers were further investigated. The antibiotics were isolated, initial purification attempted, and some physicochemical 
properties of the most promising antibiotics determined. 
5.2 Materials and Methods 
5.2.1 Solid Media Overlays: The Sloppy-agar Method 
The antimicrobial activity exhibited by the 34 environmental actinomycete strains was assessed by the use of the sloppy-
agar overlay technique. By using sterile toothpicks, the actinomycete strains were stab-inoculated into the centre of agar 
plates and incubated at 30°C for 5 and 11 days. The antimicrobial activity of the strains was tested against each of five test 
bacteria: Escherichia coli ATCC 25922 (a standard antibiotic-susceptibility testing strain; Gram-negative), E. coli CA 84-39 
(streptomycin-resistant strain), a vancomycin resistant clinical isolate of Enterococcus faecium (Van A; Gram-positive), 
Bacillus subtilis subsp. subti/is NCIS 3610 (Gram-positive), and Mycobacterium aurum A+ (acid fast). 00 day 4 and day 10, 
each test bacterium was inoculated into 10 ml 2YT broth (1), except for E. coli CA 84-39, which required 10 ml 2YT broth 
supplemented with 2 J.l1 of streptomycin (100 J.lg/ml), and incubated overnight at 37°C with shaking. The test bacteria were 
Gram stained to verify the purity of the cultures. The optical density at 600 nm (OD600) of each culture was measured using a 
Beckman OU-64 spectrophotometer. Cultures were diluted, before taking the reading, as follows: E. colt. diluted 1-in-10 in 
sterile 2YT broth; E. faecium, B. subti/is: diluted 1-in-4 in sterile 2YT broth; and M. aurum: diluted 1-in-6 in sterile 2YT broth. 
Empirically determined calculations were used to ensure that there would be the same concentration of test bacterium cells 
in the sloppy-agar from one overlay experiment to the next. The number of microlitres of bacterial culture used per sloppy-
agar test tube was calculated as follows (solve for x): 00600 x test bacterium's dilution factor x (x J.l1) :: test bacterium's 
constant. The values vary for the different test bacteria: E. coli: 00600·10x:: 4; E faecium, B. subtilis: 006oo·4x:: 160; M. 
aurum: 00600·6x = 160. The calculated volume (in J.l1) of test culture was pipetted into test tubes containing 6 ml2YT sloppy-
agar (1), vortexed gently, and poured onto the 5 and 11 day old stab inoculated plates, ensuring that the sloppy-agar was 
distributed evenly over the entire surface of the plate. These plates were incubated overnight (14 -18 h) at 37°C for E. coli, 
E. (aecium, and B. subtilis, and for 40 - 45 h at 37°C for M. aurum. The diameter (in mm) of each colony was measured 
before overlaying. The diameter (in mm) of the zone of growth inhibition of the test bacteria was measured if a strain showed 
antimicrobial activity. The area of the inhibition zone in mm2 was calculated. The arbitrary assignment of strength of 
antimicrobial activity was as follows: very weak «100 mm2); weak (100 -1000 mm2); moderate (1001 - 2000 mm2); strong 
(2001 - 3000 mm2); and very strong (>3OO0 mm2). 
The degree of antimicrobial activity against the five test bacteria was compared for 7 different growth media: Middlebrook 
7H9 agar (7H9), ISP Medium No.2 [yeast extract-malt extract agar (YEME)]. 8M-Glucose, 8M-Glycerol and modified 172F 
agars (see 3.2,2); MMP-S and MMP-F agars (see 5.2.4). 
5.2.2 Solvents Used in This Study 
Acetone, benzene, n-butanol, chloroform, absolute and technical ethanol, n-hexane, methanol and toluene were supplied 
by Saarchem, while acetic acid was supplied by Merck. 
5.2.3 Fermentation and Methods For Obtaining Antibiotic Samples Produced by the Micromonospora Strains 
8M-Glycerol broth was used for initial fermentations. Fermentation was carried out at 30°C with shaking. 
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A preculture of each strain was grown in a 200 ml Erlenmeyer flask containing 20 ml 8M-Glycerol for 5 days. The cultures 
were then transferred to 500 ml Erlenmeyer flasks containing 50 ml 8M-Glycerol and incubated with shaking for 7 days, at 
which point the liquid medium (the supematant) was removed and filtered (using coffee filters). Gram stains were performed 
to verify the purity of the culture. 
Cells of each strain were scraped off of the filter paper and left overnight to dry. The following day, 10 ml methanol or 
chloroform was added to each dried cell sample and stirred overnight by using a magnetic stirrer. The solvent was removed 
the following day and transferred to a universal/standard container. The solvent was left to evaporate in a fume hood and 
then redissolved in methanol or chloroform so that samples were concentrated 50 times with respect to the original extract. 
Organic extraction of antibiotics from the culture supernatants was performed with chloroform. The chloroform layer was 
removed, allowed to evaporate and was concentrated 50 times with chloroform. The supernatant (aqueous layer, post 
extraction with chloroform) was freeze-dried. 
All culture filtrates were freeze-dried. The freeze-dried samples were redissolved in sterile water so that the samples had 
been concentrated 50 times. 
5.2.4 The Micromonospora Macrolide Protocol 
The protocol for investigating macrolide antibiotic production by Micromonospora was modified from a method of Kawamoto 
et a/. (5). The two production media developed were as follows (Goodwin, unpublished). Micromonospora Macrolide 
Production Medium S (MMP-S), the 'seed medium', contained the following (gIL): soluble starch (11), glucose (11), casitone 
(Difco; 5), yeast extract (6), CaC03 (1), pH 7.2. For solid media, 15 giL agar was added. Micromonospora Macrolide 
Production Medium F (MMP-F), the 'fermentation medium', contained the following (gIL): soluble starch (20), casitone (Difco; 
6.5), yeast extract (6), K2HP04 (0.5), MgS04·7H20 (0.5), KCI (0.3), CaC03 (1), pH 8.0. For solid media, 20 gIL agar was 
added. 
The fermentation protocol was as follows. A heavy inoculum of the strain from an agar plate was inoculated into 3 ml of 
sterile water, then transferred to 10 ml of MMP-S in a 100 ml Erlenmeyer flask and incubated for 2 days at 30°C with 
shaking. The culture was then transferred to 30 ml of MMP·S in a 250 ml Erlenmeyer flask and incubated at 30°C for 4 days 
with shaking. The culture was then transferred to 100 ml of MMP-F in a 1 L Erlenmeyer flask and left shaking at 30°C for 70 
hours. At 70 hours, the cell mass was separated from the broth (supematant) as described in 5.2.3. 
Purification of antibiotics from the cell mass was performed as follows: the cell (mycelial) mass was covered with 22 ml of 
chloroform and left to stir vigorously overnight. The chloroform layer was removed, allowed to evaporate, and concentrated 3 
times with chloroform. 
Antibiotic purification from the filtrate (supematant) of the fermentation broth was performed as follows: the pH of the 
supernatant was adjusted to pH 9.5 with 2 N NaOH. To the supernatant, 65 ml of chloroform was added, and left to stir 
vigorously overnight. The step was repeated once more. The chloroform layers from each step were pooled, allowed to 
evaporate. and concentrated 3 times with chloroform. Twenty two (22) ml of distilled water (pH 4.0; adjusted with 2 N HCI) 
was added to the chloroform concentrate and left to stir vigorously overnight. The water layer was removed and its pH was 
adjusted to pH 9.5 with 2 N NaOH. Twenty two (22) ml of chloroform was added to the water layer and left to stir vigorously 
overnight. The chloroform layer was removed and concentrated. At this step, partially purified antibiotic should be obtained 
from the chloroform layer. Samples were spotted on silica TLC and bioautographed (see 5.2.6). 
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5.2.5 Thin Layer Chromatography 
Thin Layer Chromatography (TLC) plates used in this research were TLC aluminium-backed silica gel 60 F254 (Merck; 
Catalogue Number: 1.05554.0001). A 254 nm transilluminator (UVP©) was used to visualize UVabsorbing spots, which 
were marked on the TLC plate with a pencil. Solvents used in TLC solvent systems for the separation of compounds in 
antibiotic samples are listed in 5.2.2. TLC plates were developed in glass beakers covered with tinfoil. 
5.2.6 Bioautography for the Visualization of Antibiotically Active Spots 
Cultures were grown as described in 5.2.1. The cultures were diluted with sterile 2YT broth to give an ODsoo of 0.5. 
Antibiotic samples were spotted on TLC plates (see 5.2.5) and/or spotted, dried, and developed in a solvent system. Once 
the solvent had evaporated, the test bacteria were applied to the TLC plate by dabbing with sterile cotton wool until the entire 
plate was covered with test bacterium. The TLC plates were transferred to a plastic container, the bottom of which was lined 
with wet paper towel to create a moist environment, and placed face up on the paper towel. The container was sealed and 
incubated at 37°C for at least 6 hours. TLC plates were removed from the container and sprayed with 0.25% (w/v) MTT [3-(4, 
5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] (SIGMA) dissolved in Phosphate Buffered Saline (pH 7.3). The 
paper towel was removed and the TLC plates were returned to the container, which was sealed and left at 37°C for at least 
45 min, so that a colour change was observed. The activity spots on TLC plates are visualized by using MTT, which acts as 
an oxidising agent, serving as the final electron acceptor in the bacterial electron transport chain. If MTT is reduced, a colour 
change from yellow to purple-blue is observed. The presence of the purple-blue colour indicates where the test bacteria are 
actively respiring, whereas areas lacking the purple-blue colour indicate the existence of an antibiotically active spot that the 
test bacteria are sensitive to. 
The Rf values were calculated as follows: distanced moved by the centre of the solute zone (activity spot, UV spot, or 
colour component) + the distance moved by the solvent front. 
5.2.7 Physicochemical Properties and Antibacterial Spectrum 
Fehling's reagent (8) was used to test for the presence of reducing sugars. The positive control was 10% glucose (Merck) 
and the negative control was 10% sucrose (Merck). Exposure to iodine vapours was used for the detection of organic 
compounds having carbon-carbon double bonds. Cerium (IV) ammonium sulphate (6.3% dissolved in 3% concentrated 
sulphuric acid; Saarchem) and 50% sulphuric acid (Merck) were also used to detect organic compounds. To detect for the 
presence of free amino groups in antibiotic samples, 0.1 g ninhydrin (Riedel-de Haen) was dissolved in 100 ml acetone 
(Saarchem) and used as the visualization reagent. Antibiotic samples were spotted on silica TLC plates, developed with 95% 
chloroform: 5% technical ethanol (96.4%), and then subjected to testing with the reagents described in this section. 
Sugar hydrolysis was performed as follows: 40 III of antibiotic sample was added to an equal volume of 6M HCI (NT 
Laboratory Supplies), and heated at 100°C in a water bath for 2 hours. Five (5) ).II of each sample (and 1 ).II of the 1 % sugar 
standards: glucose, mannose, ribose; and galactose. arabinose, xylose) was spotted on cellulose TLC aluminium-backed 
sheets (Merck; Catalogue Number: 1.0552.). The solvent system and visualization agent used was as described by 
Hasegawa et a/. (4). 
All TLC plates were heated in an oven at 130°C for at least 5 minutes to allow the spots to develop. 
pH sensitivity was tested as follows: 40 III of antibiotic sample was added to each of three 1.5 ml microfuge tubes. One tube 
acted as the control, while 40 III of 50 mM HCI and 50 mM NaOH were added to the other two tubes and a colour change 
observed. 
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Antibiotics used in this study as controls were: oleandomycin (Sigma), gentamicin (Sigma), kanamycin (Sigma), neomycin 
(Intramed), and streptomycin (Calbiochem). 
Test bacteria used for examining the antimicrobial spectrum are the 5 strains listed in 5.2.1, as well as AcinetobBCfer 
calcoaceticus C91 , Pseudomonas aeruginos8 ATCC 27853 (a standard antibiotic-susceptibility test strain), Staphylococcus 
8ureus ATCC 25923 (a standard antibiotic-susceptibility test strain), and Mycob8cterium bovis BCG (Tokyo). All strains were 
grown ovemight in 10 ml of 2YT broth (1) at 37°C, except for M. bovis, which was grown for 2 weeks at 37°C in Middlebrook 
7H9 broth supplemented with AD (0.2% glucose and 0.5% BSA) and 0.05% Tween 80 (1). 
5.2.8 The Modified Eli Lilly Procedure to Test for Antimicrobial Activity 
The procedure performed was modified from a method obtained from the Internet: 
http://www.accessexcelience.org/AE/AEC/ AEF?1995?goudie soil.htrnl . 
Eleven-day-old cultures of the strains grown on agar media were used. Small blocks of agar (approximately 1 cm x 1 em) 
were cut out with a scalpel and placed on silica TLC plates. A few drops of a solvent were pipetted onto the agar pieces. The 
TLC plate was left at 4°C for 20 min. The agar blocks were then removed, the TLC plate allowed to dry, and then covered 
with test bacterium and bioautographed as outlined in 5.2.6. 
5.3 Results and Discussion 
5.3.1 Solid Media Overlays 
Results of the sloppy-agar overlay technique are shown in Table 5.1. The table shows only the strains that exhibited 
antibacterial activity. Numerical values indicate the area of the zone of inhibition in mm2. Overlay experiments were 
performed at 5 days and 11 days; the general trend was for activity to increase over time, viz. the greatest activity was 
shown at 11 days relative to 5 days. Of the agar media used in this study (see 5.2.1), 7H9 was used as a standard medium 
for the production of antibiotics by Streptomyces species, while YEME, BM-Glucose and BM-Glycerol were used as standard 
media for the production of antibiotics by Micromonospora. Strains of Micromonospora showed excellent growth on modified 
172F agar and thus this medium was used to test for a correlation between good growth and good antibiotic production. The 
MMP media were included as they enhance the production of macrolides (5) and thus any antimicrobial activity shown on 
these media may be the result of a macrolide antibiotic. B. subtilis subsp. subtilis NCIB 3610 is recommended as the test 
organism for bioautography showing antimicrobial activity caused by macrolides. M. aurum A+ has a similar antibiotic-
susceptibility profile to M. tuberculosis (3). M. 8urum also grows faster than M. tuberculosis and is non-pathogenic. Activity 
against M. 8urum was of most value and the antibiotics of such strains were further pursued as potential antitubercular 
agents. 
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Table 5.1. Strains exhibiting antimicrobial activity with an inhibition zone of greater than 1000 mm2 in the agar overlays. 
Test Bacterium: Escherichia coli ATCC Eo coli CA 84-39 Bacillus subtilis subsp. Mycobacterium l Strains: 25922 subtilis NCIB 3610 aurumA+ 
Mlcromono.pora 
spp.: 
MMS1 11 days: 8M-Glucose: 3798 (+5) 
YEME: 2749 (+s) 
11 days: 
MMS2 MMP-S: 1442 
(-5) 
11 days: 11 days: MMS3 YEME: 1477 (+5) 
8M-Glycerol: 1005 (+5) MMP-S: 1282 (+5) 
11 days: 
m172F: 4033 (+5) 
MMS4 MMP-S: 3487 (+5) MMP-F: 2808 (+5) 
8M-Glucose: 1979 
(+5) 
11 days: 11 days: MMS-OA 8M-Glucose: 
2859 (5+) YEME: 1512 (+5) 
11 days: 
MMSS YEME: 2695 (+5) 
Streptomyces spp.: 
BAM 1 11 days: 7H9: 1697 (+s) 
BAM3 11 days: 11 days: 7H9: 1193(+5) MMP-S: 1225 (+s) 
BAM7 11 days: 172F: 1178 (-s) 
11 days: 
PB 7H9: 2128 (+s) 
BM-Glucose: 1512 (+s) 
11 days: 11 days: Kit2004 m172F: 1119(+5) 8M-Glucose: 1298 (+s) 
m172F: 1030 (+s) 
11 days: 11 days: U~P-TD YEME: 1159 (+s) MMP-S: 3212 (+s) 
m172F: 1100 (+s) 
11 days: 
LMP-BRP 8M-Glycerol: 2205 (+s) 
BM-Glucose: 2118 (+s) 
Abbreviations: (-+5), presence of sporulation; (-s), absence of sporulation. 
Since the results of activity against M. aurum were of most interest and the emphasis of the study lay with the 
Micromonospora strains, strains MMS3, MMS4 and MMS-DA were chosen to investigate further. For strains MMS3 and 
MMS4, it could be suggested that the antibiotics may be macrolides because the activity was shown on the MMP media. 
However, one must keep in mind that strain MMS4 was positive for the grm primers, indicating the presence of the 
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aminoglycoside resistance gene. Furthermore, we do not have evidence of the presence or absence of macrolide 
biosynlhetic genes in strain MMS4's genome. 
5.3.2 Initial Fennentation Experiments 
Initial fermentation (see 5.2.3) was carried out on only the Group A Micromonospora strains (Table 5.2). The concentrated 
antibiotic samples were spotted in triplicate on TLC plates to test for activity against three test bacteria (TLC is a much more 
sensitive method than the agar overlays). This fermentation was carried out in one medium only (BM-Glycerol) and was 
incubated with shaking for a total of 12 days (see 5.2.3). 
Table 5.2. Preliminary investigation of the antimicrobial potential of the Group A Micromonospora strains, 
Fifty Times Concentrated 
Antibiotic Sample From: 
Bennett's Broth Supernatant: 
Bennett's Broth Supernatant 
Post Organic Extraction 
(i.e. aqueous layer after 
extraction with chloroform): 
Chloroform (organic) Layer: 
Methanol Organic Extract of 
the Cell Mass: 
MMS1 
Activity of Micromonospora Strains Against Test Bacteria: 
MMS2 
Ma,Ef, 
Ec 
Ma, Ef 
Ma, Ef 
Ma, Ef 
MMS3 MMS4 MMS5 MMS6 MMS7 R2J.! MLR 
Ec Ec Ef 
Ec 
Ma, 
Ef 
Ef 
Ma 
Abbreviations: Ec, Escherichia coli ATCC 25922; Ef, Enterococcus faecium (VanA); Ma, Mycobacterium aurum A+. 
MMS-
DA 
Ef 
These results show that there may be multiple antibiotics produced by strain MMS2 and MMS7: some antibiotics remained 
in the aqueous phase while others moved into the organic phase. 
Strains MMS2, MMS7 and MMS-DA all showed that antibiotics were extracted into the chloroform layer. Strains MMS2 and 
MMS7 were also positive for the grm primers, however, aminoglycosides are not solvent extractable. On the other hand, 
macrolide antibiotics readily extract into chloroform. The antibiotics of strains MMS2 and MMS7, which remained in the 
aqueous phase, could be aminoglycosides. 
5.3.3 The Mlcromonospora Macrolide Protocol 
The macrolide protocol was performed on strains MMS2, MMS7, and MMS-DA as previous results (Table 5.2) showed that 
antibiotics extracted into the chloroform layer during initial fermentation experiments. The protocol was performed with the 
media outlined in 5.2.4, but also with BM-Glycerol (the medium used for the initial fermentations). Aqueous and organic 
phases from each step of the protocol were concentrated, spotted on TLC plates and bioautographed against M. aurum (the 
test bacterium of most interest) and B. subtilis (the macrolide-sensitivity test organism). The results are shown in Table 5,3. 
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Table 5.3. Antimicrobial activity resulting from the macrolide protocol performed on strains MMS2, MMS7 and MMS-DA grown in BM and 
MMPmedia. 
MMS2 activity against test MMS7 activity against test MMS-DA activity against 
Fifty Times Concentrated bacteria in: bacteria in: test bacteria in: 
Antibiotic Sample From: 8M: MMP: 8M: MMP: BM: MMP: 
Chloroform Organic Extract of the 
Cell Mass: Ma, Bs Ma,Bs Bs Ma,Bs Bs Ma,Bs 
Chloroform Layer 1, Post H2O 
Extraction 
(Le. chloroform layer after water Bs, Ef Ma (w), Bs, Ef Ma (w), Bs, Ma, Bs, Ef Bs Ma, Bs 
Ef 
extraction step): 
H20 Layer 
Ma Ma 
Chloroform Layer 2 
Ef 1Ef, Bs 1Ef, Bs Ma(w), Bs, 1Ef, Bs(w) Ma, 1Ef, Bs(w) (Le. final step of protocol): Ef 
Abbreviations: (w), the activity was weak; Bs, Bacillus subtilis subsp. subtilis NCIS 3610; Ec, Escherichia coli ATCC 25922; Ef, 
Enterococcus faecium (VanA); Ma, Mycobacterium aurum A+; BM, Bennett's broth; MMP, Micromonospora Macrolide Production medium. 
The samples showing activity against M. aurum (not including the water layer samples) were developed in 100% chloroform 
and bioautographed against M. aurum and B. subtilis (Table 5.4). 
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Table 5.4. Results of antibiotic samples from the macrolide protocol developed in 1000k chloroform as the solvent system on sifica TLC 
plates. 
Mycobacterium aurum A+ Bacillus subtllis subsp. subtllis NCIB 3610 
Antibiotic Sample (50 Rrot Rrof 
MMS 
times concentrated) Activity Remarks: Activity Remarks: 
Strain: 
From: Spot: Spot: 
BM Cell Mass Extract (= Activity spot and UV 
Weak activity spot, 
0.21 N.D. overlapping with UV spot, on 
antibiotic sample No. 1) spot overlap. 
the solvent front. 
MMP Cell Mass Extract Weak activity spot, 
(= antibiotic sample No. 0.23 Activity spot and UV N.D. overlapping with UV spot, on 
2) spot overlap. the solvent front. 
MMS2 
1. Weak activity spot, 
overlapping with UV spot, on 
the solvent front. 
MMP Chloroform Layer 1 N.A. N.D. 
2. Strong activity spot 
overlaps UV spot on the 
origin. 
MMP Celi Mass Extract Activity spot overlaps 
(= antibiotic sample No. 0.24 with a colour 0.18 Strong activity spot overlaps 
with a colour component. 
3) component. 
MMS7 BM Chloroform Layer 1 N.A. 0.15 Weak activity spot. 
MMP Chloroform Layer 1 N.A. 0.15 
Weak activity spot, 
overlapping with UV spot. 
MMP Chloroform Layer 2 N.A. 0.15 Weak activity spot. 
MMP Cell Mass Extract N.A. N.D. 
Strong activity spot overlaps 
MMS- UV spot just above the origin. 
DA MMP Chloroform Layer 1 N.A. N.A. 
MMP Chloroform Layer 2 N.A. N.A. 
. . .. AbbreViations: N.A., no activity; N.D., not determined; BM, Bennett's broth; MMP, Mlcromonospora Macrolide Production medium. 
Based on the anti-M. aurum activity, 3 antibiotic samples were chosen to be investigated further. These are indicated in red: 
the chloroform cell mass extract of strain MMS2 grown in BM (antibiotic sample No. 1), grown in MMP (antibiotic sample No. 
2) and the chloroform cell mass extract of MMS7 grown in MMP (antibiotic sample No.3). 
It is a rule of thumb that an optimal solvent system is one that gives an Rr value of 0.5 for the active spot, indicating that the 
spot has moved half way up of the TLC plate. This is a good pOSition as many other compounds exist in a partially purified 
antibiotic sample that are not of interest and often travel to a position near the solvent front or near the origin. Thus, given the 
data in Table 5.4, a more suitable solvent system needed to be found to increase the Rr value. Many solvent systems were 
tested (Table 5.5), but the optimal solvent system proved to be 95% chloroform: 5% technical ethanol (96.4%). By the end of 
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this search, the antibiotic samples were all depleted and more sample had to be attained. Unfortunately, after many 
attempts, it was found that strain MMS2 had lost the activity previously extracted into chloroform from the cell mass grown in 
BM (antibiotic sample No.1). Thus, further work continued with antibiotic samples No.2 and NO.3 only. Their respective Rf 
values in the optimal solvent system were 0.50 and 0.53, and further indicated that the two samples potentially contained 
different antibiotic compounds. 
Table 5.5. List of solvent systems used for purification of antibiotics from Micromonospora strains. 
Solvent Systems Used for Antibiotic Samples From I Solvent Systems Used for Antibiotic Samples From Strains MMS3. 
Strains MMS2 and MMS7: MMS4. and MMS-DA: 
• 100% chloroform 
• 90% chloroform: 10% n-butanol 
• 90% chloroform: 10% absolute ethanol 
• n-Butanol: acetic acid: water (3:1:1) 
• Water-saturated butanol 
Optimal Solvent System: 
95% chloroform: 5% technical ethanol (96.4%) 
Solvent Systems which showed slight movement of the activity 
spots from the origin (low Rfvalues): 
• n-Butanol: acetic acid: water (3:1:1) 
• 100% acetone 
• 1 00% n-butanol 
• 100% ethanol 
• 100% methanol 
Solvent Systems which show good movement of the activity spots 
from the origin (higher Rf values): 
• 80% methanol: 20% n-butanol 
• 50% methanol: 50% chloroform 
• 50% methanol: 50% water 
• 80% n-butanol: 20% water 
• 50% n-butanol: 50% water 
5.3.4 Physicochemical Properties and Antibacterial Spectra of Antibiotic Samples No.2 and No.3 
Antibiotic samples No.2 and NO.3 were developed in two different solvent systems (n-butanol: acetic acid: water [3:1:1]. 
and water-saturated butanol) along with a known macrolide antibiotic (oleandomycin) and the aminoglycoside antibiotics. 
kanamycin, neomycin. gentamicin. and streptomycin. When bioautographed against M. aurum, the Rf values of samples No. 
Z and NO.3 were distinct from the Rf values of the control aminoglycosides and macrolide antibiotic used. 
Acid hydrolysis revealed that the aminoglycoside controls and samples No. 2 and No. 3 all shared a common hydrolysate 
spot on the TLC plate. No spot was observed for oleandomycin. Furthermore, the ninhydrin result was positive for all 
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samples except oleandomycin. which was as expected since macrolides do give a negative result. Thus. these two 
experiments indicate that samples No. 2 and No. 3 may be aminoglycoside-type antibiotics, distinct from gentamicin. 
kanamycin. neomycin, and streptomycin (based on the different Rfvalues). 
The pattem of spots produced by cerium (IV) ammonium sulphate and by the use of 50% sulphuric acid was similar. This 
suggests that there were many organic compounds in the samples and further purification attempts are most certainly 
required. Iodine vapours revealed many spots positive for compounds having C=C bonds. Antibiotic samples No.2 and NO.3 
were positive for the reduction of Fehling's reagent. however, since the samples were not pure. it could not be determined 
which component was responsible for the reaction, as many contaminating compounds were in the samples. 
Figures 5.6 and 5.7 show the features of the anti-M. aurum active spot of interest in samples No.2 and No.3. 
Sample No.2 showed pH sensitivity when treated with HCI and NaOH: the colour of the sample changed from a dark 
orange to light yellow colour in each case. Sample NO.3 changed colour from dark red-orange to light orange when treated 
with HCI and NaOH. 
The samples were spotted on silica TLC and developed in the optimal solvent system 195% chloroform: 5% technical 
ethanol (96.4%)], and bioautographed against the 9 test bacteria (see 5.2.7). The TLC plate showing activity against M. 
8urum A+ is shown in Fig. 5.6 and the plates showing activity against B. subti/is subsp. subti/is NCIB 3610 and P. aeruginosB 
ATCC 27853 are shown in Fig. 5.8. £. coli ATCC 25922. £. coli CA 84-39, and £. faecium (VanA) were extremely sensitive 
to the antibiotic samples (not shown). Multiple activity spots along the length of the TLC plate were seen for S. aureus and 
for A. ca/coaceticus C91 (not shown). Only sample No.2 showed activity against Mycobacterium bovis BCG (Tokyo): a 
single activity spot with an Rf value of 0.51 (not shown). The Rf value of the Single activity spot of sample No.2 against M. 
aurum was O.SO. This antimycobacterial activity is promising and should be tested against Mycobacterium tuberculosis. 
There are many opportunistic pathogens involved in outbreaks of hospital infections, which are becoming totally resistant to 
antibiotics such as aminoglycosides and i}-Iactams (19. 20). These include vancomycin-resistant Enterococcus faecium 
(VRE), methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Acinetobacter and Pseudomonas 
aeruginosa (19). Thus there is a need for novel antibiotics to treat such infections. Samples No.2 and NO.3 could be 
potentially useful to treat infections caused by Enterococcus, Staphylococcus. Acinetobacter, and Pseudomonas spp. 
Samples No.2 and No.3 may be considered broad-spectrum antibiotics. such as macrolide antibiotics. 
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Fig. 5.6. Silica TLC plates: Left, the colour components of antibiotic samples No. 2 and No. 3; Right, bioautography with M. aurum, showing the 
antimicrobial activity of the antibiotic samples, and the position of the UV-absorbing spots. Solvent system: 95% chloroform: 5% technical 
ethanol (96.4%). 
) 
1_ 
Fig. 5.7. TLC plates showing some physicochemical properties of antibiotic samples No.2 and No. 3: cerium (IV) ammonium sulphate (left) 
detects organic compounds in the sample (black-grey spots); iodine vapours (right) detect organic compounds having carbon-carbon double 
bonds (shades of brown). The red circles indicate the approximate position of the activity spot of interest against M. aurum. 
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Bacillus subtilis subsp. 
subtilis NCIB 3610 
4 x 2.5/11 
sample 
Pseudomonas aeruginosa 
ATCC 27853 
Fig. 5.B. Silica TLC plates showing the antimicrobial activity (zones of clearing) of antibiotic samples No.2 and NO. 3 against B. subtilis (left) and 
P. aeruginosa (right). Solvent system: 95% chloroform: 5% technical ethanol (96.4%). 
5.3.5 Antibiotics from Strains MMS3, MMS4, and MMS·DA 
The results of the overlay experiments suggested that strains MMS3, MMS4, and MMS-DA be further pursued (see 5.3.1). 
The strains were grown in the optimal media indicated by the solid agar overlay results. Broth culture conditions were the 
same as for the agar overlays: the strains were grown at 30°C for 11 days. Bioautography was perfonned with M. aurum, the 
test bacterium of interest. The results are shown in Table 5.6. 
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Table 5.6. Antibiotic activity of strains, grown in the optimal medium suggested by the overlay experiments, at 300 e for 11 days and 
bioautographed against Mycobacterium aurum A+. 
Fifty Times Concentrated Antibiotic 
Sample From: 
Methanol Organic Extract of the 
Cell Mass: 
Chloroform Organic Extract of the 
Cell Mass: 
Specific Medium's Supernatant: 
BM-
Glucose: 
++ 
+ 
MMS4 activity in: 
m172F: 
++ 
++ 
MMP-
S: 
++ 
+++ 
MMP-
F: 
+++ 
Abbreviations: -, no activity; +, weak activity; ++, moderate activity; +++, strong activity. 
MMS3 activity in 
MMP-S: 
MMS-DA activity in 
YEME: 
+++ 
+++ 
It is noticeable that strain MMS3 did not show any activity after being grown in liquid medium under the same conditions the 
agar overlay experiment was performed. Thus, a modified Eli Lilly procedure (5.2.8) was performed using 11 solvents of 
differing polarity, in an effort to detect the antibacterial activity observed in the agar overlays (Table 5.7). 
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Table 5.7. Table of Eli Lilly procedure results, bioautographed against Mycobacterium aurum A+. 
Solvents: 
Water 
Technical 
Ethanol 
(96.4%) 
Absolute 
Ethanol 
(100%) 
Acetic Acid 
Acetone 
Methanol 
n-Butanol 
Chloroform 
Benzene 
n-Hexane 
Toluene 
MMS30n 
MMP-Sat: 
300 e 37°e 
+ 
+ + 
Abbreviations: - , no activity; +, activity. 
MMS-DAon 
YEME at 
300 e 37°e 
+ + 
+ 
MMS40n BM-
Glucose at: 
300 e 37°e 
MMS4 on MMS4 on 
m172F at MMP-S at: 
300 e 37°e 300 e 37°e 
+ + + 
+ + + + 
+ + + + 
+ 
Strain MMS3 exhibited antibacterial activity when water and absolute ethanol (a polar solvent) were used. 
MMS40n 
MMP-F at: 
300 e 37°e 
+ + 
+ + 
The fermentation of the strains in their optimal media was repeated and the supernatant tested for activity against M. aurum 
after development in various solvent systems (Table 5.5). Each of the 6 supernatant samples (MMS3 grown in MMP-S broth; 
MMS-DA grown in YEME broth; MMS4 grown in BM-Glucose, modified 172F, MMP-S, and MMP-F broths) contained only 
one active compound, as TLe revealed the presence of one active spot when experimenting with different solvent systems. 
An optimal solvent system for each of the 6 samples is still to be determined. 
5.4 Conclusion 
Anti-M. aurum antibiotics were shown to be produced by Micromonospora strains MMS2, MMS3, MMS4, MMS7, and MMS-
DA. Thus, 5 out of the 10 Group A strains investigated have antibiotics that should be pursued, as they may have good 
antitubercular activity. The strains that were not investigated further than the overlay experiments (Micromonospora strain 
MMS8 and 7 Streptomyces strains; Table 5.1) should be investigated by performing initial fermentations in the optimal 
medium suggested by the overlays, and an attempt made to isolate the antibiotics. Since the Streptomyces strains were not 
the focus of this study, but do have antimicrobial activity, it would be worth screening them with the battery of peR primers 
discussed in Chapter 4, to attempt to determine the type of antibiotic they may produce. 
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MicromonospofB strains MMS2 and MMS7 produce antibiotic samples No. 2 and No. 3, which were the focus of this 
chapter. By examining the physicochemical properties of the partially purified antibiotic samples, it is clear that many 
contaminating compounds are present in the samples and that further purification must be carried out to isolate the antibiotic 
of interest. These samples are of particular interest because of their broad spectrum activity against many pathogenic 
bacteria. 
Since the optimal solvent system was found for samples No. 2 and No.3, silica column chromatography should be 
performed using 95% chloroform: 5% technical ethanol (96.4%) as the mobile phase. This will allow one to further purify the 
antibiotic compounds. Bioautography will confirm the presence of the antibiotics and repeating the physicochemical tests 
[such as cerium (IV) ammonium sulphate] will give an indication of how many impurities have been removed. 
The genome screening in Chapter 4 showed that both strains MMS2 and MMS7 may have the biosynthetic capability to 
produce gentamiCin-type aminoglycoside antibiotics. The results obtained by working with the antibiotic samples did not 
identify the antibiotic class: the compounds in the samples could be macrolides, aminoglycosides, or novel antibiotic 
compounds. There is evidence for all three suggestions. Nuclear magnetic resonance (NMR) studies will determine the 
structure of the compounds once they have been purified. 
The antibiotics produced by strains MMS3, MMS4, and MMS-DA require much more work, starting with finding an optimal 
solvent system and Rf values for the compounds in the six samples obtained from these strains. Strain MMS4 was positive 
for the grm PCR, indicating the potential ability to produce a gentamicin-type antibiotic. However, the overlay experiments 
showed that great activity was produced on the macrolide production media. 
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Chapter 6 
Conclusion and 
Future Work 
The Klein Estuary (Herman us Lagoon) is a suitable environment for isolating novel Micromonospora strains. The other 
marine environments investigated in this study (Noordhoek Beach; Phuket Island; Plettenberg Bay) yielded additional 
Micromonospora strains, members of the rare acUnomycete genus Pseudonocarrlia, and interesting Streptomyces strains. Of 
the 34 actinomycete strains isolated, 28 are potentially novel species. Nine (9) new species are proposed: 'Micromonospora 
aquatica', 'Micromonospora areninco/ae', 'Micromonospora cinerea', 'Micromonospora grate/oupico/ae', 'Micromonospora 
hermanusense', 'Micromonospora lacunae', 'Micromonospora stanfordense', 'Micromonospora terrae', and 'Streptomyces 
noordhoekensis'. Several of the potentially novel strains showed promising antimicrobial activities against pathogenic 
bacteria. Unexplored marine environments should be further investigated for strains having promising antimicrobial activities. 
The genus Micromonospora was easily isolated on YEME and modified 172F agars supplemented with selective inhibitors to 
reduce the numbers of contaminating Gram-negative bacteria and fungi, and are thus not so rare. Strains that have not been 
fully characterised should have their descriptions completed. The menaquinone profile of the Micromonospora strains should 
be investigated, as this is perhaps the only worthwhile chemotaxonomic feature of the genus that could be used to discern 
between Micromonospora species. Complete 16S rRNA gene sequencing should be undertaken on those strains that do not 
already have complete sequences. Physiological testing on the last 6 strains discussed in Chapter 3 should be completed, 
especially the Pseudonocarrlia strains, so that their novelty can be assessed. 
The genus Micromonospora has few distinctive morphological features and species delineation is difficult. Thus an 
identification key was created to easily determine whether a strain should be pursued by asking if it shares the features of a 
validly published Micromonospora species. The identification key makes use of a few carefully selected physiological tests. 
The key should be used to assess the novelty of every Micromonospora strain isolated, and should be updated and modified 
when new species are described in the literature. A further benefit of the identification key is that standardized media were 
developed for the testing of important phYSiological characters of the genus Micromonospora, such as maximum sodium 
chloride tolerance and the production of diffusible pigments. Additional physiological characters of 15 of the validly published 
Micromonospora species are described, in an attempt to assist with species delineation. It is also of interest that many 
Micromonospora strains do produce aerial mycelia and that almost all of the Micromonospora strains investigated can grow 
under anaerobic conditions. Many of the environmental Micromonospora isolates are capable of using glycerol (1.0% w/v) 
and inositol (1.0% w/v) as sole carbon sources, whereas previously, only Micromonospora purpureochromogenes utilized 
glycerol as a sole carbon source and Micromonospora inositola utilized inositol as a sole carbon source. 
Many strains showed encouraging antimicrobial activity with the overlay experiments. Of the 10 Micromonospora strains 
investigated beyond overlay experiments, 5 produce antibiotics worth pursuing further. The anti mycobacterial activity 
appears promising and testing against M. tuberculosis should be carried out. However, there is no definitive idea at this time 
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as to the identity of the antibiotics in the samples. A macrolide purification protocol was performed on strains MMS2, MMS7, 
and MMS-DA but did not yield antibiotics with strong anti-M. aurum activity. Aminoglycoside purification procedures should 
be performed, and because these antibiotics can be purified by means of ion-exchange chromatography, one could quickly 
confirm if charged antibiotic molecules are present in the samples. However, structure determination by NMR will ultimately 
reveal the class of antibiotic the molecules belong to. 
Aminoglycosides are of special interest because the resistance genes to these antibiotics are part of the biosynthetic cluster 
that synthesises these same antibiotics. The presence of the resistance genes indicates which antibiotic type a strain is 
capable of producing, provided the biosynthetic cluster is actively transcribed. The resistance gene indicating the 
biosynthesis of gentamicin-type aminoglycoside antibiotics (grm) can be detected with PCR primers and a plate assay, which 
complement each other, and are reliable. The neomycin-type detection strategy (fmrT) needs further investigation: Is the 
resistance gene specific to the biosynthetic cluster or can the resistance gene be acquired by many strains? The primers for 
the fmrT PCR are degenerate and would need to be improved, however, there are few gene sequences available from which 
to design primers. The concern when targeting antibiotic resistance genes is that they may not be part of a biosynthetic 
cluster and thus are not indicative of the ability to produce the specific antibiotic. Genes encoding specific molecules 
essential for the synthesis of aminoglycosides could be considered as targets for primer design. However, as mentioned in 
Chapter 4, there are 6 different groups of aminoglycoside antibiotics and it is difficult to target a gene common in all the 
biosynthetic pathways. A pair of primers would have to be designed for each of the different aminoglycoside sub-groups. 
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